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ABSTRACT 
 
Sustaining a fall can be hazardous for those with low bone mass. Interventions exist to 
reduce fall-risk, but may not retain long-term interest. “Exergaming” has become popular 
in older adults as a therapy, but no research has been done on its preventative ability in 
non-clinical populations. The purpose was to determine the impact of 12-weeks of 
interactive play with the Wii Fit® on balance, muscular fitness, and bone health in peri- 
menopausal women. METHODS: 24 peri-menopausal-women were randomized into 
study groups. Balance was assessed using the Berg/FICSIT-4 and a force plate. Muscular 
strength was measured using the isokinetic dynamometer at 60°/180°/240°/sec and 
endurance was assessed using 50 repetitions at 240°/sec. Bone health was tracked using 
dual-energy x-ray absorptiometry (DXA) for the hip/lumbar spine and qualitative 
ultrasound (QUS) of the heel. Serum osteocalcin was assessed by enzyme immunoassay. 
Physical activity was quantified using the Women’s Health Initiative Physical Activity 
Questionnaire and dietary patterns were measured using the Nurses’ Health Food 
Frequency Questionnaire. All measures were repeated at weeks 6 and 12, except for the 
DXA, which was completed pre-post. RESULTS: There were no significant differences 
in diet and PA between groups.  Wii Fit® training did not improve scores on the 
Berg/FICSIT-4, but improved center of pressure on the force plate for Tandem Step, Eyes 
Closed (p-values: 0.001-0.051). There were no significant improvements for muscular 
fitness at any of the angular velocities. DXA BMD of the left femoral neck improved in 
the intervention group (+1.15%) and decreased in the control (-1.13%), but no other sites 
had significant changes. Osteocalcin indicated no differences in bone turnover between 
groups at baseline, but the intervention group showed increased bone turnover between 
i 
ii  
weeks 6 and 12. CONCLUSIONS: Findings indicate that WiiFit® training may improve 
balance by preserving center of pressure. QUS, DXA and osteocalcin data confirm that 
those in the intervention group were experiencing more bone turnover and bone 
formation than the control group. In summary, twelve weeks of strength /balance training 
with the Wii Fit® shows promise as a preventative intervention to reduce fall and fracture 
risk in non-clinical middle aged women who are at risk. 
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Chapter 1 
INTRODUCTION 
 
 
 
Falls can result in muscular injury, head injury, or other impairments, but sustaining a fall 
for those who have weak bone can have serious, if not fatal, consequences. At the onset 
of menopause, there is typically an accelerated bone loss that makes some women even 
more susceptible, or "at risk", for serious consequences related to loss of balance and 
falls, such as a hip or vertebral fracture (Downey, Perry, & Anderson, 2012). Currently, 
the medical costs related to falling are approximately $25 billion, and by 2020, the 
healthcare costs associated with falling are estimated to exceed $54.9 billion (Stevens, 
Corso, Finkelstein, & Miller, 2006; Englander, Hodson, & Terregrossa, 1996). This 
estimate includes both direct costs, such as medical treatment and rehabilitation, and 
indirect costs, such as lost work time or impairments in quality of life. 
 
 
 
A resulting fracture, particularly hip fracture, is the major direct medical expenditure that 
occurs from a fall. Approximately 1/3 of nonfatal fall injuries are fractures and the 
medical costs of fracture accounts for 61% of all nonfatal fall healthcare expenditures 
(Stevens et al., 2006). So while fracture only comprises a third of fall-related injuries, it is 
responsible for greater than 50% of the medical expenses associated with falls. One of the 
greatest predictors of suffering a fall-related fracture is low bone mineral density (BMD), 
which is often observed in older women, following the onset of menopause (Downey et 
al., 2012). 
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Fall risk is a multi-faceted problem, involving physiological, psychological, and 
neurocognitive changes that influence a person’s ability to properly interact with his or 
her environment. However, one suggested technique for preventing falls is to improve 
whole body balance.  While many exercise programs and interventions currently exist 
with the goal of improving balance and decreasing fall risk, many of them are 
hospital/clinic-based, and typically target geriatric populations (Howe, Rochester, Neil, 
Skelton, & Ballinger, 2011). In addition, these interventions typically require fairly 
monotonous exercise procedures that fail to arouse enough long-term interest to elicit the 
intended improvements. In other words, while the exercise intervention may be 
beneficial, participants quit before they can realize substantial gains. 
 
 
 
The Wii Fit® game and balance board includes various strength and balance exercises 
integrated into games and competitions which are intended for the participant to have fun 
and retain interest, while also improving fitness. Its interactive game system includes 
many exercises that are typically included in traditional rehabilitation or therapy-based 
balance and muscular endurance improvement programs, but it uses an interactive 
interface. The Wii Fit® requires the participant to practice controlling their movement and 
center of pressure (balance) while using a fun, gaming-type interactive approach which 
makes completing exercise training goals more appealing. The system also provides 
immediate feedback to the user, which can take the form of tips, suggestions, 
encouraging phrases, or actual visual depictions of the user’s movements. 
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Currently, no evidence exists regarding the efficacy of the Wii Fit® as a means to  
improve balance, strength and bone health in a middle-aged, non-clinical population. This 
study proposes to utilize the Wii Fit® balance game as an exercise intervention to  
improve balance and bone health of those at-risk for age related bone loss. This novel, 
technology-based intervention has clear public health importance as it can be easily used 
at home for primary fall prevention or integrated into standard rehabilitation and 
treatment practices. Long-term, it could be developed as a community-based intervention 
tool to promote balance and fitness training in a preventative sense, potentially reducing 
the healthcare burden related to falls and fracture later in life. 
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PURPOSE 
 
To evaluate changes in balance and muscular endurance in middle-aged women with low 
bone mass randomly assigned to a 12-week home-based exercise intervention 
incorporating the Wii Fit® balance game as compared to a sedentary control group. 
 
 
 
SPECIFIC AIMS 
 
Primary Aim. To determine the effectiveness of interactive play using the Wii 
Fit® game system over a 12-week study period on balance in middle-aged women as 
compared to a randomly assigned control group. 
 
 
 
Secondary Aim 1. To determine the effectiveness of interactive play using the 
Wii Fit® game system over a 12-week study period on muscular strength and endurance 
of the leg extensors and flexors in middle-aged women as compared to a randomly 
assigned control group. 
 
 
 
Secondary Aim 2. To assess potential changes in bone formation through bone 
stiffness index as measured by qualitative ultrasound of the Os Calcis (heel). 
 
 
 
Secondary Aim 3. To assess potential changes in bone turnover (formation and 
breakdown) through biochemical analyses of serum osteocalcin and c-telopeptide (CTX). 
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HYPOTHESES 
 
Primary Aim 1. 12 weeks of interactive play will significantly improve balance 
in middle-aged women as compared to a randomly assigned control group. 
 
 
 
Secondary Aim 1. 12 weeks of interactive play will significantly increase 
muscular strength and endurance of the leg extensors and flexors in middle-aged women 
as compared to a randomly assigned control group. 
 
 
 
Secondary Aim 2. 12 weeks of interactive play will significantly increase bone 
health parameters at the Os Calcis, as measured by qualitative ultrasound, and site- 
specific measures of bone health, as measured by DXA, in middle-aged women as 
compared to a randomly assigned control group 
 
 
 
Secondary Aim 3. 12 weeks of interactive play will significantly increase bone 
turnover (increase serum osteocalcin) in middle-aged women as compared to a randomly 
assigned control group. 
 
 
 
DELIMITATIONS 
 
The study was delimited to peri-menopausal women between the ages of 45-60 who did 
not have a diagnosis of osteoporosis but who had indications of low bone mass based on 
a DXA t-score of less than 0.  Participants were able-bodied and could not have 
contraindications to standing or walking. No women in the study were to take any 
hormone replacement therapy drugs. Participants were required to have transportation, 
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have a TV set in their home that is appropriate for use with the Wii Fit® device, and have 
enough room in their home to have the device set up to be played daily. All had to be able 
to read and write in English. 
 
 
 
LIMITATIONS 
 
The study was a convenience sample of volunteers. Study participants were asked not to 
change their daily physical activity, other than that prescribed to those in the intervention 
group, for the 12 weeks of the study. Study participants were asked not to change their 
medications, supplement use, or general diet for the 12 weeks of the study. However this 
was only validated with a verbal confirmation and the Food Frequency Questionnaire. 
 
 
 
DEFINITIONS 
 
Area Effective: the area that encompasses 66% of the total balance ellipsis. 
 
 
 
 
Berg Balance Scale: an assessment tool used to estimate fall risk and dynamic balance. 
A score of less than 45 out of 54 is considered to be “at-risk” for sustaining a fall. 
 
 
 
Broadband Ultrasound Attenuation (BUA): the relationship between the dampening of 
the amplitude of the qualitative ultrasound sound wave in conjunction with the decrease 
in wave speed, and is expressed as dB/MHz 
 
 
 
DXA: dual-energy x-ray absorptiometry is a skeletal imaging and assessment tool to 
measure bone density and skeletal health. 
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Dynamic Balance: is the ability to manage center of gravity and total body balance while 
moving. 
 
 
 
Exergaming: is participating in physical activity- or exercise-based video games (Wii 
Fit®, Xbox Kinect®, etc.). 
 
 
 
Fatigue Index: drop in peak torque from the first knee extension-flexion cycle to the last. 
 
 
 
 
FFQ: Food Frequency Questionnaire is a brief battery of questions used to assess typical 
dietary patterns. 
 
 
 
FICSIT-4: Frailty and Injuries: Cooperative Studies of Intervention Techniques is an 
assessment tool used to estimate fall risk and static balance. The test is scored out of 28, 
but there are no cut-off criteria to define fall-risk, although higher numbers are associated 
with lower risk. 
 
 
 
Major Axis: the length of the major axis of movement within the overall center of 
pressure ellipsis. 
 
 
 
Menopause: process by which menarche ceases for reasons other than dietary issues, 
underlying medical conditions, or surgical removal of reproductive organs. 
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Osteoblast: bone cell responsible for the deposition of skeletal tissue and minerals during 
bone formation. 
 
 
 
Osteocalcin: a metabolic marker representative of osteoblastic cellular activity and bone 
formation. 
 
 
 
Osteoclast: bone cell responsible for the breakdown and resorption of skeletal tissue and 
minerals during bone remodeling. 
 
 
 
Osteopenia: lower than “normal” bone mass, but not progressed enough to diagnose 
osteoporosis; at-risk for osteoporosis. 
 
 
 
Osteoporosis: a clinical diagnosis of a weakening of the skeletal system; clinically low 
bone mass. 
 
 
 
Perimenopausal: women between the ages of 45-65 who are either a) within one year of 
beginning menopause, b) currently experiencing menopause, or c) one year post- 
menopause. 
 
 
 
Qualitative Ultrasound (QUS): qualitative ultrasound is a form of bone imaging 
technology that uses ultrasound waves to measure bone quality. 
 
 
 
Remodeling: the breakdown and rebuilding of skeletal tissue. 
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Resorption: the process of bone tissue breakdown and the release of skeletal minerals in 
the bloodstream. 
 
 
 
Speed of Sound (SOS): the change in the velocity of the ultrasound sound wave, and is 
expressed in m/s. 
 
 
 
Static Balance: the ability to manage center of gravity and total body balance while 
standing or remaining still. 
 
 
 
Stiffness Index (SI): is a measure of bone quality, and is a mathematical derivation using 
both BUA and SOS. 
 
 
 
T-score: A standard deviation from the mean for young adults, adjusted for gender and 
ethnicity. It is derived from bone mineral density value from DXA and from stiffness 
index value from QUS. 
 
 
 
Z-score: A standard deviation from the mean for a particular age group, adjusted for 
gender and ethnicity. It is derived from bone mineral density value from DXA and from 
stiffness index value from QUS. 
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Chapter 2 
REVIEW OF LITERATURE 
 
 
FALL-RISK 
 
Multi-faceted aspects of falling. With age, there are a variety of physiological 
changes that may occur that can impact balance. Approximately 130 independent risk 
factors have been identified as contributors to changes in balance and age-associated fall- 
risk (Carter, Kannus, & Khan, 2001). Generally speaking, the elements that seem to have 
the greatest influence on balance ability are declines in the visual/ vestibular/ 
somatosensory systems along with declines in lean muscle mass (Carter et al., 2001). 
These changes can create problems with older adults in regards to interacting with the 
environment and identifying/avoiding obstacles, such as curbs or debris on walkways. 
Even if the visual system is still functioning adequately, musculoskeletal declines can 
decrease total-body balance and increase the risk of sustaining a balance-related fall 
(Carter et al., 2001). 
 
 
 
One of the more obvious manifestations of declining balance is postural sway, or a large 
degree of postural instability, while walking or standing. One explanation for postural 
sway is related to the decrease in neuromuscular tone that accompanies aging. A 
reduction in neuromuscular tone results in an overall greater need for muscle activation 
and increased muscle fiber recruitment to initiate or sustain any movement (Laughton et 
al., 2003). This excess energy expended for any muscular movement then limits the 
amount of energy available for continuous or sustained muscular control that is necessary 
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for stable, upright posture (Laughton et al., 2003). Additionally, greater motor 
recruitment and limited neural availability can decrease reaction time and reduce 
muscular force production (Patla et al., 1993).Thus, in those with reduced neuromuscular 
tone, even if an obstacle is identified appropriately, the declines in neuromuscular activity 
may hamper the ability to react and lessen the ability to make quick directional changes  
to avoid an obstacle while maintaining balance (Patla et al., 1993). 
 
 
 
Exercise and balance/fall risk. Evidence for the use of exercise interventions to treat 
balance impairments and prevent fall-risk appears to be promising. Current research 
indicates that for a balance intervention to be successful, it needs to target several aspects 
related to balance and falls. Traditionally, balance therapy consisted of standardized 
balance exercises (standing on one foot, tandem walking, standing with eyes closed, etc.) 
and resistance training along with activities to improve spatial awareness are also 
recommended (Chang et al., 2004). Howe, Rochester, Jackson, Banks, and Blair (2007) 
concluded that such interventions, when put into either home-based or rehab-based 
programs, are successful in reducing balance-related falls. Specifically, therapies that 
included a strength or resistance training exercise program in addition to standard balance 
training significantly improve balance outcomes over standard balance therapy alone 
(Howe et al., 2007). 
 
 
 
However, changes in muscular strength may not be necessary for improvements in 
balance and fall-risk. Barnett, Smith, Lord, Williams, and Baumand (2003) developed a 
year-long stepping, throwing, and Tai Chi intervention for older adults to improve 
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balance and decrease falls. At the end of the intervention, those in the exercise group had 
improved balance and spatial awareness compared to the control group, although there 
were no changes in muscular strength or lean muscle mass. Despite this, those in the 
intervention group had a 44% lower incidence of falls than the control during study 
follow-up (Barnett et al., 2003). 
 
 
 
Components of falling. As previously noted (Carter et al., 2001), there are several 
components related to fall-risk.  Figure 1 displays the major categorical components and 
some interactions between the factors related to fall-risk. Some factors are known to be 
directly associated with falling such as motor control and muscular fitness, while other 
physiological and psychological factors may indirectly influence falling by influencing 
gait or mobility. In addition most risk factors are inter-related. 
 
 
 
Two components that are strongly inter-related in regards to fall-related fracture are 
muscular fitness (strength and endurance) and balance. Figure 1 depicts a feedback 
system between muscular fitness and balance indicating that physical inactivity and 
deconditioning lead to muscular impairment which negatively impacts neural control 
resulting in disrupted joint movements and gait patterns. Disrupted gait patterns as a 
result of weak muscles, can result in gait instability, which can lead to an increased risk 
for falls. 
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Figure 1. Components of Fall-Risk 
 
Adapted from:  Hausdorff, J. M. (2005). Gait variability: methods, modeling and 
meaning. Journal of NeuroEngineering and Rehabilitation, 2(1), 19. doi:10.1186/1743- 
0003-2-19. 
 
 
 
Additionally, it is known that a history of previous falls increases the subsequent fear of 
falling (Tsur et al., 2013.  This fear of falling can lead to heightened anxiety with 
physical activity in general. This resulting inactivity leads to a negative cycle of further 
deconditioning and further muscle loss, resulting in more gait instability and more falls. 
At the core of this negative behavioral spiral is a person’s underlying bone health.  As 
seen in Figure 1, bone health may also be an important predictor of falling as it is 
considered be a component of the “limbs/joints” subsection. While it is true that low 
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bone mass may not necessarily cause a fall, it is known that a weak skeleton is clearly 
more likely to fracture as the result of the fall and will require increased recovery time 
after sustaining a fall. Thus in one with low bone mass, a previous fall may not only 
increase their fear of falling, but when coupled with a lengthening of the recovery period, 
further increases inactivity and deconditioning thereby perpetuating and elevating the risk 
for future falls. 
 
 
 
MUSCULAR STRENGTH AND ENDURANCE 
 
Muscular strength and endurance are two components of muscular fitness that have been 
implicated as necessary for maintaining independence and completing activities of daily 
living. Simple tasks, such as climbing a flight of stairs, require muscular endurance, 
while opening a jar is more dependent on muscular strength. While younger adults 
typically do not struggle with these sorts of tasks under normal conditions, the muscle 
loss that accompanies aging can make these everyday tasks challenging or near 
impossible to complete without assistance. 
 
 
 
Sarcopenia. One of the issues related to a loss of balance and falls is the age-related 
decline in muscle mass, or sarcopenia. As addressed previously, older adults lack 
neuromuscular tone as compared to younger adults, which can make balance and 
maintaining posture difficult (Laughton et al., 2003). However, declines in muscle mass 
can also decrease muscular strength and endurance, which could also lead to difficulties 
in completing activities of daily living, as well as contributing to mobility and balance 
issues. 
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Generally defined, sarcopenia is the slow and progressive loss of lean muscle mass 
associated with the aging process (Ryall, Scherter, and Lynch, 2008). Unlike other age- 
related conditions, there is currently no medically accepted diagnostic definition of 
sarcopenia. Because loss of muscle mass is relative to a person’s frame size, gender, and 
activity level, it is difficult to quantify an amount of loss that would be classified as 
significant or as impairing daily function. However, the European Working Group on 
Sarcopenia in Older People (EWGSOP) has developed a working definition that 
encompasses total lean mass in conjunction with low muscular strength and endurance 
(Cruz-Jentoft et al., 2010). 
 
 
 
Exercise for improving muscular strength and endurance. Sedentary behavior and a 
lack of weight-bearing or resistance exercise are both considered to be risk-factors for the 
development of sarcopenia. Like many of the declines in function related to aging, proper 
exercise or physical activity can help slow the progression, but not eliminate the 
condition completely. Even those who remain highly physically active through the 
lifespan, such as Master class athletes, will still progressively lose muscle mass with age 
(Ryall et al., 2008). However, those who do participate in load-bearing activity through 
older adulthood typically experience better health outcomes than those who do not and 
are able to slow muscle loss (Shephard, Park, Park, & Aoyagi, 2013) 
 
 
 
Longitudinal data in older Japanese adults (65-84 y.o.) demonstrated that those who were 
walking 7000-8000 steps/day, or participating in a minimum 15-20 minutes of structured 
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exercise per day at an intensity greater than 3 METs, were 2.3-3.0 times less likely to 
develop sarcopenia than those who were sedentary or had less activity that those 
threshold values (Shephard et al., 2013).  Similarly, participants enrolled in the Research 
on Osteoarthritis/osteoporosis Against Disability (ROAD) study found that exercise 
habits beginning in middle-age were strong predictors of sarcopenia risk. In 1000 older 
adults, while lean muscle decreased across all study participants, those who reported 
regular physical activity in middle-age experienced less impairment, and had greater 
handgrip strength (p < 0.001) and one-leg standing time (p = 0.005) (Akune et al., 2013). 
 
 
 
Structured activity also has been shown to not only maintain some lean mass, but also 
increase muscle size and strength in older adults. Eighteen older adults were randomized 
into one of two groups: Group 1 performed very low-intensity (30% 1-repition max 
(1RM) knee extension exercise with continuous muscle contraction (3-second (3-s) 
eccentric, 3-s concentric, and 1-s isometric actions with no rest between reps). Group 2 
performed intermittent muscle contraction (1-s concentric and 1-s eccentric actions with 
1-s rest between each rep) for the same time period. Both groups performed these 
exercises twice a week over the course of 12 weeks (Watanabe, Madarame, Ogasawara, 
Nakazato, & Ishii, 2013).  At the end of the study, those in the low intensity group 
increased their muscle size as compared to the control, although the exercise load was 
considered to be very low. 
 
 
 
The activity can even be as infrequent as once per week, and still demonstrate some 
improvement in lean muscle mass. Thirty-three older adult men were randomly assigned 
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to either an intervention group, which consisted of completing seven exercises once per 
week (bench press, leg press, latissimus dorsi pull-down, leg extension, military press, 
leg curl, and arm curl) at 65-75% of one-repetition max (1-RM) or to a control group 
(Sousa, Mendes, Abrantes, Sampaio, & Oliveira, 2013). At the end of the 32-week study 
period, those in the intervention group had a cumulative strength gain exceeding 67% at 
the 32-week period, and 2.9% decrease in body fat from weeks 8-32 (Sousa et al., 2013). 
 
 
 
BONE HEALTH 
 
The aging process is associated with a variety of physiological changes that can increase 
the likelihood of sustaining a fall, such as declines in muscular strength and endurance 
and loss of regulation of center of pressure. However, the risk of sustaining a fracture as a 
result of a fall is often a function of bone mass at the site of impact (Christen et al., 2013). 
Bone loss typically occurs at the onset of menopause for women and after the age of 65 
for men, and both incidences may be due to disruptions in estrogen signaling and 
production (Khosla, 2012). The pathogenesis of bone loss is not identical for all 
individuals, but is a combination of dietary deficiencies, hormonal disruptions, lack of 
weight-bearing exercise, metabolic disorders, or other underlying disease states (Khosla, 
2012). However, regardless of the physiological reason, the mechanism behind age- 
related bone loss is the uncoupling of the cellular balance between osteoblastic and 
osteoclastic cells. Especially in women, age impairs osteoblast differentiation and cellular 
activity, partially due to hormonal deficiencies, and increased osteoclastic activity (Chan 
& Duque, 2002). 
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Bone remodeling regulation. Bone tissue is extremely metabolically active, yet slow- 
moving, in regards to cell turnover and remodeling. While many may view the skeletal 
system as static, bone undergoes multiple regenerative cycles over the course of a 
lifetime.  The actual process of bone remodeling involves both the breakdown/resorption 
and the replacement of pockets of old/damaged bone tissue, and it is estimated that the 
entire skeleton is remodeled every 10 years (Manolagas, 1999). There are two major cell 
types involved in the regulation and process of bone remodeling: osteoclasts and 
osteoblasts. Osteoclastic cells are responsible for bone breakdown and resorption, while 
osteoblasts re-ossify the skeletal matrix and deposit new bone tissue. While the process of 
“building up” and “breaking down” bone may seem relatively straightforward, it is 
actually an incredibly complex and dynamic system that requires “cross-talk” between 
cell types as well as a variety of mechanical and hormonal cues. 
 
 
 
During the developmental years, the skeleton is soft and somewhat pliable. This is 
necessary to allow for the rapid growth necessary to support an adult-sized frame. In 
childhood, the osteoblastic activity greatly outpaces the osteoclastic activity, due to the 
high rate of skeletal deposition to allow for the ossification of the skeletal system (Frost, 
1985). Once peak bone mass is achieved (typically at the end of puberty), there is a tight 
regulation between the osteoclasts and osteoblasts that maintain skeletal mass. However, 
with age, osteoclastic activity becomes more prominent, leading to increased bone 
breakdown that is not as easily matched by osteoblastic cells. This can lead to loss of 
bone mass and weak/brittle skeletal tissue (Frost, 1990). Although bone resorption is 
increased, the system is still tightly maintained to attempt to prevent excessive and rapid 
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bone loss. The only exception to this is in the case of metabolic bone disorders or the use 
of osteoporotic drugs, which inhibit bone turnover at both the osteoblastic and 
osteoclastic level. 
 
 
 
The cues for bone turnover are related to many factors including hormonal signals and 
mechanical strain. In regards to mechanical load and strain, such as from bone loading 
forces or from small microfractures within the osteocyte, the regulatory system is able to 
target a specific site for remodeling (Hadjidakis & Androulakis, 2006). During the 
remodeling process, Basic Multicellular Units (BMUs), which are comprised of both 
osteoblasts and osteoclasts, form tunnels in the portions of bone that need repair. Ten 
osteoblastic cells dig a small circle in the surface of the bone that needed to be repaired, 
and that area is then filled with thousands of osteoblastic cells (Frost, 1997). Regardless 
of whether the turnover is initiated by hormones or mechanical forces, the process of 
bone remodeling is identical. 
 
 
 
Cellular signaling. The major signal to start the process of remodeling is 
osteocyte death within the skeletal matrix, which often results from  the formation of 
microcracks within the osteocyte itself (Martin & Seeman, 2008). The actual process of 
bone remodeling occurs in three phases: resorption, reversal, and formation. The 
resorption phase is activated by the migration of partially differentiated mononucleated 
preosteoclasts to the bone surface. At the surface of the bone, the cells become 
multinucleated and begin the actual process of bone resorption (Hadjidakis & 
Androulakis, 2006). Dead cells and deposited minerals are broken down and released into 
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the blood stream by the now-nucleated osteoclast cells. Following the resorption of all 
targeted tissues, the reversal phase is activated by the presence of mononuclear osteoblast 
cells. These cells signal osteoblast activity and osteoblast formation/differentiation. After 
the activation of the osteoblastic cells, the formation phase begins. This involves the 
saturatation of the exposed bone matrix with mature osteoblastic cells, which replace all 
minerals and structural cells that were lost during resorption. Flattened lining cells then 
coat the bone surface, and remain in a dormant phase until another remodeling cycle at 
that site is activated (Hadjidakis & Androulakis, 2006). The entire process from signaling 
of resorption to the deposition of flattened lining cells takes approximately 4 months. 
 
 
 
To ensure that the osteoblastic and osteoclastic cells work in equilibrium, a complex 
coupling system exists. The actual resorption phase is activated by osteoclasts at either 
the cell surface or the marrow, which signal the migration of the partially differentiated 
preosteoclasts to the cell surface. These signaling cells then change shape and secret 
enzymes that digest the proteins that are bound to the cell surface, in addition to secreting 
r eceptor activator of nuclear factor kappa-B ligand (RANKL). RANKL is responsible for 
the differentiation to multi-nucleated osteoclasts, which are the cells actually responsible 
for the resorption of bone (Hsu et al., 1999). At some point during the resorption phase, 
osteoprotegerin (OPG) is produced by the osteoblasts and preosteoblasts, which blocks 
RANKL and activates osteoblast apoptosis (Hofbauer & Schoppet, 2004). The exact 
mechanism behind the onset of secretion of OPG is not entirely understood, but the 
current hypothesis is that there may be metabolic markers of bone resorption that activate 
osteoblasts within the marrow at high levels (Hadjidakis & Androulakis, 2006). Once 
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OPG is secreted and RANKL activity is blocked, the mononuclear osteoblast cells are 
able to migrate to the bone surface to begin the reversal and formation phases. 
 
 
 
Hormonal and protein influence: systemic and local regulation. In general, bone 
remodeling at the systemic level is controlled through a variety of hormonal pathways. 
The hormone with perhaps the greatest impact of skeletal health is parathyroid hormone 
(PTH), which is directly implicated in calcium homeostasis. PTH signals bone resorption 
and renal calcium uptake during times of low blood calcium levels, but it is also able to 
stimulate bone formation. Continuously elevated PTH activates calcium uptake and bone 
resorption, while intermittent PTH spikes signal bone formation (Kim 2003). Also at the 
systemic level, calcitonin, calcitriol, and thyroid hormones all impact calcium regulation 
via absorption in the intestines and the kidneys. The other hormone group most directly 
related to bone turnover is the estrogens. Specifically, estrogens decrease osteoclast 
progenitor cells’ responsiveness to RANKL, thereby decreasing osteoclast formation and 
bone resorption. Additionally, estrogens stimulate osteoblast formation and suppress 
osteoblast apoptosis (Manolagas, 2000). 
 
 
 
Local regulation, as mentioned previously, is controlled via RANKL and OPG activity at 
the cellular surface. However, cytokines are necessary for appropriate cellular coupling 
and protein regulation. The primary cytokines necessary for the cross-talk are tumor 
necrosis factor α (TNF-α) and interleukin-10 (IL-10). These work by activated 
macrophage colony stimulating factor (MCSF), which is necessary for osteoclast 
differentiation (Hofbauer et al., 1999). Another important cytokine is interleukin-6 (IL-6), 
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which is secreted by both osteoblastic and osteoclastic cells. IL-6 typically stimulates 
bone resorption by the osteoclasts, but under the condition of high bone resorption, IL-6 
is also able to promote bone osteoblast formation and differentiation (Moonga et al., 
2002). 
 
 
 
Genetic and modifiable osteoporotic fracture risk factors. With increasing 
age, the risk of osteoporotic fracture generally increases due to a variety of physiological 
changes. The population considered to be most at-risk for developing a non-traumatic 
fracture is typically post-menopausal Caucasian and Asian women (Cumming & 
Klineberg, 1994), but osteoporosis can impact all ethnicities, genders, and ages. The risk 
for sustaining a fracture is multi-faceted, involving a combination of physiological 
changes, lifestyle factors, and genetic predisposition. Of all of the risk factors for 
osteoporotic fracture, the one most often associated with increased risk is impaired bone 
health or low bone mass. 
 
 
 
Bone mass. Both bone mass and bone quality change with age. Throughout life, a 
complex system of mechanical and hormonal signals maintains skeletal structure, 
constantly turning over old cells. The process of “breaking down” and “building up” of 
skeletal tissue is referred to as remodeling. During development and ossification of soft 
skeletal tissues, the “building up” tends to outpace the “breaking down,” which allows for 
gains in skeletal strength. Through young adulthood, the processes are closely matched to 
maintain peak bone mass. However, after menopause for women and in the elderly years 
for men, the coupling system can become disrupted, which leads to more bone being 
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resorbed than is replaced (Frost, 1985). This can lead to weakening of the skeletal 
structure, and eventually, osteoporotic fracture. Bone health is typically tracked via dual- 
energy x-ray absorptiometry (DXA), which provides information regarding both bone 
mineral density (BMD) and bone mineral content (BMC). BMD is often the variable 
more closely associated with impaired bone health. 
 
 
 
There is a large body of work to suggest that low BMD is a cause for concern in regards 
to sustaining an osteoporotic fracture. For both men and women, some evidence suggests 
that the relative risk (RR) of sustaining an osteoporotic fracture increases by 3-4 fold for 
every one standard deviation (SD) decrease in femoral neck BMD (Nguyen, 
Pongchaiyakul, Center, Eisman, & Nguyen, 2005). Similarly, Johnell et al. (2005) 
showed that in a population of approximately 40,000 older adults across 12 prospective 
cohort studies, the RR of sustaining a hip fracture increased by 1.4 for every one SD 
decrease in BMD at the femoral neck. 
 
 
 
Body size and lifestyle factors. Despite the clear importance of bone mass, the 
risk of sustaining an osteoporotic fracture is more complicated than BMD alone. The 
Fracture Risk Assessment Score (FRAX) was developed to screen for a variety of clinical 
and epidemiological risk factors to assess for true fracture risk over a 10-year period 
(Fardellone, 2008). The proponents of the assessment tool noted that the women who 
were sustaining osteoporotic fracture were often not the ones with the lowest BMD 
scores, indicating that other factors may play an equally important role in fracture risk 
(Fardellone, 2008). The FRAX was developed using over 60,000 older adults from 12 
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prospective cohort studies, and it currently screens for total body BMD, height, weight, 
gender, age, family history, smoking status, alcohol use, and glucocorticoid use 
(Fardellone, 2008). 
 
 
 
Each of these risk factors identified in the FRAX have evidence to support their 
implication in osteoporotic fracture risk. To date, most clinicians and researchers are well 
aware that age, gender, family history, and BMD are highly associated with fracture risk. 
However, recent research has indicated that body size and body mass may play a critical 
role as well. De Laet et al. (2005) studied the same 60,000 adults from the 12 prospective 
cohort studies used to develop the FRAX, and found that body mass index (BMI) had a 
large impact on lifetime fracture risk. Those with a BMI of 20 had a 2-fold greater risk of 
sustaining a hip fracture than those with a BMI of 25. Other research has shown that body 
size may actually be more critical than body mass. Sordia et al. (2004) found that in a 
population of post-menopausal women, low height and low weight were associated with 
greater fracture risk, regardless of BMI. Maintaining weight and weight loss are also of 
concern. In a study population consisting of both older men and women, losing weight as 
an older adult was more likely to result in an osteoporotic fracture than remaining weight 
stable or losing weight (Cumming & Klineberg, 1994). 
 
 
 
Lifestyle factors, such as smoking status and alcohol use, also appear to play a large role 
in lifetime fracture risk. Several studies have documented the detrimental impact of 
smoking on bone health, but the largest study to date, analyzing over 60,000 older adults, 
found that the RR of sustaining any fracture for smokers was 1.25, with non-smokers 
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serving as the reference group.  This risk was lowered to 1.13 once adjustments for BMD 
were made, but the risk remaining significantly elevated over that of non-smokers (Kanis, 
Johnell et al., 2005). The results for alcohol consumption, using the same 60,000 older 
adults from the 12 prospective cohort studies, also found a detrimental effect. High 
alcohol consumption, defined as drinking greater than two units per day, had a RR of 
1.38 for both men and women as compared to moderate drinkers and abstainers (Kanis, 
Johansson et al., 2005).  A unit can range from 25ml to 284 ml depending on the type of 
alcoholic beverage, which hard alcohols having less volume per unit that beer or wine. 
However, age and BMD did not influence the model, indicating that alcohol consumption 
appears to affect fracture risk in ways aside from decreasing BMD (Kanis, Johansson et 
al., 2005). 
 
 
 
The last screening criterion on the FRAX, glucocorticoid use, also appears to negatively 
impact bone health. It has been shown that premenopausal women (18-45 y) who used 
glucocorticoid inhalers in the treatment of asthma had impaired BMD at the femoral neck 
(Israel et al., 2001). For every puff per year, the women on the glucocorticoid therapy lost 
approximately 0.00044 g/cm2 of bone mass at the proximal femur. The study was 
controlled for oral glucocorticoid use, and none of the women suffered from any 
condition known to impair bone metabolism. 
 
 
 
Physiological changes. Another main risk factor for sustaining osteoporotic 
fracture is changes in physiology, such as loss of muscular strength and endurance or 
cognitive decline. Older men and women (>60 y) were followed for a total of 12 years to 
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determine which factors were most associated with fracture risk. The authors found that 
quadriceps/lower limb weakness and high degree of postural sway were highly correlated 
with fracture (Nguyen et a., 2005).  In regards to cognitive function, first-time, non- 
traumatic fracture patients and healthy, age-matched controls were assessed to identify 
any physiological differences that may explain the fracture. Poor scores on the mini- 
mental state examination, along with poor handgrip strength and low BMD, were 
associated with increased fracture risk (Lan et al., 2010). 
 
 
 
Nutritional Deficiencies. Due to the fact that skeletal tissue is constantly undergoing 
resorption and remodeling, the appropriate intake of a variety of vitamins and minerals 
are necessary to maintain skeletal integrity. Several nutrients have been identified as 
contributing to skeletal health, and their roles vary from actually composing the skeletal 
matrix to regulating cellular activity and mineral deposition. More vitamins and minerals 
are determined to be “bone essential” as more research is conducted, but currently there 
is evidence to confirm the importance of three vitamins and minerals: calcium, vitamin 
D, and phosphorus. 
 
 
 
 
 
 
Calcium, vitamin D, and phosphorus. Perhaps the mineral most often associated 
with bone health is calcium. The importance of calcium is due to the fact that it 
comprises the majority of the structural integrity of the skeleton. Hydroxyapatite, the 
naturally-occurring mineral form of calcium apatite, is responsible for approximately 
40% of skeletal mass and is the major form of stored calcium (Zhu & Prince, 2012). 
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However, calcium ions have a variety of functions in the body, aside from lending 
strength to bone, that require appropriate circulating levels in the bloodstream. In 
childhood, calcium deficiency has an obvious visual manifestation through the 
development of rickets, but adult deficiency can often go undetected and result in 
impaired bone structure or osteoporosis (Price, Langford, & Liporace, 2012). 
 
 
 
The pathophysiology of the development of osteoporosis is due to increased bone 
resorption and inadequate bone deposition. When calcium levels in the bloodstream are 
low, parathyroid hormone (PTH) sends a signal to increase renal calcium 
uptake/resorption. If calcium needs are still not met, further PTH stimulation signals for 
calcium release from the long bones (Zhu & Prince, 2012). If the calcium deficiency is 
quickly addressed via dietary replacement, there is no long-term damage to the skeleton. 
If deficiency is long-term then bone is not properly remodeled and bone can become 
brittle (Zhu & Prince, 2012). When PTH signals for calcium release, it targets healthy, 
strong bones to meet calcium needs rather than weaker sites that may require remodeling. 
Therefore, healthy sites are weakened and unhealthy sites remain impaired as cellular 
activity is focused on release rather than repair (Zhu & Prince, 2012). Once the formation 
stage of remodeling begins, if there is not sufficient calcium available, the site is 
remodeled without an equivalent calcium replacement for what was lost. 
 
 
 
The next nutrient closely associated with bone health and osteoporosis is vitamin D. 
Unlike calcium, vitamin D is not necessary for skeletal structure, but instead has a 
regulatory role for calcium uptake and homeostasis (Dawson-Hughes & Bischoff-Ferrari, 
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2007). Like calcium, vitamin D deficiency can result in rickets or osteoporosis, but the 
disease state is a result of a secondary calcium deficiency rather than a vitamin D 
deficiency, per se. Insufficient vitamin D impairs calcium uptake, which then reduces 
calcium availability for other functions, such as skeletal deposition. Also, if calcium 
levels in the bloodstream are low, low vitamin D could result in bone resorption, even if 
dietary calcium intake is sufficient (Price et al., 2012). Aside from vitamin D’s role in 
calcium uptake, it may also be important for calcium/phosphorus homeostasis. Vitamin D 
may influence activation of vitamin D receptor signaling for fibroblast growth factor (fgf) 
23 (Lieben & Carmeliet, 2013). fgf 23 has been implicated in the maintenance of 
appropriate calcium/phosphorus levels to ensure appropriate mineral uptake, transport, 
and deposition in the skeleton (Lieben & Carmeliet, 2013). 
 
 
 
The last major identified nutrient for bone health is phosphorus. Like vitamin D, 
phosphorus and calcium metabolism and uptake are very closely linked. However, high 
calcium intake actually suppresses phosphorus uptake (Heaney & Nordin, 2002). Results 
from supplementation studies have shown that when calcium intake is high and 
phosphorus intake is low, net phosphorus excretion is increased. However, when 
phosphorus intake is increased while calcium remains static, net excretion of calcium is 
unchanged (Spencer 1978). Due to the composition of hydroxyapatite, phosphorus is also 
a major contributor to skeletal strength and deficiency could potentially result in a 
weakened lattice (Heaney & Nordin, 2002). Additionally, phosphorus also has a 
regulatory cellular role in addition to composing the skeletal structure. Phosphorus is 
necessary for osteoblast differentiation and proliferation, so impaired phosphorus status 
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via increased calcium intake or through dietary phosphorus deficiency could result in 
impaired bone formation (Bonjour, 2011). In the diet, calcium and phosphorus should be 
in appropriate ratios as to not disrupt uptake of either mineral, but calcium supplements 
that lack phosphorus could create a potentially unfavorable environment (Bonjour, 2011). 
 
 
 
Vitamin K, magnesium, and boron. There is a large body of epidemiological 
work linking vitamin K status with markers of bone health, but the exact mechanism 
behind the relationship is only hypothesized at this point. Like vitamin D, vitamin K’s 
role seems to be primarily regulatory. There are two key components of bone remodeling 
that are vitamin K dependent: bone GLA protein and carboxylated osteocalcin (Chan, 
Leung, & Woo, 2012). GLA protein may have calcium-binding properties, which would 
be important for calcium transport and deposition during bone remodeling (Ahmadieh & 
Arabi, 2011). Additionally, osteocalcin, once carboxylated, binds to calcium for proper 
bone mineralization during the formation stage. During the carboxylation of osteocalcin, 
vitamin K is necessary component; vitamin K deficiency appears to disrupt the 
carboxylation process (Chan et al., 2012). While research is still on-going, vitamin K 
appears to impact bone health via calcium transport and regulation, with deficiency 
impairing calcium deposition during the formation stage. 
 
 
 
Like vitamin K, the mechanism by which magnesium influences bone health is poorly 
understood, with only some epidemiological and animal model studies linking 
magnesium deficiency and osteopenia/osteoporosis (Nieves, 2013). In some 
supplementation studies, magnesium supplementation did improve markers of bone 
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health. However, this only appears to serve as a benefit for those who are already 
magnesium deficient, and supplementation may not have any positive impact for the 
average population (Nieves, 2013). In murine models, induced magnesium deficiency can 
result in impaired bone health. Over 16 weeks, controlled magnesium deficiency resulted 
in the disruption of the tightly regulated system between the osteoclastic and osteoblastic 
cells, leading to impaired bone remodeling (Rude et al., 1999). While similar studies have 
not been conducted in humans due to ethical considerations, it appears that magnesium 
may be essential for maintaining the cellular signaling system for bone turnover. 
 
 
 
The effect of boron on bone is not entirely understood, as research dealing with boron 
and bone health status has only emerged within the last 15 years. Some controlled 
supplementation studies in humans using 3 mg of boron supplementation daily (average 
intake is 1 mg/daily) have shown positive effects on metabolic markers of bone health, 
such as osteocalcin (Nieves, 2013). The proposed mechanism for the importance of boron 
is related to renal clearance. The main site of boron homeostasis in the kidney; as boron 
intake increases, boron excretion increases. However, in relation to calcium, increased 
boron excretion results in reduced calcium excretion when calcium intake remains static 
(Hunt, Herbel, & Nielsen, 1997). More research is needed to better understand the 
importance of boron as it relates to bone health, but it appears that it works by increasing 
calcium availability in the bloodstream, reducing the need to resorb calcium from the 
bone (Hunt et al., 1997). 
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HOME-BASED EXERCISE 
 
Home-based exercise intervention programs are being recommended more frequently by 
rehabilitation and clinical specialists because participation is not contingent on attending 
a fitness center, gym, or other facility to complete an activity. 
 
 
 
One concern with a home based program is compliance; participants are not able to be 
regularly monitored when they exercise outside of the rehab facility. A pilot study that 
assessed compliance to a home-based exercise program in cardiac patients noted that 
after 72 months, approximately 50% of those originally enrolled were still participating 
(Marzolini, Mertens, Oh, & Plyley, 2010). While this is not necessarily limited 
compliance, it may still impact overall outcomes, especially if compliance continues to 
decline with time. However, research using home-based exercise in women diagnosed 
with osteoporosis found that home-based interventions are at least effective as long as 
participants can comply with the intervention. For example, following a 12-month home- 
based, resistance training program, those in the intervention group significantly improved 
markers of muscular strength and endurance over baseline values and the control group 
(Kanemaru et al., 2010). 
 
 
 
EXERGAMING 
 
The use of exercise video games, or “exergaming,” has gained increasing popularity in 
both clinical and long-term care facilities. Its interactive interface is believed to increase 
enjoyment and compliance, and prevents participants from becoming bored. It has been 
used predominantly in older, clinical populations, but no work has been published 
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supporting its use in middle aged adults as a means of preventative therapy. Most of the 
existing literature focuses primarily on balance outcomes.  Limited information is 
provided regarding any impact of exergaming on muscular fitness. Currently, there are no 
published reports available regarding the use of exergaming to positively influence 
skeletal health in any population. 
 
 
 
Acceptability. The Wii Fit® system has been successfully implemented in older 
adult populations.  Several studies indicate that older adults enjoy this form of novel 
exercise technology. Agmon, Perry, Phelan, Demiris, and Nguyen (2011) used the system 
as a balance therapy with seven older adults over a three month study period. These 
participants rated high enjoyment with using the system and expressed an interest in 
using the system with their grandchildren within their homes. A recent separate study that 
also gauged enjoyment with using the WiiFit®in older adults, found similar results 
(Meldrum, Glennon, Herdman, Murray, & McConn-Walsh, 2012).  In this study, 26 older 
adults played with the Wii Fit® system one time for 30 minutes and then rated their 
enjoyment.  The mean enjoyment score was 82 out of 100 (i.e., 100 being the highest 
enjoyment possible) and only two participants rated the system below 50. Additionally, 
73% of the participants indicated that they enjoyed the Wii Fit® system more than 
traditional balance therapy (Meldrum et al., 2012). 
 
 
 
There is some discrepancy in the literature about older adults’ preference of an 
exergaming system over traditional clinic-based therapy. After completing several 
physical therapy sessions that included using the Wii Fit®, 21 older adult participants 
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completed a discrete choice experiment regarding using the system in comparison to 
typical balance rehabilitation programs. Unlike the participants in the Meldrum et al. 
(2012) study, this group of participants preferred traditional therapy. They cited concerns 
regarding cost, ease of use, and percentage of recovery made as reasons why they did not 
find the Wii® system appealing (Laver, Ratcliffe, George, Burgess, & Crotty, 2011). A 
major difference between these studies was the number of times the participants played 
the game.  It may be that for some of these older adults the novelty and fun of the game 
“wears off” over time. 
 
 
 
Balance Outcomes in Older Adults. Exergaming, especially the Wii Fit®  
system, is comprised of mainly balance games intended to improve center of pressure in 
users. This feature was identified as a potential tool to improve balance in older adults, 
especially those who may suffer from balance impairment or considered high fall-risk. In 
two separate intervention trials using older adults, both comprised of 30 minutes of Wii 
exercise twice per week, there is some evidence to suggest that balance improvements 
may be possible. A study by Nitz, J.C., Kuys, S., Isles, R., and Fu, S. (2010) indicated a 
that those who participated  in a WiiFit® balance program showed non-significant 
improvements in the Berg Balance Test over the control group. However, this study was 
underpowered, limiting the ability to detect any significant outcomes. Franco et al. (2012) 
also reported a non-significant but positive trend in balance improvement with the 
WiiFit® intervention in a group of older men and women. However, their study was also 
underpowered and lasted only three weeks, compared to ten for the Nitz et al. (2010) 
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study. Nevertheless, they suggested that significant changes may have been detected with 
a longer intervention period (Franco et al., 2012). 
 
 
 
In older adults with a known balance impairment, which was defined at a score of < 52 of 
the Berg Balance Scale, the Wii® system did appear to improve balance (Agmon et al., 
2011). The play time was similar to other interventions, 30 minutes, but the gameplay 
was done three times per week instead of two. Also, the total study time was longer, 
lasting three months. Seven older adults completed the study, without a control group, 
and at the end of the study period, several markers of balance improved (Agmon et al., 
2011). The Berg Balance results increased from 49 (SD ± 2.1) to 53 (SD ± 1.8), and 
walking speed improved by approximately 0.3 m/s. 
 
 
 
In general, the Wii Fit® system does not appear to be better than standard treatment alone 
in improving balance for older adults. Seventeen older adults were randomized into one 
of three groups: Physical Therapy, Wii Fit®, and Combined Wii® and Therapy. Following 
four weeks of training consisting of three visits per week, there was no significant 
difference between the combined group and the therapy alone group, but both were 
significantly better than the Wii® system alone (Bateni, 2012). 
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Chapter 3 
METHODOLOGY 
 
STUDY DESIGN 
 
12 Week, randomized, home based, controlled, pre-post intervention of 24 peri- 
menopausal  middle-aged women with low bone mass. 
 
 
 
RECRUITMENT 
 
Middle aged women were recruited from the ASU campuses and greater Phoenix 
metropolitan area via listserves sent to faculty, staff, and local downtown businesses. 
Women who participated in pilot testing who indicated that they would be willing to 
participate in research using the Wii Fit® were contacted if they met all inclusion criteria. 
All recruitment materials can be found in Appendix A. 
 
 
 
ELIGIBILITY 
 
Inclusion Criteria. Eligible participants were apparently healthy, 
sedentary women between the ages of 45-60. Sedentary was defined as 
accumulating fewer than 60 minutes per week of purposeful light to moderate 
physical activity. Volunteers could not have contraindications to walking or 
standing. They could not be on hormonal replacement therapy or any medications 
or supplements (except for calcium, daily multivitamin, vitamin D) that affect the 
bone. Any vitamin supplements were to be over-the-counter (OTC) and could not 
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be prescription-grade. Participants were to have access to an available TV within 
their home that can be used with the Wii Fit® system. 
 
 
 
Exclusion Criteria. Those who responded “yes” to any of the questions 
on the PAR-Q+, and/or did not have any underlying conditions that are well- 
managed, were excluded. Any woman who had an exergaming system (Wii Fit®, 
Xbox Kinect®) in her home was excluded. Those who indicated plans to travel 
for more than 5 days over the 4 months of the study were also excluded. If a 
prospective participant had a DXA total hip or spine t-score of ≤0 but not lower 
than -1.5, then they were deemed eligible. Eligible participants were then 
randomized into one of the two groups (Wii Fit® or control). (Note: any woman 
who had a DXA t-score less than -1.5 was referred to their health care provider 
for further follow up and was not allowed into the study without the approval of 
their health care professional). 
 
 
 
PROCEDURES 
 
All volunteers were informed of the study requirements and asked to sign the 
informed consent form.  Screening for eligibility consisted of completing a PAR- 
Q+ and health history questionnaire, and assessing bone density using the QUS 
and DXA.  After initial eligibility assessment was determined, women were tested 
for whole body balance, bone density, and muscular strength and endurance of the 
lower limbs. All testing was conducted in the Healthy Lifestyles Research Center 
(HLRC) on the Downtown Phoenix Campus (DPC) of Arizona State University 
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(ASU) in Phoenix, AZ. Once randomized, the intervention group was given a 
WiiFit® system, to take home to complete their training sessions. At 6 weeks 
(mid-intervention) and 12-weeks (posttest) testing all outcome variables except 
the DXA was reassessed. A copy of the consent form can be found in Appendix 
B. 
 
 
 
Health history questionnaire. All volunteers completed the Physical 
Activity Readiness+ Questionnaire (PAR-Q+) and a health history questionnaire. 
The PAR-Q+ was used to screen for any health issues that would contraindicate 
physical activity. Potential participants who answered “yes” to any of the 
questions were required to provide further information regarding health status to 
determine inclusion. The Health History Questionnaire served to identify any 
familial or personal bone-related issues. The Par-Q+ is considered to be highly 
reliability, with a three-month score correlation of 0.99 (Warburton, Bredin, 
Jamnik, & Gledhill, 2011). A copy of both the PAR-Q+ and the Health History 
Questionnaire can be found in Appendix C. 
 
 
 
Food frequency questionnaire. All participants completed a Food 
Frequency Questionnaire (FFQ) at baseline, 6-weeks, and 12-weeks to assess if 
dietary habits changed over the course of the study. Special attention was given to 
dietary increases in vitamin K, vitamin D, and calcium. Any vitamins/minerals 
from supplements were included in calculating total daily vitamin/mineral intake. 
The FFQ used has been shown to have an intra-class correlation coefficient of 
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0.59 when the questionnaire is taken twice with one year between sessions 
(Morris, Tangney, Bienias, Evans, & Wilson, 2003). The questionnaire can be 
found in Appendix D. 
 
 
 
Qualitative Ultrasound (QUS) and Dual-Energy X-ray 
Absorptiometry (DXA) to assess low bone mass eligibility. To determine bone- 
specific inclusion criteria, participants completed a heel scan of the Os Calcis 
using the Achilles InSight Qualitative Ultrasonometer (GE Lunar, Madison, WI). 
Participants placed their bare foot into the ultrasonometer, which transmited a 
harmless ultrasound wave through the Os Calcis. If the stiffness index (SI) t-score 
from the device was above 1.0, the participant was excluded from the study. If the 
t-score was equal to or below 1.0, they were asked to continue to have a whole 
body DXA scan to confirm low bone mass. Total hip and/or spine bone mineral 
density (BMD) from the DXA was to be below 0, but not lower than -1.5. (Note: 
any woman who had a DXA t-score less than -1.5 was referred to her health care 
provider and was not admitted to the study without physician consent.) The 
Achilles InSight QUS has a coefficient of variation (CV%) of 2.0% when used 
following manufacturer guidelines (Cepollaro et al., 2005). 
 
 
 
Physical activity questionnaires. Eligible women completed the 
Women’s Health Initiative Physical Activity Questionnaire (WHI-PAQ) to assess 
baseline physical activity levels, as well as additional questions from the Rapid 
Physical Activity Assessment regarding strength, yoga, and flexibility exercise. 
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These questionnaires were completed every two weeks via phone call to track 
changes in physical activity habits of both groups over the 12-week intervention. 
This questionnaire has been shown to have an interclass correlation coefficient of 
1.91 (p<0.0001) when measured 1 week apart, and a weighed kappa statistic 
between 0.53 and 0.72 when given 3 months apart (Pettee Gabriel et al., 2009). A 
copy of the questionnaire can be found in Appendix E. 
 
 
 
Biochemical indices of bone turnover. A 10 ml venous blood sample 
was taken to measure serum osteocalcin, a marker of bone formation. Participants 
did not need to be fasted. All blood draws were done by a certified phlebotomist. 
Serum was separated from the blood prior to storage using a centrifuge. Samples 
were stored at -20°C until all blood samples were collected at the end of the 
study. Blood cell precipitate was also stored separately for future analysis. 
 
 
 
For analysis, serum samples were allowed to thaw to room temperature, standards 
were prepared, and the plates were prepped for use. Samples were only thawed 
once as they cannot be re-frozen after being thawed. All procedures for preparing 
the kit and the sample were followed for the osteocalcin ELISA assay 
(Biomedical Technologies, INC, catalogue number: BT-460) . Full procedures 
and considerations were conducted per manufacturer’s protocol, and can be found 
in Appendix F.  Coefficients of variation (CV%) were determined for each 
sample. If CV% exceeded 7%, the sample was re-run and analysis repeated. 
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Body composition testing. Bioelectrical impedance (BIA) analysis was 
conducted at both baseline and 12 weeks to measure any changes in body 
composition (Tanita TBF-300WA, Arlington Heights, IL) . The areas of interest 
were total body fat mass and total body lean mass. No site-specific measures were 
analyzed. BIA has an ICC of 0.93 under ideal conditions and under same-day 
testing, but the ICC can be as low as 0.71 (or greater than a 2% difference) when 
tested across days (Loenneke et al., 2013). 
 
 
 
Balance testing. All screened and eligible participants completed two 
balance test batteries to assess total body static and dynamic balance (Appendix 
G). All of the standing exercises were done on the AMTI force plate (Watertown, 
MA) which collected data on the area and velocity of shifts in center of balance. 
The within-day ICC using the AMTI for mean velocity was between 0.67 and 
0.84, and it was approximately 0.70 for between-day (Lin, Seol, Nussbaum, & 
Madigan, 2008). 
 
 
 
Foot Positions. All measurements were taken for 10 seconds or until loss 
of balance, unless noted otherwise. The standing positions included: 
 
 
 
Open Base, Eyes Open. The feet are placed approximately hip-distance 
apart and eyes are open. Participants look straight ahead with the head upright, 
focusing on a black dot placed on the wall in front of them. This position is 
maintained for two minutes 
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Closed Base, Eyes Open. The feet are together with medial sides of the 
feet in contact. Participants look straight ahead with the head upright, focusing on 
a black dot placed on the wall in front of them. 
 
 
 
Closed Base, Eyes Closed. The feet are together with medial sides of the 
feet in contact. Eyes are closed with the head upright. 
 
 
 
Semi-Tandem, Eyes Open. The heel of one foot is placed next to the first 
toe of the opposite foot. The participant gets to choose which foot is placed in 
front. Participants look straight ahead with the head upright, focusing on a black 
dot placed on the wall in front of them. 
 
 
 
Semi-Tandem, Eyes Closed. The heel of one foot is placed next to the first 
toe of the opposite foot. The participant gets to choose which foot is placed in 
front. Eyes are closed with the head upright. 
 
 
 
Tandem Step, Eyes Open.  The heel of one foot is placed directly in front 
of the first toe of the opposite foot. The participant gets to choose which foot is 
placed in front. Participants look straight ahead with the head upright, focusing on 
a black dot placed on the wall in front of them. This position is done twice: once 
for 10 seconds and once for 30 seconds. 
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Tandem Step, Eyes Closed. The heel of one foot is placed directly in front 
of the first toe of the opposite foot. The participant gets to choose which foot is 
placed in front. Eyes are closed with the head upright. 
 
 
 
Single-leg Stand, Eyes Open. The participants raise one foot off of the 
ground while supporting weight on the adjacent leg. The foot that is raised cannot 
rest against the standing leg and must be held independently. The participant gets 
to choose which foot is raised. Participants look straight ahead with the head 
upright, focusing on a black dot placed on the wall in front of them. 
 
 
 
Open Base, Eyes Closed. The feet are placed approximately hip-distance 
apart. Eyes are closed with the head upright. 
 
 
 
Balance Scales. 
 
The Berg Balance Scale. This scale is a 14-item test that measures fall- 
risk during usual activities. Some examples of test procedures are “sitting to 
standing,” “standing unsupported,” and “turning 360 degrees.” Each test is scored 
on a scale from 0-4, with 0 being unable to complete the test, and 4 representing 
full ability. The test has a total of 56 points, with a higher score indicating a 
decreased fall-risk (Berg, 1989). Any score below 40 points is considered to be at 
an elevated risk of falling, and any score below 20 is considered high risk. The 
Berg Balance Scale has been shown to have an inter-rater interclass correlation 
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coefficient (ICC) of 0.98, and an intra-rater ICC of 0.97 (Berg, Wood-Dauphinee, 
 
& Williams, 1995). 
 
 
 
 
The Frailty and Injuries: Cooperative Studies of Intervention 
Techniques (FICSIT)-4. This scale is a 7-item test that assesses static balance. 
While some items are similar to the Berg, the FICSIT-4 includes tandem standing 
with eyes both open and closed, and other more complex challenges to balance. 
Test-retest reliability was assessed and was acceptable (r = 0.66, p<0.001), and 
does not appear to be influenced by age (Rossiter-Fornoff, Wolf, Wolfson, & 
Buchner, 1995). 
 
 
 
Muscular testing. Muscular strength, power and endurance of knee 
extensors and flexors was measured using an isokinetic dynamometer (HUMAC 
NORM, Stoughton, MA). Strength (peak torque) was measured at three speeds: 
60°/sec, 180°/sec, and 240°/sec.  Two repetitions at each speed were assessed. 
Muscular endurance was assessed using 50 repetitions at 240°/sec. Muscular 
endurance was quantified using a fatigue index score, calculated as peak power 
minus minimum power, divided by the time (seconds) between peak and 
minimum power. The ICC for peak torque varies from 0.95 to 0.97, depending on 
the angular velocity, and the ICC for muscular endurance values ranged from 0.96 
to 0.97 (Feiring, Ellenbecker, & Derscheid, 1990). 
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Randomization. Eligible participants were assigned using the random 
number generator program included in Microsoft EXCEL.  Study participant 
numbers were created up to 30, and EXCEL produced an equal number of even 
and odd decimal values. A separate investigator chose which set of numbers (even 
or odd) corresponded to the intervention group and assigned participant numbers 
appropriately. Group assignment was sealed in an envelope labeled with the 
participant number so that the researcher was blinded to group assignment during 
baseline testing. Following baseline testing the envelope was opened so that the 
primary investigator and the participant learned their group assignment at the 
same time. 
 
 
 
Control group. Those assigned to the control group were asked to not 
change their dietary or physical activity habits over the 12-week study period. 
They were not given any equipment during the intervention however, the control 
group did have the opportunity to use Wii Fit® system once the study was over. 
 
 
 
Exercise intervention. Participants assigned to the intervention group 
were familiarized with the Wii® console. The intervention group was taught how 
to play various exercises on the Wii Fit®. After familiarization, participants in the 
intervention group were assigned a Wii console and a Wii Fit® balance board. 
They were also be given the option of having a member of the research team 
come to their home to install the gaming system if they did not feel comfortable 
with setting the system up on their own. Participants were provided an e-mail 
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address and phone number where they could report any technical problems with 
the equipment, or could request additional assistance in set-up, use, or exercise 
instructions. 
 
 
 
The intervention group was asked to use only the participant profile pre-programmed for 
them.  Participants were asked to play the Wii Fit® games for 30 minutes, 3 times per 
week. They completed yoga poses and strength training exercises for the first 10 minutes. 
These exercises included warrior pose, half-moon pose, torso twists, lunges, and side 
lunges. For the remaining 20 minutes, participants completed balance games such as 
Soccer Heading, Ski Slalom, and Table Tilt. They were asked to avoid Ski Jump. They 
were asked to complete each exercise at least twice, preferably by cycling through all 
exercises. Participants were asked to do all of the exercises in one 30-minute session, 
rather than breaking them up throughout the day. Screenshots of the included Wii 
exercises can be found in Appendix H. 
 
 
 
Half-moon pose. Participants will stand on the balance board with their feet 
together. Their will extend their arms above their hand with their palms together. They 
will bend at the waist to the right as far as is comfortable, and hold for 15 seconds. They 
will repeat this same pose on the left. 
 
 
 
Warrior pose. The right foot will be placed on the balance board and the left foot 
will be on the ground. Participants will be in a side lunge position, with the leg on the 
46 
 
 
balance board flexed at the knee. Participants will lean into the lead/balance board leg 
and hold this position for 15 seconds. They will repeat this on the left leg. 
 
 
 
Standing knee. Participants will stand on the balance board with their feet 
together. They will extend their arms above their hand with their palms together. They 
will bend at the waist to the right as far as is comfortable, and hold for 15 seconds. They 
will repeat this same pose on the left. 
 
 
 
Torso twists. Participants will stand on the balance board with feet hip-distance 
apart. They will extend their arms outward into a "T" shape. They will rotate to the right 
at the waist as far as is comfortable and return to center. They will repeat this on the left 
side. They will complete 5-10 left/right rotations. 
 
 
 
Lunges. Participants will stand with one foot on the balance board and one foot 
on the ground behind them. They will flex both knees, and drop the rear knee as close to 
the ground as possible. They should reach a 90 degree flexion at the front knee. They will 
repeat this position with both the right and the left leg as the lead leg. 
 
 
 
Soccer Heading. Participants will shift their weight from right to left to guide a 
soccer player on the screen. The goal is to move the soccer player so that he fields the 
soccer balls with his head, but avoids incoming obstacles, such as soccer cleats. The 
game is over once time has expired, or the player has hit too many obstacles. 
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Balance Bubble. Participants will shift their weight from left to right and from 
front to back to maneuver an avatar through a river obstacle course. The goal is to avoid 
the river banks, various obstacles in the water (rocks, whirlpools) and to avoid airborne 
obstacles (bees). 
 
 
 
Table Tilt. Participants will shift their weight from left to right, or from front to 
back, to move a table with various obstacles. The goal is to guide a ball on the table into a 
hole by moving the table accordingly. 
 
 
 
All participants were asked to keep a record of which games they play and for how long. 
Participants were provided a journal and will be asked to record the time of day, type, and 
duration of activity for all purposeful exercise, including time spent using the Wii Fit®. 
The Wii Fit® software also keeps a digital record of which exercises were completed and 
how long they were performed. At the end of the intervention the investigator was able to 
use the information stored in the Wii, as well as activity logs, to assess compliance. 
Participants were permitted to play games other than those prescribed, but they were 
asked to do so outside of the 30 minute daily game play time. Any additional games they 
played was to be included in the exercise log. A copy of the exercise log can be found in 
Appendix I. 
 
 
 
Reminder phone calls/emails. Study personnel telephoned or emailed the 
participants (based on participant preference) every two weeks to ask them to 
complete the physical activity questionnaire (WHI-PAQ) and to allow participants 
48 
 
 
to voice any concerns they may have about the equipment. Any health or 
physical activity changes will be noted. 
 
 
 
Mid-intervention testing (6 weeks). At week 6, participants returned to 
the lab to complete the FICSIT-4, Berg Balance Test, the Women's Health 
Initiative Physical Activity Questionnaire, a blood draw, muscular fitness testing, 
and an ultrasound heel scan. 
 
 
 
Post-test (12 weeks). During the week 12 post-test visit, participants 
completed the same measures as the 6-week visit, as well as a final DXA 
measure, and returned the Wii Fit® equipment. 
 
 
 
Incentives. Participants had their parking costs covered during testing at the lab. 
In addition each participant received $25 in cash for completing the 12 weeks. All 
subjects names were also entered into a drawing to win one of two (2) Wii Fit® consoles 
and balance boards. One was raffled to the intervention group, and the other to the 
control group. Lastly, when the study was complete anyone in the control group was 
provided instruction on the Wii Fit® should she want it. 
 
 
 
Sample Size Calculation. Based on current literature utilizing the Wii 
Fit® in balance interventions, a sample size of 24 was determined to be 
appropriate. Previous studies have reported significant changes in balance test 
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scores with using 8-10 subjects (Nitz et al., 2010; Meldrum et al., 2012). No data 
on subject drop out could be found. 
 
 
 
An analysis powered for the effects of exergaming on balance indicated that a minimum 
of 22 participants are needed to detect any statistically significant change. The SAS 
macro “PROC POWER” was used to determine sufficient group numbers. The mean 
difference and standard deviation from Bateni (2012) was used for sample size 
calculation (n=17, β = 0.80, Cohen’s d= 0.5656). Thus, two groups of 14 were 
determined appropriate to allow for enough power to detect significant changes in 
balance and to allow for about a 25% drop out. 25% dropout was anticipated based on 
previous experience conducting exercise studies that involve a longer time frame. 
 
 
 
Data analysis. Data was entered into an Excel spreadsheet, which then was 
imported for analyzing in PASW Statistics 22 (SPSS/IBM, Quarry Bay, Hong 
Kong). Data was checked for normality and then differences between the 
intervention and control group analyzed using two-way repeated measures 
analysis of variance (ANOVA). Changes in body weight, several indices of 
balance, muscular strength/endurance, physical activity, QUS indices of bone 
quality, and osteocalcin, were compared between groups and any time x group 
interactions was assessed. Alpha was set at 0.05 for determining significance. 
Proper checks and corrections were conducted for all outcome variables 
(normality, sphericity, homogeneity), and no transformations were necessary for 
any of the data. 
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Chapter 4 
RESULTS 
 
 
 
Twenty-four peri or post-menopausal women were deemed eligible to participate in the 
study. Of the 24 women, 22 women completed the baseline and follow-up visits for the 
study. Reasons for dropout included a family medical emergency and not being interested 
in participating in the control group. All statistics were run in IBM SPSS 22. Figure 2 
provides the screening, recruitment, and dropout sequence. 
 
 
 
Participants in the intervention group were 92% compliant. 100% compliance was 
defined as completing all prescribed exercises for at least 30 minutes for all 36 exercise 
sessions. The participants completed all exercises for a full 30 minutes on all days that 
they played the Wii system, but not all participants completed all 36 exercise sessions. 
Three participants exceeded 36 sessions, and were over 100% compliant. Only two of the 
total 11 intervention participants were less than 80% compliant. 
 
 
 
Descriptive data, nutritional data, and physical activity habits at baseline are presented in 
Table 1, Table 2, and Table 3, respectively. There were no significant differences 
between groups at baseline. 
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Enrollment Assessed for eligibility (n= 78 ) 
 
Excluded (n= 54 ) 
◆ Not meeting inclusion criteria (n= 29) 
◆ Declined to participate (n= 25) 
◆ Other reasons (n= 0) 
 
Randomized (n= 24) 
 
 
 
Allocation 
 
Allocated to intervention (n= 12) 
◆ Received allocated intervention (n= 12) 
 
Allocated to control (n= 12) 
◆ Received control condition (n= 12) 
 
 
Follow-Up 
 
Discontinued intervention (n= 1) 
◆ Family Emergency (n= 1) 
Discontinued control (n= 1) 
◆ No longer interested (n= 1) 
 
 
 
 
Analyzed (n= 11) 
Analysis 
 
 
Analyzed (n= 11) 
 
 
Figure 2. Flow Diagram of Participant Recruitment and Retention 
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BASELINE DATA 
 
 
 
 
Table 1 
 
Descriptive Characteristics 
 
 
 
Age (years) 
Weight (lbs) 
Body fat (%) 
 
Height (in) 
Intervention (M ± SD) Control (M ± SD) p-value 
54.82 ± 4.75  52.36 ± 5.94   0.297 
158.10 ± 13.95 168.00 ± 37.24 0.415 
 
37.68 ± 3.25 33.94 ± 6.76 0.119 
 
63.31 ± 1.95 64.91 ± 2.66 0.127 
 
 
Ethnicity 
Intervention N (%) Control N (%) Total N (%) 
Caucasian 8 (73) 9 (82) 17 (77) 
African American 1 (9) 1 (9) 2 (9) 
Asian 1 (9) 0 (0) 1 (5) 
Hispanic 1 (9) 1 (9) 2 (9) 
Other 0 (0) 0 (0) 0 (0) 
Total 11 (100) 11 (100) 22 (100) 
 
 
 
 
 
 
Table 2 
 
Baseline Dietary Patterns from Harvard Food Frequency Questionnaire (n=22) 
 
Intervention (M ± SD) Control (M ± SD) p-value 
 
Protein Servings/Month 
 
45 ± 31 
 
47 ± 33 0.859 
 
Vegetable Servings/Month 
 
138 ± 54 106 ± 74 
 
0.133 
Calcium Intake (mg/day)
¤
 936 ± 600 877 ± 467 0.707 
 
¤Combined dietary and supplement intake 
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Table 3 
 
Baseline Physical Activity Habits (n=22) 
 
Intervention (M ± SD)  Control (M ± SD) p-value 
 
Walking (min/week) 
 
34.55 ± 23.81 25.45 ± 18.10 0.325 
 
MVPA (min/week) 
 
1.82 ± 6.03 
 
7.27 ± 13.48 0.235 
Mild(min/week) 
Strength Training (min/week) 
Flexibility/Balance Training (min/week) 
0 0 -- 
0 0 -- 
 
0 0 -- 
 
 
 
 
 
 
There were no significant differences between the Intervention and Control groups in 
regards to any descriptive information (age, height, weight, body fat percentage), 
nutritional intake, or physical activity habits at baseline. Repeated Measures ANOVAs 
for all descriptive and baseline characteristics can be found in Table 5, Table 7, and Table 
9, for weight/body fat, dietary patterns, and physical activity habits, respectively. Means 
and standard deviations for each group across study visits can be found in Table 4 
(weight/body fat), Table 6 (dietary patterns), and Table 8 (physical activity habits). 
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CHANGE IN BASELINE DESCRIPTIVE DATA 
 
 
 
 
Table 4 
 
Means and Standard Deviations across Visits for Body Weight and Body Fat Percentage 
(n=22) 
 
 
 
 
 
Weight (lbs) 
Visit 1 (M ± SD) Visit 3 (M ± SD) 
Intervention (n=11) 
Control (n=11) 
Body Fat % 
Intervention (n=11) 
Control (n=11) 
158.10 ± 13.95 
168.00 ± 37.24 
 
 
37.68 ± 3.25 
33.94 ± 6.76 
159.22 ± 15.24 
169.05 ± 37.18 
 
 
37.20 ± 5.59 
37.04 ± 7.26 
 
 
 
 
Table 5 
 
RM-ANOVA for Body Weight (lbs) and Body Fat Percentage (n=22) 
 
 
 
Weight 
F df p-value partial eta squared 
 
 
Time 
 
3.22 
 
1 
 
0.088 
 
0.139‡ 
Time*Group 0.01 1 0.908 0.001 
Body Fat 
 
Time 3.69 1 0.069 0.156‡ 
Time*Group 1.68 1 0.210 0.077‡ 
 
‡ effect size > 0.06 
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Table 6 
 
Means and Standard Deviations across Visits for Dietary Patterns Assessed via Food 
Frequency Questionnaire (n=22) 
 
 
Protein Servings/Month 
Visit 1 (M ± SD) Visit 2 (M ± SD) Visit 3 (M ± SD) 
Intervention (n=11) 
Control (n=11) 
Vegetable Servings/Month 
Intervention (n=11) 
Control (n=11) 
Calcium Intake (mg/day)
¤ 
Intervention (n=11) 
Control (n=11) 
45 ± 31 
47 ± 33 
 
 
138 ± 54 
105 ± 74 
 
 
936 ± 600 
877 ± 467 
46 ± 31 47 ± 31 
48 ± 33 49 ± 33 
 
 
144 ± 55 143 ± 57 
103 ± 68 104 ± 67 
 
 
918 ± 354 945 ± 372 
863 ± 412 859 ± 474 
 
¤Combined dietary and supplement intake 
 
 
 
 
Table 7 
 
RM-ANOVA for Dietary Patterns as Assessed via Food Frequency Questionnaire (n=22) 
 
 F df p-value partial eta squared 
Protein Servings-Month     
 
Time 
 
0.40 
 
2 
 
0.537 
 
0.019 
Time*Group 0.14 2 0.710 0.007 
 
Vegetable Servings/Month 
    
Time 0.64 2 0.434 0.031 
Time*Group 
Calcium Intake (mg/day)
¤
 
1.91 2 0.182 0.087‡ 
Time 1.80 2 0.195 0.083‡ 
Time*Group 0.20 2 0.660 0.010 
 
¤Combined dietary and supplement intake 
‡ effect size > 0.06 
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Table 8 
 
Means and Standards Deviations across Visits 1, 2, and 3 for Physical Activity Habits ¤ 
 
from the Women’s Health Initiative Physical Activity Questionnaire (n=22) 
 
 
 
 
 
Walking (min/week) 
Visit 1 (M ± SD) Visit 2 (M ± SD) Visit 3 (M ± SD) 
Intervention (n=11) 
Control (n=11) 
MVPA (min/week) 
Intervention (n=11) 
Control (n=11) 
Mild (min/week) 
Intervention (n=11) 
Control (n=11) 
34.55 ± 23.81 
25.45 ± 18.10 
 
 
1.82 ± 6.03 
7.27 ± 13.48 
 
 
0.00 ± 0.00 
0.00 ± 0.00 
34.00 ± 21.19 
28.89 ± 17.64 
 
 
2.22 ± 6.67 
8.00 ± 19.32 
 
 
94.00 ± 35.024 
0.00 ± 0.00 
34.00 ± 21.25 
26.67 ± 20.00 
 
 
6.67 ± 14.14 
8.00 ± 19.32 
 
 
85.50 ± 34.12 
0.00 ± 0.00 
 
¤No strength training or flexibility training was reported at any study visit 
 
 
 
Table 9 
 
RM-ANOVA for Physical Activity Habits from the Women’s Health Initiative Physical 
 
Activity Questionnaire (n=22) 
 
 
 
F 
 
 
 
df 
 
 
 
p-value 
 
 
 
partial eta squared 
Walking (min/week)     
 
Time 
 
0.71 
 
2 
 
0.498 
 
0.040 
Time*Group 
MVPA (min/week) 
0.24 2 0.789 0.014 
Time 0.45 2 0.450 0.046 
Time*Group 
Mild (min/week) 
2.22 2 0.138 0.115‡ 
Time 58.39 2 0.000† 0.775‡ 
Time*Group 58.39 2 0.000† 0.775‡ 
 
† p-value < 0.05 
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‡ effect size > 0.06 
There were no significant main effects or interactions for weight/body fat or dietary 
 
patterns across the 12-week study period. There was a significant main effect for time 
and a significant time*group interaction for mild physical activity. Only the intervention 
group increased total mild activity time during the study period by using the Wii Fit® 
device, and no other physical activity habits were significantly difference at baseline or 
any subsequent visit. All physical activity times were reported using the Women’s Health 
Initiative Physical Activity Questionnaire (WHI-PAQ), except for Mild activity in the 
intervention group; that was tracked use actual play time logged on the Wii Fit® console. 
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PRIMARY HYPOTHESIS 
 
12 weeks of interactive play will significantly improve balance in middle-aged women as 
compared to a randomly assigned control group. Independent samples t-tests were 
conducted to determine any differences between groups at baseline across all measures 
(Table 10 (balance scales) and Table 13 in Appendix J (force plate)). Repeated Measures 
Analysis of Variance (RM-ANOVA) were run to assess a main effect for time and any 
time*group interaction (Table 12 (balance scales) and Tables 15, 17, 19, 21, 23, 25, 27, 
29, 31, 33 (force plate)). Means and standards deviations for each group at each study 
visit can be found in Table 11 (balance scales) and Tables 14, 16, 18, 20, 22, 24, 26, 28, 
30, 32 (force plate). 
 
 
 
 
Baseline data for the balance scales is presented first, followed by the means and standard 
deviations for all study visits and the Repeated Measures Analysis of Variance (RM- 
ANOVA) for the balance scales. A brief interpretation of the outcomes is located below 
the tables for the balance scales. 
 
 
 
For the force plate outcomes, the tables follow the same table pairing, with each table 
pair representing the means and standard deviations across all three visits for the 
intervention and the control group as well as the RM-ANOVA for the 10 individual foot 
positions. The tables progress as follows: Means and Standard Deviations for first foot 
position, RM-ANOVA for first foot position; Means and Standard Deviations for second 
foot position, RM-ANOVA for second foot position, etc. The brief interpretation for each 
position follows each table pair for the given foot position. Any pertinent figures will 
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follow the table pairs, but precede the interpretation. The upcoming foot positions will 
progress in the following order: Open Base, Eyes Open; Closed Base, Eyes Open; Closed 
Base, Eyes Closed; Semi-Tandem, Eyes Open; Semi-Tandem, Eyes Closed; Tandem 
Step, Eyes Open (10 second); Tandem Step, Eyes Closed; Single Leg, Eyes Open; Open 
Base, Eyes Closed; Tandem Step, Eyes Open (30 second). 
60 
 
 
Balance scales. 
 
Table 10 
 
Baseline Score Results for Balance Scales (Berg and FICSIT-4*) across Groups (n=22) 
 
 
 
Berg (Raw Score) 
FICSIT-4 (Raw Score) 
Intervention (M ± SD)  Control (M ± SD) p-
value 54.73 ± 2.24 55.36 ± 1.50   0.443 
26.91 ± 1.81 26.18 ± 1.60 0.331 
 
*Frailty and Injuries: Cooperative Studies of Intervention Techniques 
 
 
 
 
 
 
 
Table 11 
 
Means and Standard Deviations across Visits for Balance Scales (Berg and FICSIT-4*, 
n=22) 
 
 
Berg 
 
 
 
Intervention (n=11) 
Control (n=11) 
Visit 1 (M ± SD) Visit 2 (M ± SD) Visit 3 (M ± SD) 
 
 
54.73 ± 2.24 55.91 ± 0.30 56.00 ± 0.00 
55.36 ± 1.50 55.45 ± 1.04 55.45 ± 1.51 
FICSIT 
Intervention (n=11) 
Control (n=11) 
 
 
26.80 ± 1.87 27.90 ± 0.32 27.60 ± 0.84 
26.00 ± 1.66 26.22 ± 2.33 27.33 ± 1.00 
 
*Frailty and Injuries: Cooperative Studies of Intervention Techniques 
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Table 12 
 
RM- ANOVA for Balance Scales (Berg and FICSIT-4*, n=22) 
 
 
 
Berg 
F df p-value partial eta squared 
 
Time 2.223 2 0.121 0.133‡ 
Time*group 
FICSIT-4 
1.654 2 0.204 0.085‡ 
Time 3.061 2 0.060 0.365
‡
 
Time*group 1.340 2 0.275 0.135‡ 
 
*Frailty and Injuries: Cooperative Studies of Intervention Techniques 
‡ partial eta squared > 0.06 
 
 
 
There were no significant main effects for time or any time*group interactions for the 
Berg or the FICSIT-4. The main effect for Time for the FICSIT-4 was trending toward 
significance and has a large effect size, indicating that both groups improved their scores 
across visits. There were also large effect sizes for the main effect for Time (Berg) and 
the Time*Group interaction (FICSIT-4). There was a medium effect size for the 
Time*Group interaction (Berg). 
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Force plate. 
 
 
 
 
Table 14 
 
Means and Standard Deviations across Visits for Open Base, Eyes Open Assessed via the 
AMTI Force Plate (n=22) 
 
 
 
Maximum Velocity X (mm/s) 
Visit 1 (M ± SD) Visit 2 (M ± SD) Visit 3 (M ± SD) 
Intervention (n=11) 
Control (n=11) 
Maximum Velocity Y (mm/s) 
Intervention (n=11) 
Control (n=11) 
Average Velocity (mm/s) 
Intervention (n=11) 
Control (n=11) 
 
Major Axis (mm
2) 
Intervention (n=11) 
Control (n=11) 
 
Area Effective (mm
2
) 
Intervention (n=11) 
Control (n=11) 
 
Area 95 (mm
2
) 
Intervention (n=11) 
Control (n=11) 
3.96 ± 2.43 
2.51 ± 0.70 
 
 
-3.34 ± 1.49 
-3.43 ± 1.90 
 
 
0.83 ± 0.21 
0.88 ± 0.22 
 
 
 
1.37 ± 0.56 
1.25 ± 0.39 
 
 
 
1.30 ± 0.94 
0.99 ± 0.57 
 
 
 
2.44 ± 1.43 
1.77 ± 0.92 
2.79 ± 0.75 3.37 ± 1.38 
2.53 ± 0.92 2.81 ± 1.81 
 
 
-2.75 ± 1.01 -3.07 ± 0.70 
-2.89 ± 1.29 -2.89 ± 1.33 
 
 
0.82 ± 0.17 0.96 ± 0.25 
0.89 ± 0.21 0.86 ± 0.17 
 
 
 
1.36 ± 0.47 1.67 ± 0.65 
1.24 ± 0.31 1.12 ± 0.16 
 
 
 
1.24 ± 0.71 1.98 ± 1.45 
0.97 ± 0.49 0.82 ± 0.18 
 
 
 
2.58 ± 1.06 3.43 ± 1.69 
1.89 ± 0.87 1.71 ± 0.51 
63 
 
 
Table 15 
 
RM-ANOVA for the Open Base, Eyes Open Position for the Parameters from the AMTI 
 
Force Plate (n=22) 
 
 
 
F 
 
 
 
df 
 
 
 
p-value 
 
 
 
partial eta squared 
Maximum Velocity X (mm/s)     
Time 0.78 2 0.466 0.044 
Time*Group 1.63 2 0.212 0.087‡ 
Maximum Velocity Y (mm/s) 
Time 
 
 
0.88 
 
 
2 
 
 
0.424 
 
 
0.049 *Group 0 9 8 04
Average Velocity (mm/s)     
Time 0.82 2 0.451 0.046 
Time*Group 1.69 2 0.199 0.091‡ 
Major Axis (mm
2)
 
    
Time 0.32 2 0.726 0.019 
Time*Group 1.76 2 0.187 0.094‡ 
Area Effective (mm
2
) 
Time 
 
 
0.75 
 
 
2 
 
 
0.482 
 
 
0.042 Ti e*Group 1.99 2 0.160 0.102‡ 
Area 95 (mm
2
)     
Time 1.06 2 0.360 0.062‡ 
Time*Group 1.88 2 0.170 0.105‡ 
 
† p-value < 0.05 
‡effect size > 0.06 
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There was no significant main effect for time or any significant group*time interaction 
for any of the balance parameters in the open base, eyes open position. All mean 
velocities for each group were in the range of what is considered “stable”. There were 
medium effect sizes for the Time*Group interaction (Average Velocity), the Time*Group 
interaction (Major Axis), the Time*Group interaction (Area Effective), the main effect 
for time (Area 95), and the Time*Group Interaction (Area 95). All other effect sizes were 
small. 
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Table 16 
 
Means and Standard Deviations across Visits for Closed Base, Eyes Open Assessed via 
the AMTI Force Plate (n=22) 
 
 
Maximum Velocity X (mm/s) 
Visit 1 (M ± SD) Visit 2 (M ± SD) Visit 3 (M ± SD) 
Intervention (n=11) 
Control (n=11) 
Maximum Velocity Y (mm/s) 
Intervention (n=11) 
Control (n=11) 
Average Velocity (mm/s) 
Intervention (n=11) 
4.42 ± 2.14 
4.44 ± 3.02 
 
 
-4.17 ± 1.66 
-3.84 ± 1.13 
 
 
1.48 ± 0.40 
5.76 ± 2.10 4.84 ± 1.48 
5.10 ± 1.54 5.17 ± 2.33 
 
 
-5.67 ± 2.61 -4.98 ± 2.48 
-5.87 ± 2.03 -5.49 ± 2.51 
 
 
2.03 ± 0.74 1.76 ± 0.44 
Control (n=11) 
 
Major Axis (mm
2)
 
1.55 ± 0.54 1.86 ± 0.28 1.85 ± 0.48 
Intervention (n=11) 1.26 ± 0.54 1.267 ± 0.48 1.26 ± 0.42 
Control (n=11) 
 
Area Effective (mm
2
) 
Intervention (n=11) 
Control (n=11) 
 
Area 95 (mm
2
) 
Intervention (n=11) 
Control (n=11) 
1.11 ± 0.36 
 
 
 
1.34 ± 0.99 
0.98 ± 0.57 
 
 
 
3.25 ± 1.66 
2.61 ± 1.33 
1.25 ± 0.33 1.32 ± 0.45 
 
 
 
1.38 ± 1.04 1.29 ± 0.76 
1.25 ± 0.56 1.35 ± 0.76 
 
 
 
3.82± 2.94 3.37 ± 1.82 
3.45 ± 1.45 3.41 ± 1.88 
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Table 17 
 
RM-ANOVA for the Closed Base, Eyes Open Position for the Parameters from the AMTI 
 
Force Plate (n=22) 
 
 
 
F 
 
 
 
df 
 
 
 
p-value 
 
 
 
partial eta squared 
Maximum Velocity X (mm/s)     
Time 1.41 2 0.258 0.044 
Time*Group 0.35 2 0.689 0.087‡ 
Maximum Velocity Y (mm/s)     
Time 5.21 2 0.011† 0.049 
Time*Group 0.29 2 0.752 0.004 
Average Velocity (mm/s) 
Time 
 
 
5.09 
 
 
2 
 
 
0.012† 
 
 
0.046 i e*Group 0.58 2 0.566 0.091‡ 
Major Axis (mm
2)
 
    
Time 0.26 2 0.771 0.019 
Time*Group 0.28 2 0.757 0.094‡ 
Area Effective (mm
2
)     
Time 0.26 2 0.771 0.042 
Time*Group 0.30 2 0.743 0.102‡ 
Area 95 (mm
2
) 
Time 
 
 
0.69 
 
 
2 
 
 
0.509 
 
 
0.062‡ Time*Group 0.16 2 0.850 0.105‡ 
 
† p-value < 0.05 
‡effect size > 0.06 
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There was a significant main effect for time for the Maximum Velocity Y and the 
Average Velocity measures, indicating that both groups improved across the study 
period. There was no other significant main effects for time or any significant group*time 
interactions for any of the balance parameters in the closed base, eyes open position. All 
average velocities for each group fell into the range of what is considered “stable”. There 
were medium effect sizes for the Time*Group interaction (Maximum Velocity X), the 
Time*Group interaction (Average Velocity), and Time*Group interaction (Major Axis), 
the main effect for time (Area 95), and the Time*Group interaction (Area 95). All other 
effect sizes were small. 
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Table 18 
 
Means and Standard Deviations across Visits for Closed Base, Eyes Closed Assessed via 
the AMTI Force Plate (n=22) 
 
 
Maximum Velocity X (mm/s) 
Visit 1 (M ± SD) Visit 2 (M ± SD) Visit 3 (M ± SD) 
Intervention (n=11) 
Control (n=11) 
Maximum Velocity Y (mm/s) 
Intervention (n=11) 
Control (n=11) 
Average Velocity (mm/s) 
Intervention (n=11) 
8.06 ± 4.79 
6.12 ± 2.65 
 
 
-7.72 ± 5.83 
-6.15 ± 2.16 
 
 
2.66 ± 1.16 
8.72 ± 6.56 8.23 ± 2.19 
7.23 ± 2.03 6.58 ± 3.16 
 
 
-8.44 ± 6.48 -9.24 ± 3.93 
-7.90 ± 2.60 -6.80 ± 5.36 
 
 
2.64 ± 1.40 2.71 ± 0.74 
Control (n=11) 
 
Major Axis (mm
2)
 
2.03 ± 0.33 2.41 ± 0.65 2.42 ± 1.04 
Intervention (n=11) 
Control (n=11) 
 
Area Effective (mm
2
) 
Intervention (n=11) 
Control (n=11) 
 
Area 95 (mm
2
) 
Intervention (n=11) 
1.66 ± 0.51 
1.36 ± 0.41 
 
 
 
2.35 ± 1.27 
1.48 ± 0.91 
 
 
 
5.02 ± 2.14 
1.83 ± 0.59 1.72 ± 0.51 
1.62 ± 0.44 1.66 ± 0.61 
 
 
 
2.84 ± 1.95 2.64 ± 1.69 
2.05 ± 0.92 2.41 ± 1.83 
 
 
 
6.83 ± 5.07 7.01 ± 3.23 
Control (n=11) 3.96 ± 2.41 5.29 ± 2.10 6.78 ± 5.12 
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Table 19 
 
RM-ANOVA for the Closed Base, Eyes Closed Position for the Parameters from the 
 
AMTI Force Plate (n=22) 
 
 
 
F 
 
 
 
df 
 
 
 
p-value 
 
 
 
partial eta squared 
Maximum Velocity X (mm/s)     
Time 0.36 2 0.701 0.021 
Time*Group 0.02 2 0.976 0.001 
Maximum Velocity Y (mm/s)     
Time 0.67 2 0.520 0.038 
Time*Group 0.33 2 0.722 0.019 
Average Velocity (mm/s) 
Time 
 
 
0.68 
 
 
2 
 
 
0.514 
 
 
0.038 i e*Group 0.58 2 0.566 0.033 
Major Axis (mm
2)
 
    
Time 0.88 2 0.425 0.033 
Time*Group 0.21 2 0.423 0.038 
Area Effective (mm
2
)     
Time 1.35 2 0.275 0.083‡ 
Time*Group 0.39 2 0.681 0.025 
Area 95 (mm
2
) 
Time 
 
 
2.65 
 
 
2 
 
 
0.095 
 
 
0.155‡ Time*Group 0.19 2 0.829 0.013 
 
† p-value < 0.05 
‡effect size > 0.06 
 
 
 
There were no significant main effects for time or any significant group*time interactions 
for any of the balance parameters in the closed base, eyes closed position. There was a 
medium effect size for the main effect for time (Area Effective) and a large effect size for 
the main effect for time (Area 95). All other effect sizes were small. 
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Table 20 
 
Means and Standard Deviations across Visits for Semi-Tandem, Eyes Open Assessed via 
the AMTI Force Plate (n=22) 
 
 
Maximum Velocity X (mm/s) 
Visit 1 (M ± SD) Visit 2 (M ± SD) Visit 3 (M ± SD) 
Intervention (n=11) 
Control (n=11) 
Maximum Velocity Y (mm/s) 
Intervention (n=11) 
Control (n=11) 
Average Velocity (mm/s) 
Intervention (n=11) 
Control (n=11) 
 
Major Axis (mm
2)
 
Intervention (n=11) 
Control (n=11) 
 
Area Effective (mm
2
) 
Intervention (n=11) 
Control (n=11) 
 
Area 95 (mm
2
) 
Intervention (n=11) 
Control (n=11) 
5.42 ± 1.64 
32.83 ± 81.8 
 
 
-5.32 ± 1.36 
-17.37 ± 34.88 
 
 
2.06 ± 0.37 
3.72 ± 5.09 
 
 
 
1.36 ± 0.29 
2.52 ± 3.24 
 
 
 
1.44 ± 0.51 
9.14 ± 22.75 
 
 
 
3.87 ± 1.18 
15.53 ± 35.38 
5.59 ± 2.60 5.56 ± 1.33 
6.18 ± 1.83 5.57 ± 1.78 
 
 
-5.81 ± 2.56 -6.16 ± 1.41 
-6.14 ± 2.03 -6.34 ± 3.83 
 
 
2.05 ± 076 2.09 ± 0.36 
2.34 ± 0.69 2.09 ± 0.37 
 
 
 
1.37 ± 0.45 1.38 ± 0.26 
1.48 ± 0.26 1.40 ± 0.25 
 
 
 
1.48 ± 0.92 1.51± 0.48 
1.56 ± 0.48 1.50± 0.60 
 
 
 
3.84 ± 2.39 4.13 ± 1.33 
3.89 ± 1.39 4.09 ± 1.80 
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Table 21 
 
RM-ANOVA for the Semi-Tandem, Eyes Open Position for the Parameters from the 
 
AMTI Force Plate (n=22) 
 
 
 
F 
 
 
 
df 
 
 
 
p-value 
 
 
 
partial eta squared 
Maximum Velocity X (mm/s)     
Time 1.09 2 0.348 0.060‡ 
Time*Group 1.11 2 0.340 0.062‡ 
Maximum Velocity Y (mm/s) 
Time 
 
 
0.88 
 
 
2 
 
 
0.425 
 
 
0.049 *Group 1 11 341 0.061‡ 
Average Velocity (mm/s)     
Time 0.83 2 0.446 0.046 
Time*Group 0.85 2 0.438 0.047 
Major Axis (mm
2)
 
Time 
 
 
1.01 
 
 
2 
 
 
0.376 
 
 
0.056 Ti e*Group 1.10 2 0.344 0.061‡ 
Area Effective (mm
2
) 
Time 
 
 
1.09 
 
 
2 
 
 
0.349 
 
 
0.060‡ i e*Group 1.12 2 0.339 0.062‡ 
Area 95 (mm
2
)     
Time 1.01 2 0.374 0.056 
Time*Group 1.05 2 0.361 0.058 
 
† p-value < 0.05 
‡effect size > 0.06 
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There were no significant main effects for time or any significant group*time interactions 
for any of the balance parameters in the semi-tandem, eyes open position. At baseline, the 
control group had values that were considered “abnormal” for Maximum Velocity X and 
Y. These values fell within the normal range at all subsequent visits. All of the other 
mean values were within the range of what is considered “stable” for both the 
intervention and the control groups. There were medium effect sizes for the main effect 
for time (Maximum Velocity X), the Time*Group interaction (Maximum Velocity X), 
the Time*Group interaction (Maximum Velocity Y), the Time*Group interaction (Major 
Axis), the main effect for time (Area Effective), and the Time*Group interaction (Area 
Effective). All other effect sizes were small. 
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Table 22 
 
Means and Standard Deviations across Visits for Semi-Tandem, Eyes Closed Assessed 
via the AMTI Force Plate (n=22) 
 
 
Maximum Velocity X (mm/s) 
Visit 1 (M ± SD) Visit 2 (M ± SD) Visit 3 (M ± SD) 
Intervention (n=11) 
Control (n=11) 
Maximum Velocity Y (mm/s) 
Intervention (n=11) 
Control (n=11) 
Average Velocity (mm/s) 
Intervention (n=11) 
Control (n=11) 
 
Major Axis (mm
2)
 
12.60 ± 4.46 
38.50 ± 85.07 
 
 
-12.21 ± 5.05 
-20.20 ± 36.45 
 
 
3.83 ± 1.21 
4.55 ± 5.21 
10.48 ± 4.91 10.20 ± 4.02 
8.23 ± 1.88 9.88 ± 4.07 
 
 
-10.11 ± 5.14 -10.83 ± 4.68 
-8.88 ± 2.62 -8.73 ± 2.45 
 
 
3.45 ± 1.35 3.61 ± 1.35 
3.13 ± 0.68 3.06 ± 0.88 
Intervention (n=11) 2.29 ± 1.05 2.36 ± 0.89 2.18 ± 1.19 
Control (n=11) 
 
Area Effective (mm
2
) 
Intervention (n=11) 
Control (n=11) 
 
Area 95 (mm
2
) 
Intervention (n=11) 
Control (n=11) 
2.98 ± 3.33 
 
 
 
4.35 ± 3.51 
10.92 ± 23.84 
 
 
 
10.79 ± 7.28 
19.31 ± 36.76 
1.99 ± 0.44 1.92 ±0.41 
 
 
 
4.22 ± 2.49 4.31 ± 5.26 
2.98 ± 1.29 2.82 ± 0.91 
 
 
 
9.99 ± 5.31 11.30 ± 13.06 
7.90 ± 3.62 7.40 ± 2.60 
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Table 23 
 
RM-ANOVA for the Semi-Tandem, Eyes Closed Position for the Parameters from the 
 
AMTI Force Plate (n=22) 
 
 
 
F 
 
 
 
df 
 
 
 
p-value 
 
 
 
partial eta squared 
Maximum Velocity X (mm/s)     
Time 1.42 2 0.256 0.082‡ 
Time*Group 1.05 2 0.363 0.061‡ 
Maximum Velocity Y (mm/s) 
Time 
 
 
1.28 
 
 
2 
 
 
0.292 
 
 
0.074‡ *Group 0 70 506 0.042 
Average Velocity (mm/s) 
Time 
 
 
1.13 
 
 
2 
 
 
0.335 
 
 
0.066‡ i e*Group 0.51 2 0.605 0.031 
Major Axis (mm
2)
 
    
Time 0.80 2 0.459 0.053 
Time*Group 0.70 2 0.506 0.051 
Area Effective (mm
2
) 
Time 
 
 
1.09 
 
 
2 
 
 
0.347 
 
 
0.047 Ti e*Group 1.05 2 0.363 0.042 
Area 95 (mm
2
) 
Time 
 
 
0.90 
 
 
2 
 
 
0.418 
 
 
0.064‡ Time*Group 0.87 2 0.430 0.061‡ 
 
† p-value < 0.05 
‡effect size > 0.06 
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There were no significant main effects for time or any significant group*time interactions 
for any of the balance parameters in the semi-tandem, eyes closed position. The mean 
values for both the intervention and the control were considered “abnormal” for the 
Maximum Velocity X and Y outcomes. These values came into the “stable” range for all 
remaining study visits. The other parameters were considered “stable” across all visits for 
both study groups. There was a medium effect size for the main effect for Time 
(Maximum Velocity X), the Time*Group interaction (Maximum Velocity X), the main 
effect for Time (Maximum Velocity Y), the main effect for Time (Average Velocity), the 
main effect for time (Area 95), and the Time*Group interaction (Area 95). All other 
effect sizes were small. 
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Table 24 
 
Means and Standard Deviations across Visits for Tandem Step, Eyes Open (10 sec) 
Assessed via the AMTI Force Plate (n=22) 
 
 
 
Maximum Velocity X (mm/s) 
Visit 1 (M ± SD)   Visit 2 (M ± SD)  Visit 3 (M ± SD) 
Intervention (n=11) 12.99 ± 6.25 11.24 ± 2.96 12.24 ± 3.63 
Control (n=11) 
Maximum Velocity Y (mm/s) 
Intervention (n=11) 
Control (n=11) 
Average Velocity (mm/s) 
Intervention (n=11) 
Control (n=11) 
 
Major Axis (mm
2)
 
Intervention (n=11) 
Control (n=11) 
 
Area Effective (mm
2
) 
Intervention (n=11) 
Control (n=11) 
 
Area 95 (mm
2
) 
Intervention (n=11) 
Control (n=11) 
18.87 ± 15.70 
 
 
-12.17 ± 6.25 
-19.17 ± 19.73 
 
 
4.12 ± 1.21 
4.92 ± 2.48 
 
 
 
1.79 ± 0.66 
3.60 ± 4.00 
 
 
 
2.56 ± 1.42 
16.18 ± 32.19 
 
 
 
6.53 ± 3.44 
30.46 ± 57.03 
12.65 ± 4.23 12.24 ± 3.86 
 
 
-12.59 ± 5.69 -11.06 ± 4.01 
-11.17 ± 1.99 -11.78 ± 5.23 
 
 
3.99 ± 1.01 4.00 ± 1.16 
4.37 ± 1.34 4.34 ± 1.44 
 
 
 
2.22 ± 0.98 2.12 ± 0.84 
1.92 ± 0.56 1.97 ± 0.67 
 
 
 
4.05 ± 3.06 3.63 ± 2.53 
3.02 ± 1.95 3.03 ± 2.01 
 
 
 
8.04 ± 5.94 9.28 ± 6.20 
10.28 ± 6.76 7.83 ± 4.96 
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Table 25 
 
RM-ANOVA for the Tandem Step, Eyes Open (10 sec) Position for the Parameters from 
 
the AMTI Force Plate (n=22) 
 
 
 
F 
 
 
 
df 
 
 
 
p-value 
 
 
 
partial eta squared 
Maximum Velocity X (mm/s)     
Time 1.69 2 0.199 0.091‡ 
Time*Group 0.81 2 0.453 0.045 
Maximum Velocity Y (mm/s)     
Time 1.32 2 0.281 0.072‡ 
Time*Group 0.72 2 0.495 0.040 
Average Velocity (mm/s) 
Time 
 
 
0.51 
 
 
2 
 
 
0.607 
 
 
0.029 i e*Group 1.04 2 0.363 0.058 
Major Axis (mm
2) 
Time 
 
 
0.91 
 
 
2 
 
 
0.411 
 
 
0.051 Ti e*Group 2.29 2 0.117 0.119‡ 
Area Effective (mm
2
)     
Time 1.32 2 0.280 0.072‡ 
Time*Group 1.95 2 0.157 0.103‡ 
Area 95 (mm
2
) 
Time 
 
 
1.09 
 
 
2 
 
 
0.349 
 
 
0.060‡ Time*Group 1.94 2 0.160 0.102‡ 
 
† p-value < 0.05 
‡ partial eta squared > 0.06 
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There was no significant main effect for time or a significant group*time interaction for 
any of the balance parameters in the tandem step, eyes open (10 sec) position. The 
Maximum Velocity X and Y values were considered “abnormal” for both the intervention 
and the control group across all study visits. All other outcome measures fell within the 
“stable” range for both groups. There was a medium effect size for the main effect for 
time (Maximum Velocity X), the main effect for time (Maximum Velocity Y), the 
Time*Group interaction (Major Axis), the main effect for Time (Area Effective), the 
Time*Group interaction (Area Effective), the main effect for Time (Area 95), and the 
Time*Group interaction (Area 95). All other effect sizes were small. 
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Table 26 
 
Means and Standard Deviations across Visits for Tandem Step, Eyes Closed Assessed via 
the AMTI Force Plate (n=10) 
 
 
Maximum Velocity X (mm/s) 
Visit 1 (M ± SD) Visit 2 (M ± SD) Visit 3 (M ± SD) 
Intervention (n=5) 20.84 ± 7.04 14.95 ± 4.96 16.13 ± 5.07 
Control (n=5) 
Maximum Velocity Y (mm/s) 
9.60 ± 11.57 19.05 ± 5.43 22.96 ± 6.35 
Intervention (n=5) 
Control (n=5) 
Average Velocity (mm/s) 
Intervention (n=5) 
Control (n=5) 
 
Major Axis (mm
2)
 
Intervention (n=5) 
Control (n=5) 
 
Area Effective (mm
2
) 
Intervention (n=5) 
Control (n=5) 
 
Area 95 (mm
2
) 
Intervention (n=5) 
Control (n=5) 
-19.67 ± 6.45 
-8.15 ± 9.84 
 
 
6.31 ± 1.33 
2.64 ± 2.64 
 
 
 
2.68 ± 0.82 
1.73 ± 1.25 
 
 
 
5.49 ± 2.63 
2.55 ± 3.02 
 
 
 
14.34 ± 6.77 
6.31 ± 7.96 
-14.26 ± 4.48 -19.25 ± 4.34 
-17.98 ± 3.24 -16.72 ± 1.13 
 
 
4.90 ± 1.21 5.21 ± 0.92 
5.26 ± 1.16 7.43 ± 1.35 
 
 
 
2.15 ± 0.65 2.90 ± 0.39 
2.97 ± 0.05 3.96 ± 3.15 
 
 
 
3.48 ± 1.81 6.40 ± 1.75 
5.77 ± 3.21 2.35± 3.11 
 
 
 
8.54 ± 3.26 17.24 ± 5.49 
16.17 ± 3.97 36.21 ± 41.76 
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Table 27 
 
RM-ANOVA for the Tandem Step, Eyes Closed Position for the Parameters from the 
 
AMTI Force Plate (n=10) 
 
 
 
F 
 
 
 
df 
 
 
 
p-value 
 
 
 
partial eta squared 
Maximum Velocity X (mm/s)     
Time 0.74 2 0.499 0.110‡ 
Time*Group 3.72 2 0.051† 0.383‡ 
Maximum Velocity Y (mm/s)     
Time 1.13 2 0.355 0.148‡ 
Time*Group 3.99 2 0.047† 0.400‡ 
Average Velocity (mm/s) 
Time 
 
 
3.79 
 
 
2 
 
 
0.059 
 
 
0.431‡ i e*Group 14.28 2 0.001† 0.741‡ 
Major Axis (mm
2)
 
Time 
 
 
2.77 
 
 
2 
 
 
0.102 
 
 
0.316‡ Ti e*Group 2.11 2 0.164 0.260‡ 
Area Effective (mm
2
)     
Time 0.49 2 0.622 0.091‡ 
Time*Group 2.49 2 0.133 0.332‡ 
Area 95 (mm
2
) 
Time 
 
 
4.74 
 
 
2 
 
 
0.030† 
 
 
0.441‡ Time*Group 2.72 2 0.106 0.312‡ 
 
† p-value < 0.05 
‡ partial eta squared > 0.06 
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Figure 3. Group Means for Maximum Velocity (x) across Study Visits (n=10) 
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Figure 4. Group Means for Maximum Velocity (y) across Study Visits (n=10) 
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Figure 5. Group Means for Average Velocity across Study Visits (n=10) 
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Figure 6. Group Means for 95% Area across Study Visits (n=10). *Indicates a 
 
statistically significant difference from visit 2 (p < 0.05, control group only). 
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There was a significant group*time interaction and large effect sizes for all of the  
velocity parameters (main effect for Time and Time*Group interaction). For maximum x 
velocity, maximum y velocity, and average velocity, the intervention group’s values 
remained stable, indicating maintained balance along the anteroposterior and mediolateral 
axes, while the control group’s velocities increased. 
 
 
 
The main effect for time in the average velocity parameter is trending toward significance 
and has a large effect size, indicating that all groups changed throughout the course of the 
study period. The major axis also has a large effect size, but the main effect was not 
significant. There was a main effect for time and a large effect size for 95% area. Both 
groups did have a greater area change over the course of the study period, but there was 
also a large effect size for the time*group interaction. The control group had a much 
greater area change than the intervention group, with a significant area difference 
between visits 2 and 3. A large effect size was calculated for the time*group interaction 
for area effective, although the interaction was not statistically significant. 
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Table 28 
 
Means and Standard Deviations across Visits for Single Leg, Eyes Open Assessed via the 
AMTI Force Plate (n=19) 
 
 
Maximum Velocity X (mm/s) 
Visit 1 (M ± SD) Visit 2 (M ± SD) Visit 3 (M ± SD) 
Intervention (n=10) 
Control (n=9) 
Maximum Velocity Y (mm/s) 
Intervention (n=10) 
Control (n=9) 
Average Velocity (mm/s) 
Intervention (n=10) 
Control (n=9) 
 
Major Axis (mm
2)
 
16.53 ± 8.96 
18.14 ± 8.05 
 
 
-18.44 ± 10.47 
-14.21 ± 7.55 
 
 
6.00 ± 2.99 
5.13 ± 2.31 
21.95 ± 8.76 
20.44 ± 6.96 
 
 
-19.68 ± 5.50 
-17.29 ± 5.26 
 
 
6.39 ± 1.48 
5.27 ± 1.36 
16.61± 10.21 
16.56 ± 4.54 
 
 
-13.81 ± 5.98 
-14.03 ± 3.79 
 
 
4.78 ± 1.51 
4.66 ± 0.77 
Intervention (n=10) 
Control (n=9) 
 
Area Effective (mm
2
) 
Intervention (n=10) 
Control (n=9) 
 
Area 95 (mm
2
) 
Intervention (n=10) 
2.01 ± 1.22 
1.74 ± 0.53 
 
 
 
3.84 ± 4.32 
2.68 ± 1.56 
 
 
 
10.21 ± 10.81 
1.98 ± 0.29 1.48 ± 0.37 
1.73 ± 0.51 1.63 ± 0.34 
 
 
 
3.29 ± 0.79 1.94 ± 0.83 
2.93 ± 1.19 2.24 ± 0.94 
 
 
 
9.39 ± 2.23 5.61 ± 2.38 
Control (n=9) 7.64 ± 4.69 7.53 ± 3.88 6.35 ± 2.68 
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Table 29 
 
RM-ANOVA for the Single Leg, Eyes Open Position for the Parameters from the AMTI 
 
Force Plate (n=19) 
 
 
 
F 
 
 
 
df 
 
 
 
p-value 
 
 
 
partial eta squared 
Maximum Velocity X (mm/s)     
Time 1.09 2 0.350 0.068‡ 
Time*Group 1.54 2 0.230 0.093‡ 
Maximum Velocity Y (mm/s)     
Time 0.14 2 0.867 0.009 
Time*Group 1.50 2 0.240 0.091‡ 
Average Velocity (mm/s) 
Time 
 
 
0.79 
 
 
2 
 
 
0.463 
 
 
0.050 i e*Group 1.49 2 0.242 0.090‡ 
Major Axis (mm
2)
 
    
Time 0.25 2 0.784 0.016 
Time*Group 2.37 2 0.111 0.136‡ 
Area Effective (mm
2
)     
Time 0.73 2 0.490 0.046 
Time*Group 1.63 2 0.213 0.098‡ 
Area 95 (mm
2
) 
Time 
 
 
0.90 
 
 
2 
 
 
0.418 
 
 
0.064‡ Time*Group 1.47 2 0.246 0.111‡ 
 
† p-value < 0.05 
‡ partial eta squared > 0.06 
86 
 
 
There was no significant main effect for time or a significant group*time interaction for 
any of the balance parameters in the single leg, eyes open position. There values for 
Maximum Velocity X and Maximum Velocity Y were considered to be in the 
“abnormal” range for both the intervention and the control, and remained within that 
range at all study visits. There was a medium effect size for the main effect for Time 
(Maximum Velocity X), the Time*Group interaction (Maximum Velocity X), the 
Time*Group interaction (Maximum Velocity Y), the Time *Group interaction (Average 
Velocity), the Time*Group interaction (Area Effective), the main effect for Time (Area 
95), and the Time*Group interaction (Area 95). There was a large effect size for the 
Time*Group interaction (Major Axis). All other effect sizes were small. 
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Table 30 
 
Means and Standard Deviations across Visits for Open Base, Eyes Closed Assessed via 
the AMTI Force Plate (n=22) 
 
 
Maximum Velocity X (mm/s) 
Visit 1 (M ± SD) Visit 2 (M ± SD) Visit 3 (M ± SD) 
Intervention 
Control 
Maximum Velocity Y (mm/s) 
Intervention 
Control 
Average Velocity (mm/s) 
Intervention 
Control 
 
Major Axis (mm
2)
 
Intervention 
Control 
 
Area Effective (mm
2
) 
Intervention 
Control 
 
Area 95 (mm
2
) 
Intervention 
Control 
5.79 ± 9.01 
2.02 ± 0.81 
 
 
-4.43 ± 6.47 
-1.94 ± 0.54 
 
 
2.82 ± 4.73 
1.13 ± 0.23 
 
 
 
1.73 ± 1.62 
1.02 ± 0.24 
 
 
 
3.95 ± 8.89 
0.65 ± 0.26 
 
 
 
10.52 ± 25.61 
1.14 ± 0.53 
2.05 ± 0.45 3.15 ± 1.91 
2.14 ± 0.78 2.95 ± 1.89 
 
 
-2.54 ± 1.08 -3.08 ± 1.49 
-2.84 ± 2.17 -2.82 ± 0.95 
 
 
1.26 ± 0.31 1.18 ± 0.26 
1.39 ± 0.27 1.38 ± 0.39 
 
 
 
1.11 ± 0.31 1.08 ± 0.22 
1.35 ± 0.47 1.34 ± 0.77 
 
 
 
0.77 ± 0.39 0.73 ± 0.25 
1.24 ± 1.07 1.31 ± 1.59 
 
 
 
1.38 ± 0.72 1.41 ± 0.37 
2.54 ± 3.03 1.97 ± 1.98 
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Table 31 
 
RM-ANOVA for the Open Base, Eyes Closed Position for the Parameters from the AMTI 
 
Force Plate 
 
 
 
F 
 
 
 
df 
 
 
 
p-value 
 
 
 
partial eta squared 
Maximum Velocity X (mm/s)     
Time 1.09 2 0.350 0.068‡ 
Time*Group 1.54 2 0.230 0.093‡ 
Maximum Velocity Y (mm/s)     
Time 0.14 2 0.867 0.009 
Time*Group 1.50 2 0.240 0.091‡ 
Average Velocity (mm/s) 
Time 
 
 
0.79 
 
 
2 
 
 
0.463 
 
 
0.050 i e*Group 1.49 2 0.242 0.090‡ 
Major Axis (mm
2)
 
    
Time 0.25 2 0.784 0.016 
Time*Group 2.37 2 0.111 0.136‡ 
Area Effective (mm
2
)     
Time 0.73 2 0.490 0.046 
Time*Group 1.63 2 0.213 0.098‡ 
Area 95 (mm
2
) 
Time 
 
 
0.90 
 
 
2 
 
 
0.418 
 
 
0.064‡ Time*Group 1.47 2 0.246 0.111‡ 
 
† p-value < 0.05 
‡ partial eta squared > 0.06 
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There were no significant main effects for time or any significant group*time interactions 
for any of the balance parameters in the open base, eyes closed position. All parameters 
were in the range of what is considered “stable”. There was a medium effect for the main 
effect for Time (Maximum Velocity X), the Time*Group interaction (Maximum Velocity 
X), the Time*Group interaction (Maximum Velocity Y), the Time*Group interaction 
(Average Velocity), the Time*Group interaction (Major Axis), the Time*Group 
interaction (Area Effective), the main effect for time (Area 95), and the Time*Group 
interaction (Area 95). 
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Table 32 
 
Means and Standard Deviations across Visits for Tandem Step, Eyes Open (30 sec) 
Assessed via AMTI Force Plate (n=22) 
 
 
Maximum Velocity X (mm/s) 
Intervention (n=11) 
Control (n=11) 
Maximum Velocity Y (mm/s) 
Intervention (n=11) 
Control (n=11) 
Average Velocity (mm/s) 
Intervention (n=11) 
Control (n=11) 
 
Major Axis (mm
2)
 
Intervention (n=11) 
Control (n=11) 
 
Area Effective (mm
2
) 
Intervention (n=11) 
Control (n=11) 
 
Area 95 (mm
2
) 
Intervention (n=11) 
Control (n=11) 
Visit 1 (M ± SD) 
 
 
14.15 ± 3.06 
20.64 ± 10.38 
 
 
-13.17 ± 2.38 
-21.95 ± 15.10 
 
 
3.74 ± 0.80 
4.50 ± 1.65 
 
 
 
1.87 ± 0.29 
2.41 ± 0.86 
 
 
 
2.79 ± 0.81 
4.63 ± 3.07 
 
 
 
7.83 ± 2.29 
11.79 ± 7.42 
Visit 2 (M ± SD) Visit 3 (M ± SD) 
 
 
14.07 ± 6.13 14.37 ± 3.73 
13.06 ± 1.78 14.53 ± 5.19 
 
 
-13.45 ± 5.10 -12.94 ± 3.26 
-12.76 ± 3.86 -13.14 ± 7.22 
 
 
4.00 ± 1.24 3.55 ± 0.61 
3.43 ± 0.73 3.49 ± 1.08 
 
 
 
2.23 ± 0.94 1.90 ± 0.53 
1.76 ± 0.14 2.06± 0.97 
 
 
 
4.00 ± 3.09 3.02 ± 1.48 
2.45 ± 0.47 3.81 ± 4.00 
 
 
 
9.56 ± 5.12 8.34 ± 3.79 
6.81 ± 1.66 10.41 ± 10.74 
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Table 33 
 
RM-ANOVA for the Tandem Step, Eyes Open (30 sec) Position for the Parameters from 
 
the AMTI Force Plate (n=22) 
 
 
 
F 
 
 
 
df 
 
 
 
p-value 
 
 
 
partial eta squared 
Maximum Velocity X (mm/s)     
Time 2.48 2 0.102 0.151‡ 
Time*Group 2.51 2 0.100 0.152‡ 
Maximum Velocity Y (mm/s) 
Time 
 
 
2.14 
 
 
2 
 
 
0.137 
 
 
0.132‡ *Group 8 2 5
Average Velocity (mm/s) 
Time 
 
 
1.55 
 
 
2 
 
 
0.230 
 
 
0.100‡ i e*Group 1.19 2 0.173 0.118‡ 
Major Axis (mm
2)
 
    
Time 0.29 2 0.751 0.020 
Time*Group 2.43 2 0.107 0.148‡ 
Area Effective (mm
2
) 
Time 
 
 
0.17 
 
 
2 
 
 
0.844 
 
 
0.012 Ti e*Group 2.13 2 0.138 0.132‡ 
Area 95 (mm
2
) 
Time 
 
 
0.36 
 
 
2 
 
 
0.702 
 
 
0.025 Time*Group 1.51 2 0.238 0.098‡ 
 
† p-value < 0.05 
‡ partial eta squared > 0.06 
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There were no significant main effects for time or any significant group*time interactions 
for any of the balance parameters in the tandem step, eyes open (30 second) position. 
There are no guidelines for this position to establish what is considered “stable” versus 
“abnormal”. There was a large effect size for the main effect for Time (Maximum 
Velocity X), the Time*Group interaction (Maximum Velocity X), the main effect for 
Time (Maximum Velocity Y), the Time*Group interaction (Maximum Velocity Y), the 
main effect for Time (Average Velocity), the Time*Group interaction (Average 
Velocity),  the Time*Group interaction (Major Axis), the Time*Group interaction (Area 
Effective), and the Time*Group interaction (Area 95). 
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SECONDARY HYPOTHESIS 1 
 
12 weeks of interactive play will significantly increase muscular strength and endurance 
of the knee extensors and flexors in middle-aged women as compared to a randomly 
assigned control group. Independent samples t-tests were conducted to determine any 
differences between groups at baseline across all measures (Table 34 (knee extensors), 
Table 35 (knee flexors)). Repeated Measures Analysis of Variance (RM-ANOVA) were 
run to assess a main effect for time and any time*group interaction (Table 37 (knee 
extensors), Table 39 (knee flexors)). There were no significant differences between 
groups at baseline. Means and standard deviations across study visits for each group can 
be found in Table 36 (knee extensors) and Table 38 (knee flexors). 
 
 
 
Baseline data is presented first, followed by table pairs for the flexor and extensor groups. 
The table pairs consist of the means and standard deviations for both groups across all 
visits and the repeated measures analysis. These table pairs are followed by any necessary 
figures and the brief interpretation of the data. The table pairs will proceed as follows: 
Extensor Peak Torque and Endurance; Flexor Peak Torque and Endurance. 
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Table 34 
 
Baseline Knee Extensor Results across Groups for All Angular Velocities and Endurance 
Outcomes (n=22) 
 
 
60 degrees/sec 
Intervention (M ± SD) Control (M ± SD) p-value 
Right (ft∙lb) 29.63 ± 9.30 34.90 ± 13.81 0.37 
Left (ft∙lb) 
180 degrees/sec 
Right (ft∙lb) 
Left (ft∙lb) 
240 degrees/sec 
Right (ft∙lb) 
Left (ft∙lb) 
Endurance 
Right 
Left 
27.75 ± 9.34 
 
 
14.09 ± 8.92 
16.36 ± 14.39 
 
 
8.09 ± 3.51 
6.91 ± 3.23 
 
 
1.81 ± 36.47 
12.63 ± 39.14 
35.20 ± 8.62 
 
 
16.10 ± 8.67 
16.50 ± 7.76 
 
 
9.30 ± 5.27 
9.50 ± 5.27 
 
 
2.00 ± 56.11 
3.60 ± 47.87 
0.098 
 
 
0.607 
0.979 
 
 
0.540 
0.198 
 
 
0.993 
0.640 
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Table 35 
 
Baseline Knee Flexor Results across Groups for All Angular Velocities and Endurance 
Outcomes (n=22) 
 
 
 
 
 
60 degrees/sec 
Right (ft∙lb) 
Left (ft∙lb) 
180 degrees/sec 
Intervention (M ± SD) Control (M ± SD) p-value 
 
 
14.75 ± 6.31 10.80± 7.04 0.234 
12.12 ± 4.39 11.70 ± 7.57 0.890 
Right (ft∙lb) 8.45 ± 4.45 8.00 ± 5.64 0.840 
Left (ft∙lb) 
240 degrees/sec 
Right (ft∙lb) 
4.00 ± 13.87 8.10 ± 5.99 0.399 
 
 
5.27 ± 3.32 6.00 ± 3.68 0.860 
Left (ft∙lb) 
Endurance 
6.09 ± 3.91 6.30 ± 4.87 0.914 
Right 
Left 
-7.72 ± 30.73 -7.70 ± 36.78 0.999 
9.91 ± 36.84 3.40 ± 23.44 0.639 
 
 
 
 
There were no statistically significant differences between groups at baseline for either 
the knee extensor or the knee flexor muscle groups. 
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Table 36 
 
Means and Standard Deviations across Visits for Peak Torque and Fatigue for Knee 
Extensor Group Assessed via the Isokinetic Dynamometer (n=22) 
 
 
 
 
 
60 degrees/sec 
Right (ft∙lb) 
Intervention (n=11) 
Control (n=11) 
Left (ft∙lb) 
Intervention (n=11) 
Visit 1 (M ± SD) 
 
 
 
29.63 ± 9.30 
34.90 ± 13.81 
 
 
27.75 ± 9.34 
Visit 2 (M ± SD) Visit 3 (M ± SD) 
 
 
 
31.06 ± 5.68 28.10 ± 14.49 
30.65 ± 10.86 27.37 ± 9.03 
 
 
25.69 ± 13.00 27.50 ± 12.33 
Control (n=11) 
180 degrees/sec 
Right (ft∙lb) 
 
Intervention (n=11) 
35.20 ± 8.61 
 
 
 
 
14.09 ± 8.91 
34.85 ± 14.07 
 
 
 
 
18.14 ± 6.49 
26.00 ± 7.73 
 
 
 
 
17.64 ± 8.45 
Control (n=11) 
Left (ft∙lb) 
 
Intervention (n=11) 
Control (n=11) 
240 degrees/sec 
 
Right (ft∙lb) 
Intervention (n=11) 
Control (n=11) 
 
Left (ft∙lb) 
Intervention (n=11) 
Control (n=11) 
Endurance 
Right (ft∙lb) 
16.10 ± 8.67 
 
 
 
16.36 ± 14.39 
16.50 ± 7.67 
 
 
 
 
8.09 ± 3.51 
9.30 ± 5.27 
 
 
 
6.91 ± 3.23 
9.50 ± 5.27 
16.65 ± 9.32 17.70 ± 11.85 
 
 
 
17.45 ± 6.97 16.91 ± 8.47 
17.30 ± 9.21 17.40 ± 11.45 
 
 
 
 
12.55 ± 5.63 11.55 ± 6.58 
10.60 ± 7.71 11.80 ± 6.65 
 
 
 
11.96 ± 6.67 12.18 ± 6.29 
10.91 ± 7.13 12.20 ± 8.01 
Intervention (n=11) 1.81 ± 36.47 7.41 ± 57.45 24.27 ± 37.68 
Control (n=11) 
Left (ft∙lb) 
Intervention (n=11) 
Control (n=11) 
2.00 ± 56.11 
 
 
12.63 ± 39.14 
3.60 ± 47.87 
1.5 ± 41.46 4.20 ± 38.05 
 
 
0.955 ± 53.58 2.82 ± 44.73 
0.250 ± 63.12 15.60 ± 35.04 
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Velocities (n=22) 
 
 
 
F 
 
 
 
df 
 
 
 
p-value 
 
 
 
partial eta squared 
60 degrees/sec     
Right 
Time 
 
 
1.456 
 
 
2 
 
 
0.250 
 
 
0.083‡ 
Time*Group 0.615 2 0.547 0.037 
 
Time 
 
1.895 
 
2 
 
0.167 
 
0.106‡ 
Time*Group 
180 degrees/sec 
Right 
Time 
1.271 
 
 
 
0.855 
2 
 
 
 
2 
0.294 
 
 
 
0.421 
0.074‡ 
 
 
 
0.044 
Time*Group 
Left 
Time 
0.340 
 
 
0.116 
2 
 
 
2 
0.714 
 
 
0.891 
0.018 
 
 
0.006 
Time*Group 
240 degrees/sec 
Right 
Time 
0.015 
 
 
 
2.503 
2 
 
 
 
2 
0.985 
 
 
 
0.095 
0.001 
 
 
 
0.116‡ 
Time*Group 
Left 
Time 
0.573 
 
 
4.861 
2 
 
 
2 
0.569 
 
 
0.013† 
0.029 
 
 
0.204‡ 
Time*Group 
Endurance 
Right 
Time 
0.953 
 
 
 
1.034 
2 
 
 
 
2 
0.395 
 
 
 
0.365 
0.048 
 
 
 
0.052 
Time*Group 
Left 
Time 
0.41 
 
 
0.476 
2 
 
 
2 
0.667 
 
 
0.625 
0.021 
 
 
0.024 
Time*Group 0.623 2 0.542 0.032 
 
Table 37 
 
RM-ANOVA for Peak Torque and Fatigue for Knee Extensor Group for All Angular 
 
 
 
 
 
 
 
 
 
 
 
 
Left 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
† p-value < 0.05 
‡ partial eta squared > 0.06 
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There was a significant main effect for time for the left 240°/sec peak torque. There were 
no significant main effects for time or any significant group*time interactions for any of 
the other angular velocities in either leg or for the endurance outcome. There was a 
medium effect size for the main effect for Time (right 60°/sec), the main effect for Time 
(left 60°/sec), the Time*Group interaction (left 60°/sec), the main effect for time (right 
240°/sec), and the main effect for time (left 240°/sec). All other effect sizes were small. 
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Table 38 
 
Means and Standard Deviations across Visits for Peak Torque and Fatigue for Knee 
Flexor Group Assessed via the Isokinetic Dynamometer (n=22) 
 
 
 
 
 
60 degrees/sec 
Right (ft∙lb) 
Visit 1 (M ± SD) Visit 2 (M ± SD) Visit 3 (M ± SD) 
Intervention (n=11) 14.75 ± 6.31 17.56 ± 6.31 13.25 ± 5.80 
Control (n=11) 
Left (ft∙lb) 
10.80 ± 7.04 17.90 ± 20.01 9.00 ± 4.42 
Intervention (n=11) 
Control (n=11) 
180 degrees/sec 
Right (ft∙lb) 
 
Intervention (n=11) 
12.12 ± 4.39 
11.70 ± 7.57 
 
 
 
 
8.45 ± 4.52 
12.94 ± 5.36 13.00 ± 6.34 
14.65 ± 12.33 11.00 ± 7.24 
 
 
 
 
9.59 ± 4.17 7.82 ± 4.40 
Control (n=11) 
Left (ft∙lb) 
8.00 ± 5.63 6.35 ± 3.40 6.80 ± 5.53 
 
Intervention (n=11) 
 
4.00 ± 13.87 
 
8.18 ± 4.35 8.64 ± 5.10 
Control (n=11) 
240 degrees/sec 
 
Right (ft∙lb) 
Intervention (n=11) 
Control (n=11) 
 
Left (ft∙lb) 
Intervention (n=11) 
8.10 ± 5.99 
 
 
 
 
5.27 ± 3.32 
6.00 ± 3.68 
 
 
 
6.09 ± 3.91 
6.00 ± 3.46 
 
 
 
 
8.91 ± 4.28 
5.00 ± 2.75 
 
 
 
6.32 ± 3.91 
7.30 ± 4.81 
 
 
 
 
6.45 ± 2.73 
6.00 ± 3.32 
 
 
 
6.36 ± 3.56 
 
 
Endurance 
Control (n=11) 6.30 ± 4.87 5.95 ± 3.46 6.60 ± 3.72 
Right (ft∙lb) 
Intervention (n=11) 
 
 
-7.72 ± 30.73 
 
 
4.64 ± 33.08 10.18 ± 19.64 
Control (n=11) 
Left (ft∙lb) 
-7.70 ± 36.78 -12.35 ± 40.61 -22.40 ± 49.02 
Intervention (n=11) 
Control (n=11) 
9.91 ± 36.84 
3.40 ± 23.44 
-7.05 ± 44.15 0.18 ± 36.10 
0.350 ± 25.76 2.80 ± 34.29 
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Velocities (n=22) 
 
 
 
F 
 
 
 
df 
 
 
 
p-value 
 
 
 
partial eta squared 
60 degrees/sec     
Right     
Time 3.054 2 0.061 0.162‡ 
Time*Group 0.425 2 0.657 0.026 
 
Time 
 
0.487 
 
2 
 
0.619 
 
0.030 
Time*Group 0.375 2 0.690 0.023 
180 degrees/sec 
Right 
    
Time 0.520 2 0.598 0.027 
Time*Group 1.258 2 0.296 0.062‡ 
Left     
Time 0.472 2 0.627 0.024 
Time*Group 1.488 2 0.239 0.073‡ 
240 degrees/sec 
Right 
    
Time 0.916 2 0.409 0.046 
Time*Group 
Left 
3.705 2 0.034† 0.163‡ 
Time 0.151 2 0.860 0.008 
Time*Group 0.128 2 0.881 0.007 
Endurance 
Right 
    
Time 0.157 2 0.855 0.008 
Time*Group 2.787 2 0.074 0.128‡ 
Left     
Time 0.672 2 0.516 0.034 
Time*Group 0.335 2 0.717 0.017 
 
Table 39 
 
RM-ANOVA for Peak Torque and Fatigue for Knee Flexor Group for All Angular 
 
 
 
 
 
 
 
 
 
 
 
 
Left 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
† p-value < 0.05 
‡ partial eta squared > 0.06 
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Figure 7. Change in peak torque for the right knee flexors at 240 degrees/sec (n=22). 
 
*Indicates a statistically significant difference between groups (p < 0.05). 
 
 
 
 
 
 
 
There was a significant time*group interaction for peak torque in the right leg at 240 
degrees/sec. The intervention group improved their peak torque at visit 2, but any gain 
was lost at visit 3. There were no significant main effects for time and no other 
time*group interactions in any of the angular velocities in either leg. There was a 
medium effect size for the main effect for Time (right 60°/sec), the Time*Group 
interaction (right 180°/sec), the Time*Group interaction (left 180°/sec), the Time*Group 
interaction (right 240°/sec), and the Time*Group interaction (right fatigue index). All 
other effects sizes were small. 
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SECONDARY HYPOTHESIS 2 
 
12 weeks of interactive play will significantly increase bone health parameters at the Os 
Calcis, as measured by qualitative ultrasound (QUS), and site-specific measures of bone 
health, as measured by dual-energy x-ray absorptiometry (DXA), in middle-aged women 
as compared to a randomly assigned control group. Independent samples t-tests were 
conducted to determine any differences between groups at baseline across all measures 
(Table 40 (QUS), Tables 41-43 (DXA)). Repeated Measures Analysis of Variance (RM- 
ANOVA) were run to assess a main effect for time and any time*group interaction (Table 
45 (QUS), Tables 47, 49, 51 (DXA)). There were no significant differences at baseline 
between groups. Means and standard deviations for each group can be found in Table 44 
(QUS) and Tables 46, 48, 50 (DXA). 
 
 
 
Baseline data is presented first for the QUS and DXA, followed by the table pairs for the 
QUS and the DXA. The table pairs consist of the means and standard deviations across 
all visits and the RM-ANOVA results. Individual change data for the DXA results follow 
the DXA table pairs, but come before the interpretation. Any necessary figures will 
follow the tables, but precede the brief interpretation. 
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Table 40 
 
Baseline Qualitative Ultrasound (QUS) Parameters across Groups (n=22) 
 
 
 
T-score 
Right 
Left 
Z-score 
Intervention (M ± SD)  Control (M ± SD) p-value 
 
 
-0.76 ± 0.77 -0.48 ± 0.98 0.502 
-0.84 ± 0.91 -0.20 ± 0.82 0.142 
 
Right 0.21 ± 0.77 0.41 ± 0.93 0.622 
Left 0.10 ± 1.09 0.70 ± 0.85 0.222 
Broadband Ultrasound Attenuation (BUA) 
 
Right 113.48 ± 8.22 112.16 ± 15.29 0.817 
Left 109.72 ± 14.24 118.39 ± 11.76 0.186 
Speed of Sound (SOS) 
 
Right 1544.28 ± 28.14 1563.75 ± 38.19 0.231 
Left 1547.30 ± 36.54 1566.39 ± 27.72 0.240 
Stiffness Index (SI) 
 
Right 87.80 ± 12.16 92.38 ± 15.39 0.491 
Left 86.20 ± 14.86 97.538 ± 13.43 0.118 
 
 
 
Table 41 
 
Baseline Dual-Energy X-ray Absorptiometry (DXA) Parameters across Groups (n=22) 
 
 
 
Total Hip 
t-score 
z-score 
Lumbar Spine 
t-score 
z-score 
Intervention (M ± SD) Control p-value 
 
 
-0.63 ± 0.54 -0.636 ±  1.00 0.979 
-0.10 ± 0.50 -0.345 ± 1.09 0.504 
 
 
-1.00 ± 1.17 -0.38 ± 1.01 0.200 
-0.39 ± 1.05 -0.38 ± 2.18 0.303 
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Table 42 
 
Baseline Dual-Energy X-ray Absorptiometry (DXA) Parameters for Femoral Neck 
(n=22) 
 
 
Right Femoral Neck 
BMD 
T-score 
Z-score 
Left Femoral Neck 
BMD 
T-score 
Z-score 
Intervention (M ± SD) Control (M ± SD) p-value 
 
 
0.94 ± 0.07 0.93 ± 0.14 0.979 
0.56 ± 0.58 -0.64 ±  1.06 0.979 
0.03 ± 0.54 -0.36 ±  1.12 0.979 
 
 
0.92 ± 0.07 0.93 ± 0.12 0.676 
-0.71 ±  0.59 -0.61 ± 0.94 0.700 
0.16 ± 0.54 -0.36 ±  1.04 0.575 
 
 
 
 
Table 43 
 
Baseline Dual-Energy X-ray Absorptiometry (DXA) Parameters for Lumbar Spine 
(n=22) 
Intervention (M ± SD) Control (M ± SD) p-value 
 
L1 
BMD 
T-score 
Z-score 
L2 
BMD 
T-score 
Z-score 
L3 
BMD 
T-score 
Z-score 
L4 
BMD 
T-score 
Z-score 
 
 
1.07 ± 0.15 1.15 ± 0.12 0.146 
-1.38 ± 0.93 -0.78 ±  0.67 0.109 
0.79± 0.81 -0.49 ±  1.01 0.459 
 
 
1.02 ± 0.14 1.09 ± 0.08 0.165 
-1.31 ± 1.36 -0.60 ±  0.88 0.159 
-0.73 ± 1.28 -0.30 ±  0.99 0.406 
 
 
1.05 ± 0.14 1.12 ± 0.09 0.162 
-0.89 ± 1.20 -0.25 ±  0.84 0.178 
-0.29 ± 1.04 -0.07 ±  1.28 0.669 
 
 
1.10 ± 0.16 1.15 ± 0.09 0.446 
-0.65 ± 0.96 -0.78 ±  1.06 0.787 
-0.06 ± 1.08 -0.50 ±  1.2 0.394 
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Qualitative ultrasound (QUS). 
 
 
 
 
Table 44 
 
Means and Standard Deviations across Visits for Qualitative Ultrasound (QUS) (n=22) 
 
 
 
T-score 
Right 
Visit 1  (M ± SD)  Visit 2  (M ± SD)   Visit 3  (M ± SD) 
Intervention (n=11) 
Control (n=11) 
Left 
-0.76  ± 0.77 
-0.48 ± 0.98 
-0.52  ± 1.24 
-0.68 ± 1.06 
-0.57  ± 1.06 
-0.43 ± 1.07 
Intervention (n=11) -0.84 ± 0.91 -0.27 ± 1.19 -0.37 ± 0.99 
Control (n=11) Z-
score 
Right 
Intervention (n=11) 
Control (n=11) 
Left 
Intervention (n=11) 
-0.20 ± 0.82 -0.44 ± 1.03 -0.10 ± 1.41 
 
 
 
0.21 ± 0.77 0.43 ± 1.25 0.38 ± 1.07 
0.41 ± 0.93 0.18 ± 1.04 0.08 ± 0.100 
 
 
0.11 ± 1.03 0.67 ± 1.28 0.58 ± 1.08 
Control (n=11) 0.70 ± 0.85 0.425 ± 1.03 0.79 ± 1.52 
Broadband Ultrasound Attenutation (BUA) 
Right 
Intervention (n=11) 
Control (n=11) 
Left 
Intervention (n=11) 
Control (n=11) 
Speed of Sound (SOS) 
Right 
Intervention (n=11) 
Control (n=11) 
Left 
Intervention (n=11) 
Control (n=11) 
Stiffness Index (SI) 
Right 
Intervention (n=11) 
Control (n=11) 
Left 
Intervention (n=11) 
Control (n=11) 
113.48 ± 8.22 111.53 ± 23.13 112.95 ± 14.79 
112.16 ± 15.29 107.26 ± 17.01 114.53 ± 21.54 
 
 
109.28 ± 14.24 120.09 ± 16.24 119.21 ± 12.92 
118.39 ± 11.76 112.86 ± 13.05 118.17 ± 16.25 
 
 
 
1544.28 ± 28.14   1561.76 ± 39.31 1556.34 ± 31.22 
1563.75 ± 38.19   1562.99 ± 44.62 1569.25 ± 44.01 
 
 
1547.30 ± 36.54   1556.57 ± 36.53 1553.44 ± 30.82 
1566.39 ± 27.72   1563.39 ± 38.95 1570.18 ± 45.09 
 
 
 
87.80 ± 12.16 91.40 ± 19.89 90.90 ± 17.41 
92.38 ± 15.39 89.13 ± 16.84 79.50 ± 30.29 
 
 
86.20 ± 14.86 95.67 ± 18.94 94.33 ± 16.13 
97.538 ± 13.43 93.00 ± 17.02 98.88 ± 22.47 
106 
 
 
Time 0.54 2 0.591 0.032 
Time*Group 2.12 2 0.137 0.117‡ 
 
Time 0.95 2 0.397 0.056 
Time*Group 0.39 2 0.681 0.024 
 
Time 2.53 2 0.095 0.137‡ 
Time*Group 2.20 2 0.127 0.121‡ 
 
Time 0.66 2 0.526 0.039 
Time*Group 1.28 2 0.293 0.074‡ 
 
Table 45 
 
RM-ANOVA for the Bone Parameters from Qualitative Ultrasound (QUS) (n=22) 
 
 F df p-value partial eta squared 
T-score     
Right     
Time 0.67 2 0.521 0.040 
Time*Group 
Left 
2.39 2 0.118 0.125 
Time 1.10 2 0.346 0.068 
Time*Group 2.27 2 0.121 0.131 
Z-score 
Right 
 
 
Left 
Time 1.36 2 0.272 0.083‡ 
Time*Group 3.02 2 0.064 0.168‡ 
Broadband Ultrasound Attenuatio (BUA) 
Right 
 
 
Left 
Time 0.95 2 0.398 0.060 
Time*Group 2.99 2 0.081 0.155‡ 
Speed of Sound (SOS) 
Right 
 
 
 
Left 
Time 0.31 2 0.736 0.020 
Time*Group 0.77 2 0.471 0.049 
Stiffness Index (SI) 
Right 
 
 
 
Left 
Time 1.42 2 0.259 0.162‡ 
Time*Group 3.02 2 0.064 0.309‡ 
 
‡ partial eta squared > 0.06 
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Figure 8. Change in stiffness index (SI) of the left foot (n=22). 
 
 
 
 
There were no significant main effects for time for any of the QUS parameters, and there 
were no significant time*group interactions. There was a medium effect size for the 
Time*Group interaction (right z-score), the main effect for time (left z-score), and the 
Time*Group interaction (right SI). There was a large effect size for the Time*Group 
interaction (left z-score), the Time*Group interaction (left BUA), the main effect for 
Time (right SOS), the Time*Group interaction (right SOS), the main effect for Time (left 
SI), and the left Time*Group interaction (left SI).  All other effect sizes were small. 
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Dual-energy x-ray absorptiometry (DXA). 
 
 
 
 
Table 46 
 
Means and Standard Deviations across Visits for Dual-Energy X-ray Absorptiometry 
(DXA) for Total Hip and Lumbar Spine (n=22) 
 
 
 
 
 
Total Hip BMD 
Intervention (n=11) 
Control (n=11) 
Total Hip T-score 
Intervention (n=11) 
Control (n=11) 
Total Hip Z-score 
Intervention (n=11) 
Control (n=11) 
Lumbar Spine BMD 
Intervention (n=11) 
Control (n=11) 
Lumbar Spine T-score 
Intervention (n=11) 
Control (n=11) 
Lumbar Spine Z-score 
Intervention (n=11) 
Control (n=11) 
† % change > ± 1.00% 
Visit 1 (M ± SD) Visit 3 (M ± SD) 
 
 
0.85 ± 0.26 1.02 ± 0.31 
0.93 ± 0.13 0.93 ± 0.12 
 
 
0.63 ± 0.54 -0.60 ± 0.54 
-0.64 ±  1.00 -0.60 ± 0.98 
 
 
-0.10 ± 0.50 -0.04 ± 0.48 
-0.35 ± 1.09 -0.32 ± 1.06 
 
 
1.07 ± 0.15 1.07 ± 0.14 
1.15 ± 0.12 0.16 ± 0.12 
 
 
-1.00 ± 1.17 -0.98 ± 1.16 
-0.38 ± 1.01 -0.31 ± 1.00 
 
 
-0.39 ± 1.05 -0.36 ± 0.99 
-0.38 ± 2.18 -0.04 ± 1.15 
% Change 
 
 
16.66† 
0.26 
 
 
-- 
-- 
 
 
-- 
-- 
 
 
0.17 
0.77 
 
 
-- 
-- 
 
 
-- 
-- 
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Table 47 
 
RM-ANOVA for Dual-Energy X-ray Absorptiometry (DXA) for Total Hip and Lumbar 
Spine (n=22) 
 
 
Total Hip 
T-score 
F df p-value partial eta squared 
Time 
Time*Group 
Z-score 
1.96 1 0.177 0.089 
0.04 1 0.844 0.002 
Time 4.39 1
 0.049† 
0.180‡ 
Time*Group 
Lumbar Spine 
T-score 
Time 
Time*Group 
Z-score 
Time 
Time*Group 
0.70 1 0.412 0.034 
 
 
 
0.50 1 0.490 0.024 
0.18 1 0.678 0.009 
 
 
0.56 1 0.464 0.027 
0.72 1 0.405 0.035 
 
† p < 0.05 
‡ partial eta squared > 0.06 
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Figure 9. Change in z-score for the total hip (n=22). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Individual raw BMD change for total hip (n=22). 
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Figure 11. Individual raw BMD change lumbar spine (n=22). 
 
 
 
 
There was a significant main effect for time for the z-score of the total hip. Both groups 
increased across the study period. There were no other main effects for time and there 
were no time*group interactions for the total hip or the lumbar spine. There was a large 
effect size for z-score (total hip). All other effect sizes were small. Both groups were 
similarly active in regards to individual change for the total hip (Figure 10), but the 
intervention group was much more active than the control for the lumbar spine (Figure 
11). 
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Table 48 
 
Means and Standard Deviations across Visits for Dual-Energy X-ray Absorptiometry 
(DXA) for the Right and Left Femoral Neck (n=22) 
 
 
Right Femoral Neck BMD 
Visit 1 (M ± SD) Visit 3 (M ± SD) % Change 
Intervention (n=11) 
Control (n=11) 
Right Neck T-score 
Intervention (n=11) 
Control (n=11) 
Right Neck Z-score 
Intervention (n=11) 
Control (n=11) 
Left Femoral Neck BMD 
Intervention (n=11) 
Control (n=11) 
Left Neck T-score 
0.94 ± 0.07 0.94 ± 0.07 
0.93 ± 0.14 0.93 ± 0.13 
 
 
0.56 ± 0.58 -0.55 ± 0.58 
-0.64 ±  1.06 -0.59 ± 1.04 
 
 
0.027 ± 0.54 0.18 ± 0.50 
-0.364 ±  1.12 -0.30 ± 0.1.09 
 
 
0.92 ± 0.07 0.93 ± 0.07 
0.93 ± 0.12 0.92 ± 0.11 
0.18 
0.38 
 
 
-- 
-- 
 
 
-- 
-- 
 
 
1.15† 
-1.13† 
Intervention (n=11) 
Control (n=11) 
Left Neck Z-score 
-0.71 ± 0.59 
-0.61 ± 0.94 
-0.65 ± 0.55 -- 
-0.62 ±  0.94 -- 
Intervention (n=11) 
Control (n=11) 
† % change > ±1.00% 
0.16 ± 0.54 -0.09 ± 0.51 -- 
-0.36 ±  1.04 -0.32 ± 1.02 -- 
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Femoral Neck (n=22) 
 
 
 
F 
 
 
 
df 
 
 
 
p-value 
 
 
 
partial eta squared 
Right Neck     
T-score 
Time 
 
 
0.04 
 
 
1 
 
 
0.836 
 
 
0.002 
Time*Group 0.70 1 0.412 0.034 
 
Time 
 
0.79 
 
1 
 
0.385 
 
0.038 
Time*Group 0.94 1 0.344 0.045 
 
Table 49 
 
RM-ANOVA for Dual-Energy X-ray Absorptiometry (DXA) for the Right and Left 
 
 
 
 
 
 
 
 
 
 
 
 
Z-score 
 
 
 
Left Neck 
T-score 
Time 
Time*Group 
Z-score 
Time 
Time*Group 
 
 
 
0.17 1 0.687 0.008 
5.04 1 0.036† 0.201‡ 
 
 
0.14 1 0.709 0.007 
4.35 1 0.050† 0.158‡ 
 
† p < 0.05 
‡ partial eta squared > 0.06 
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Figure 12. Change in left femoral neck t-score (n=22). 
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Figure 13. Change in left femoral neck z-score (n=22). 
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Figure 14. Individual raw BMD change for right femoral neck (n=22). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. Individual raw BMD change for left femoral neck (n=22). 
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There was a significant time*group interaction for the t- and z-scores of the left femoral 
neck. For both t-score and z-score, the intervention group improved while the control 
group lost bone mass. There were no main effects for time across either the right or left 
femoral neck. There was a large effect size for the Time*Group interaction (left femoral 
t-score) and the Time*Group interaction (left femoral neck z-score). All other calculated 
effect size estimates were small. 
 
 
 
There was a clinically significant increase (> 1.00%) in BMD at the total hip for the 
intervention. There was also a clinically significant (> 1.00%) change in bone mass at the 
left femoral neck for both the intervention and the control group. The intervention group 
gained BMD and the control group lost BMD at that skeletal site. 
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L3 
Intervention (n=11) 
Control (n=11) 
-0.73 ± 1.28 
-0.30 ±  0.99 
-0.83 ± 1.21 
-0.36 ±  1.19 
-- 
-- 
 BMD    
 Intervention (n=11) 1.05 ± 0.14 1.05 ± 0.06 0.16 
 Control (n=11) 1.12 ± 0.09 1.13 ± 0.09 0.38 
 
 
 
 
L4 
Intervention (n=11) 
Control (n=11) 
-0.29 ± 1.04 
-0.07 ±  1.28 
-0.14 ± 1.17 
-0.12 ±  1.28 
-- 
-- 
 BMD 
Intervention (n=11) 
 
1.10 ± 0.16 
 
1.10 ± 0.15 
 
0.09 
 Control (n=11) 1.15 ± 0.09 0.15 ± 0.11 0.15 
 
Table 50 
 
Means and Standard Deviations across Visits for Dual-Energy X-ray Absorptiometry 
(DXA) for the Lumbar Vertebrae 
 
 
L1 
BMD 
Intervention (n=11) 
Control (n=11) 
T-score 
Intervention (n=11) 
Control (n=11) 
Z-score 
Intervention (n=11) 
Control (n=11) 
L2 
BMD 
Intervention (n=11) 
Control (n=11) 
T-score 
Intervention (n=11) 
Control (n=11) 
Z-score 
Visit 1  (M ± SD) Visit 3  (M ± SD) 
 
 
 
1.07 ± 0.15 1.07 ± 0.14 
1.15 ± 0.12 1.16 ± 0.14 
 
-1.38 ± 0.93 -1.33 ± 0.92 
-0.78 ±  0.67 -0.65 ±  0.77 
 
0.79± 0.81 -0.74 ± 0.76 
-0.49 ±  1.01 -0.56 ±  0.80 
 
 
 
1.02 ± 0.14 1.01± 0.13 
1.09 ± 0.08 1.09 ± 0.09 
 
-1.31 ± 1.36 -1.45 ± 1.28 
-0.60 ±  0.88 -0.67 ±  0.88 
% Change 
 
 
 
0.78 
0.17 
 
-- 
-- 
 
-- 
-- 
 
 
 
0.36 
-0.72 
 
-- 
-- 
 
 
 
 
 
 
 
T-score 
Intervention (n=11) 
Control (n=11) 
Z-score 
 
 
-0.89 ± 1.20 -0.75 ± 1.31 -- 
-0.25 ±  0.84 -0.18 ±  0.91 -- 
 
 
 
 
 
 
 
T-score 
Intervention (n=11) 
Control (n=11) 
Z-score 
Intervention (n=11) 
Control (n=11) 
 
 
-0.65 ± 0.96 -0.62 ± 0.99 -- 
-0.78 ±  1.06 -0.68 ±  1.20 -- 
 
 
-0.06 ± 1.08 -0.07 ± 1.07 -- 
-0.50 ±  1.2 -0.32 ±  1.24 -- 
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Table 51 
 
RM-ANOVA for Dual-Energy X-ray Absorptiometry (DXA) for the Lumbar Vertebrae 
(n=22) 
 
 
L1 
T-score 
F df p-value partial eta squared 
Time 
Time*Group 
Z-score 
Time 
Time*Group 
L2 
T-score 
Time 
Time*Group 
Z-score 
Time 
Time*Group 
L3 
T-score 
Time 
Time*Group 
Z-score 
Time 
Time*Group 
L4 
T-score 
Time 
Time*Group 
Z-score 
Time 
Time*Group 
0.77 1 0.391 0.039 
0.18 1 0.677 0.009 
 
 
0.86 1 0.365 0.043 
0.14 1 0.708 0.008 
 
 
 
0.95 1 0.341 0.048 
0.10 1 0.757 0.005 
 
 
0.60 1 0.448 0.031 
0.04 1 0.848 0.002 
 
 
 
1.23 1 0.281 0.061 
0.15 1 0.702 0.008 
 
 
3.40 1 0.081 0.152‡ 
0.04 1 0.852 0.002 
 
 
 
0.51 1 0.483 0.026 
1.29 1 0.270 0.064‡ 
 
 
1.12 1 0.304 0.055 
1.37 1 0.257 0.067‡ 
 
† p < 0.05 
‡ partial eta squared > 0.06 
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Figure 16. Individual raw BMD change for L1 vertebra (n=22). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. Individual raw BMD change for L2 vertebra (n=22). 
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Figure 18. Individual raw BMD change for L3 vertebra (n=22). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19. Individual raw BMD change for L4 vertebra (n=22). 
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There were no significant main effects for time or any time*group interactions for any of 
the lumbar vertebrae. There was a large effect size for the main effect for Time (L3 z- 
score). There was a medium effect size for the main effect for Time (L4 z-score) and the 
Group*Time interaction (L4 z-score). The control group was more variable in regards to 
individual change for L1, but the intervention group was more active for the remaining 
load-bearing lumbar vertebrae (L2-L4). 
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SECONDARY HYPOTHESIS 3 
 
12 weeks of interactive play will significantly increase bone turnover (increase serum 
osteocalcin) in middle-aged women as compared to a randomly assigned control group. 
Independent samples t-tests were conducted to determine any differences between groups 
at baseline across all measures (Table 52). Repeated Measures Analysis of Variance 
(RM-ANOVA) were run to assess a main effect for time and any time*group interaction 
(Table 54). Means and standard deviations across study visits can be found in Table 53. 
 
 
 
Baseline data is presented first, followed by the means and standard deviations across 
visits and the RM-ANOVA. Any necessary figures follow the table pairs but precede the 
brief interpretation. 
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Table 52 
 
Baseline Osteocalcin across Groups (n=22) 
 
 
 
Osteocalcin 
Intervention (M ± SD)  Control (M ± SD) p-value 
3.06 ± 0.82 2.84 ± 0.77   0.526 
 
 
 
 
 
There was no significant difference between groups at baseline. Both groups had values 
within the range of what is considered normal for their age and gender. 
 
 
 
 
 
 
Table 53 
 
Means and Standard Deviations across Visits for Osteocalcin as Assessed via 
Venipuncture (n=22) 
 
 
 
Osteocalcin 
 
 
Intervention (n=11) 
Control (n=11) 
Visit 1 (M ± SD) Visit 2 (M ± SD) Visit 3 (M ± SD) 
 
 
 
3.06 ± 0.82 3.18 ± 0.64 3.29 ± 0.63 
2.84 ± 0.77 2.53 ± 0.44 2.74 ± 0.48 
 
 
 
 
Table 54 
 
RM-ANOVA for Osteocalcin (n=22) 
 
 
 
Osteocalcin 
F
 d
f 
p-value partial eta squared 
 
Time 0.79 2 0.46 0.040 
Time*Group 1.53 2 0.230 0.075‡ 
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Figure 20. Change in Osteocalcin (n=22). 
 
 
 
 
 
 
 
 
 
Figure 21. Individual Osteocalcin Change from Week 0 to Week 6 (n=22). 
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Figure 22. Individual Osteocalcin Change from Week 0 to Week 6 (n=22). 
 
 
 
 
 
 
 
 
 
Figure 23. Individual Osteocalcin Change from Week 0 to Week 12 (n=22). 
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There was no significant main effect for time or a time*group interaction for osteocalcin. 
There was a medium effect size for the Time*Group interaction. The intervention group’s 
overall mean increased during each visit, and the individual change data shows greater 
increases in the intervention group over the control. All coefficients of variability (CV%) 
were below 7%, which is considered to be in the desirable range for the kit used. 
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CHAPTER 5 
DISCUSSION 
 
 
BASELINE CHANGES 
 
Throughout the duration of the study period, the women were weight stable, with little to 
no change in total body weight. They were not statistically different at baseline (Table 1) 
and there was no main effect for time or a time*group interaction for either body weight 
or body fat percentage (Table 5). While there was more variation in body fat percentage 
than there was in weight, the methodology used is not considered reliable for tracking 
body composition changes over time. The Tanita (Arlington Heights, IL) can be 
influenced by several factors, such as hydration status, recent food intake, time of day, 
and recent physical activity (Loenneke et al., 2013). While precautions were taken to try 
to schedule all visits at the same time of the day, bioelectrical impedance (BIA) still has 
an error of 5-13% under prime conditions (Loenneke et al., 2013), which exceeds what 
would be expected in such a short time frame. 
 
 
 
Overall, the participants in this study did not change their baseline dietary patterns, which 
could potentially influence any losses or gains over the duration of the study period 
(Table 7). At the beginning of the study, the mean calcium intake from both food and 
supplements was lower than 1200 mg/day, which is the current Recommended Daily 
Allowance (RDA) for peri- and post-menopausal women (Pinheiro et al., 2009). Some 
women did meet or exceed the RDA for calcium in both study groups, but there was no 
statistically significant difference in intake between the two. To assure that any bone 
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changes were not due to calcium status, change in bone mass was correlated with calcium 
intake, and there was no correlation between the two variables. The groups were also 
equivalent in their protein and vegetable intake, although neither group was meeting the 
recommended three or more servings/day of vegetables. However, the questionnaire used 
did not account for all vegetables that may be included in the diet, so it is not a 
comprehensive measure of total intake. Like calcium, protein intake was correlated with 
changes in muscular fitness, and there was no relationship. 
 
 
 
There were changes in physical activity habits, but any statistically significant changes 
were due to the inclusion of the exercise program in the intervention group. At baseline, 
the women were considered extremely sedentary, with less than 40 minutes of walking 
per week, and little to no moderate-to-vigorous physical activity (MVPA). There was no 
statistically significant different between groups at baseline (Table 3), and there was no 
main effect for time or a time*group interaction for walking or MVPA (Table 9). When 
provided with the questionnaire at Visits 2 and 3, the women were instructed to report all 
physical activity excluding the Wii Fit®, if applicable. The increase in time spent in mild 
activity was entered manually using the electronic and paper exercise logs completed by 
the women. While questionnaires do have some error in reporting and are subject to bias, 
the raw time changes seen in the mild category are coming from direct measures of 
activity time logged by the gaming system. Screenshots of the exercise time reported by 
the Wii System can be found in Appendix K. 
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PRIMARY HYPOTHESIS 
 
Balance Scales. The results from this study do not support the hypothesis that 12- 
weeks of interactive play would improve performance on either the Berg or the FICSIT-4 
balance scales as compared to a control. This is in part due to an insufficient sample size 
and a ceiling effect among the participants. The study was powered on previous research 
that predominantly used older adults, as there is no research is this area that has studied 
the effect on peri-menopausal women. Using the results from Bateni (2012), it was 
anticipated that the effect size would be close to 0.25, but the observed effect size 
estimate was 0.133 for time and 0.085 for time*group for the Berg Scale (Table 12). 
However, there was a medium effect size for time with the FICSIT-4 scale, and the p- 
value was trending toward significance. These results indicate that all participants were 
improving with each visit, and that any gains cannot be attributed to participation in the 
exercise intervention. Running a sample size analysis in SAS using the observed effect 
sizes for the Berg and FICSIT-4 interactions, a sample size of 54+ would have been 
necessary to detect any significant differences. 
 
 
 
The other potential issue was the fact that none of the women who participated in the 
study were what would be considered “fall-risk.” The Berg is scored out of 56 and the 
FICSIT-4 is scaled out of 28, and both groups had means in the upper range. The Berg 
requires a score of below 40 to be considered “at-risk” for falling, but no women in either 
group scored below a 48 (Berg, 1989). Previous research in older adults has shown score 
changes in the range of 5-7 points on the Berg, which were used to determine the sample 
size, but such gains would not have been possible with this group (Bateni, 2012; Nitz et 
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al., 2010). It is possible that the Wii Fit® system may be able to improve and maintain 
balance long-term as these women age, but the study population and study duration were 
not sufficient to determine any benefits of improving balance when using a validated 
balance scale. 
 
 
 
Force plate.  The results from this support the hypothesis that 12-weeks of 
interactive play will improve balance over a control group, at least in part. There were 10 
individual foot positions that were performed on the force plate, but improvement was 
not consistent across all of the foot positions. Similar to the balance scales, it appears that 
a lack of improvement may be due to a ceiling effect. Pajala et al. (2008) used force plate 
parameters as a predictor of falls and found that average velocity in most positions 
exceeded ±9 mm/sec, whereas the women in the study were typically near ±4 mm/sec. 
The authors of the study also used older, community-dwelling seniors, like most balance 
research, which potentially explains why the women used in this study performed much 
better overall that what has been reported in other studies. 
 
 
 
Another potential explanation is that the balance positions, in general, were not 
challenging enough to disturb balance or center of pressure. These women were likely 
already stable and had not yet experienced the age-related decline in neuromuscular tone. 
That decline rapidly increases after age 60 for most adults, and the upper age cut-off was 
60 years (Laughton et al., 2003). If they were not experiencing a loss of control over 
center of pressure due to maintaining a large degree of their neuromuscular tone, many of 
the foot positions would not be considered difficult. For example, standing with the feet 
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hip-distance apart and the eyes open would only show improvement or impairment if 
they experienced a large degree of postural sway at any given visit. Being that these 
women were extremely stable at baseline, there was no room for gross improvements in 
those types of situations. 
 
 
 
The more challenging foot positions, such as Tandem Step, Eyes Open or the Single Leg 
Stand, still did not show an improvement across the study period. However, that may be 
because of removed data points for certain participants. The force plate is not equipped to 
truncate data at the point of a fall and make it comparable to someone who completed the 
full 10-second or 30-second trial. Therefore, power was lost for several of the more 
challenging data points because participants’ results had to be removed. If a woman fell 
at her first visit but was able to complete the remaining trials, it was not possible to 
include her baseline visit, which ultimately removed her from the analysis. Missing data 
point analysis would not be appropriate in such a situation because each participant who 
fell does have a physiologically valid data point; there just has not been a commonly 
accepted method developed yet to deal with the velocity and area measures that result 
from such an occurrence. 
 
 
 
However, there was one foot position in particular that did elicit an improvement across 
the study period. This was the “tandem step, eyes closed” position, which proved to be 
the most challenging position of all that were tested. Several participants had to be 
excluded due to falling, but even in those who were retained for analysis, there was an 
improvement in the intervention group across several of the force plate parameters. In the 
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case of maximum velocity (x), the intervention group’s average velocity (x) decreased 
from Visit 1 to Visit 2, and this decrease was maintained through Visit 3 (Figure 3). The 
control group’s average velocity (x) continued to increase across all 3 study visits. This 
trend was repeated for average velocity overall (Figure 5). The outcomes were not as 
clear for average velocity (y). The control group seemed to improve, while the 
intervention group remained stable (Figure 4). 
 
 
 
In the case of the area outcomes for Tandem Step, Eyes Closed, it also appears that the 
intervention group improved as compared to the control. For 95% area, the intervention 
group remained stable throughout the study period, while the control group because less 
stable (Figure 6). There was even a statistically significant difference for the control 
group from Visit 2 to Visit 3, with a change of nearly 20 mm. Nearly all of the 
time*group interactions had medium to large estimates of effect size, and when analyzed 
using PROC POWER in SAS, the sample size was appropriate for this given foot 
position. Similarly to the balance scales, the effect sizes were too small for any  
significant change to be detected in any of the other foot positions. A sample size analysis 
using the effect sizes found in this study resulted in a necessary study population 
exceeding 60 participants. 
 
 
 
The improvement in the Tandem Step, Eyes Closed position is surprising because that 
position was not one that was practiced in any of the Wii Fit games. While balance 
training seeks to improve whole body balance, not just the position practiced, a tandem 
step is not a natural foot position and is typically very challenging. Several of the games 
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used an open and closed base stance, as well as a single leg stand, so it would be expected 
that those would improve due to a training effect. As was mentioned previously, this 
could be due to little room for improvement or a ceiling effect. Because these women 
were not balanced impaired, it would be expected that only the most difficult positions 
would improve, which would explain the change in that specific foot position. 
 
 
 
To date, no other study has reported a change in tandem step force plate outcomes 
following an exercise intervention, only changes in the foot positions that were part of the 
exercise program. The participants in this study were not balanced impaired, as assessed 
by the balance scales, so they likely were not suffering from a drastic loss of 
neuromuscular tone. However, they are within the age range that begins to experience the 
age-related loss of balance, which supports why only the most challenging activity was 
difficult to complete (Laughton et al., 2003). This intervention was designed from a 
preventative standpoint, so there is at least some evidence that it may help in reducing 
age-related declines in balance, as the intervention typically improved or remained stable 
while the control group declined. 
 
 
 
Strengths. One of the major strengths of this study is that it has good ecological 
validity. These women were given very brief instructions on how to use the system and 
were encouraged to try to solve problems on their own before contacting research staff. 
The home-based exercise set-up is very similar to what a person would experience should 
they decide to purchase a Wii Fit® system on their own, with the major difference being 
that an exercise prescription was provided for them. Savvy users can look up exercise 
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programs on the Wii®, and several exercise protocols come pre-programmed into the 
system, with the major difference being that the pre-programming options do not include 
balance games. 
 
 
 
Limitations. One limitation of this study is that it is a convenience sample and 
was full of women who did not necessarily need balance training. Therefore, it is difficult 
to truly assess the impact that such an intervention would have on this age group had they 
been more unstable. Another limitation was that the timeframe was relatively short, being 
only 12 weeks. Had the study been conducted over a longer period of time, the 
differences in balance outcomes may have been different. Women were also permitted to 
play additional balance games, if they chose. They were asked to report all additional 
activity, but the inclusion of extra game time prevented consistency across all participants 
for balance training. 
 
 
 
Future directions. More research is needed in this age group as a means to 
determine the importance or utility of the Wii Fit® as a means to deliver a preventative 
balance intervention. Preferably, future studies should be conducted over longer time 
frames or aim to recruit only women who are beginning to show balance impairments. 
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SECONDARY HYPOTHESIS 1 
 
Peak Torque. The results of this study did not support the hypothesis that 12 
weeks of interactive play would improve peak torque of the knee flexors and extensors as 
compared to a control group. This is partially due to being underpowered, given the 
sample size, as all effect sizes were small for both the knee flexors and the knee 
extensors. However, the main issue may be that the women were not performing to their 
full ability. 
 
 
 
Other results assessing peak torque of older women found that elderly women had a peak 
torque of the knee extensors at 60 degrees/sec around 56 ft•lb on the dominant side and 
37 ft•lb on the non-dominant side (Aquino et al., 2002). There was no difference in the 
dominant versus non-dominant side in the women who were studied, and their peak 
values at 60 degrees/sec were near 30 ft•lb. At baseline, these women were already 
performing worse than sedentary women who were at least 15 years older. Due to what is 
known about aging and a loss of muscular strength and lean muscle mass, the women in 
the Wii Fit® should have performed better than the elderly women from the Aquino et al. 
(2002) study just as a function of where they are in their life cycle (Shephard et al., 
2013). 
 
 
 
The low values could be a function of the women not performing to their full potential. 
Anecdotally, many of the women expressed being intimidated by the equipment or the 
protocol. It is possible that they did not flex and extend at the knee to their full ability 
because they were trying to preserve energy or strength for subsequent angle speeds and 
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for the muscular endurance component of the testing. This is especially likely under the 
60 degree/sec condition, as the order of speeds was randomized. Following the first visit, 
most women commented on remembering the most challenging of the three speeds that 
were used, and had a fear of injury or not being able to complete the trial. Practice trials 
were provided prior to each measured angle speed, but it may not have been enough to 
ease tension or anxiety about performing the activity. 
 
 
 
Another explanation is that the activity in the intervention was not sufficient to induce 
any change in muscular strength. The majority of the activities were balance-oriented 
rather than being strength activities, but there were two exercises built into the 
intervention aimed at improving lower limb strength, specifically the knee extensors. 
Those exercises were the lunge and the warrior pose. Both of these exercises are body 
weight lunges, and if someone was completing all three sessions per week, she would be 
doing a minimum of 90 body weight lunges/week. Research in adults aged 30-58 found 
that 30-minutes of Wii Fit® play twice per week was enough to improve lower limb 
strength (Nitz et al., 2010), although this study did not confirm these results. Many of the 
women in the intervention group complained of muscle soreness in the first few weeks of 
training, but that could be a function of their sedentary lifestyle rather than any major 
improvements occurring in muscular strength. 
 
 
 
There was a significant main effect for time at 240 degrees/sec for the left knee extensors, 
indicating a practice effect, but there were no other significant main effects for time or 
any time*group interactions (Table 37). A significant time*group interaction for the right 
137 
 
 
knee flexors at 240 degrees/sec was observed (Table 39). However, when looking at the 
means across visits (Table 38) and the mean change for each group (Figure 7), it is 
unclear if any change observed was a result of the intervention or just a random 
occurrence. The intervention group does change from Visit 1 to Visit 2, but any gain is 
lost by Visit 3, which does not make sense intuitively given that all women were still 
participating in the intervention at a level of at least 75% compliance. All estimated 
effects sizes for the knee extensor and flexor groups were small, so a larger sample size 
would be needed to detect a significant change. However, other possible explanations for 
the lack of change in the intervention group will be discussed below. 
 
 
 
Muscular fatigue. The hypothesis was not supported that 12 weeks of interactive 
play would improve muscular fatigue over a control group. Like the outcomes for peak 
torque/muscular strength, the lack of difference could be due to the participants not 
working to their full potential, or the Wii Fit® system being ineffective for improving 
fatigue in this population. 
 
 
 
The raw data seems to suggest that the women were not performing to their full capacity. 
While not published research exists regarding what is considered a “normal” fatigue 
index for this, or a similar, population, the numbers themselves indicate a lack of full 
exertion. Larger numbers are better, indicating more ability to continue peak torque over 
an extended time, whereas negative numbers mean that a participant was performing a 
greater torque near the end of the 50 repetitions than she was at the onset (Brown, Miller, 
& Eason, 2006). In Table 36, many of the values for the knee extensors are near zero, 
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which would suggest that many of the women in both groups had negative fatigue index 
scores at each visit. This is confirmed when looking at the raw data, as nearly 50% of all 
participants are negative at any one visit, the only exception to that being the intervention 
group at Visit 3 for the right extensors. More women in that group moved above the 
positive-negative threshold at that visit, but many of the values were still very small. 
 
 
 
This is similar to the pattern observed for the knee flexors. In Table 38, five of the group 
means were negative, indicating better performance at the end of the trial than at the 
beginning. For the right flexor, the control group was consistently negative across all 
three visits. When the values were positive, they were also close to zero, suggesting a 
large portion of the group was negative. When looking at the raw data, like what was 
observed for the knee extensors, at least 50% of each group was negative. The only 
exception was the control group for the right flexor, where close to 75% of the group was 
negative at any one visit. 
 
 
 
Another possibility is that the intervention was just not effective for improving muscular 
fatigue. None of the activities prescribed were specifically tailored to improve fatigue, 
but the women were completing 30 minutes of continuous weight-being activity three 
times per week, which included activity of both the knee flexors and the knee extensors. 
No published research has investigated the effect of s Wii Fit® intervention on fatigue 
outcomes, so there is no available comparison, but 90 minutes/week of weight-bearing 
activity would be expected to contribute to improvements in fatigue, especially in a 
sedentary population (Bogdanis, 2012). 
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Strengths. One strength of this portion of the study is that the muscular fitness 
testing always occurred at the same point in each visit, eliminating the possibility that 
performance could be influenced by when the muscular testing happened. Additionally, 
the order of the peak torque trials was randomized, also eliminating the impact of order 
on performance. The muscular endurance testing always came last to diminish the impact 
of fatigue on peak torque measures. Which leg was performed first was also randomized 
to minimize the impact of order of testing. Another major strength is that the prescribed 
strength program was the same across all participants. Previous work gauging muscular 
strength let participants play whatever games they chose, so it cannot be determined 
which activities are effective, or if all participants respond in a similar fashion. 
 
 
 
Limitations. The women in this study were from a sample of convenience, and 
did not have much exposure to strength training. Their lack of experience with traditional 
resistance training equipment may have made the protocol intimidating or prevented 
them from being able to appropriately gauge how to pace themselves in the muscular 
fatigue portion. 
 
 
 
Future research. More research in needed in this population, especially since 
prior evidence has suggested that improvements can be observed with Wii Fit® training 
in a similar population (Nitz et al., 2010). Future research should allow for more practice 
sessions with the isokinetic dynamometer to reduce any fear of anxiety regarding the 
equipment, as well as more instruction on peak force and pacing for each of the speeds 
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and the fatigue portion. Finally, other strength training games and poses should be 
incorporated to help determine which activities are most effective in increasing muscular 
strength and endurance of the lower limb. 
141 
 
 
SECONDARY HYPOTHESIS 2 
 
Qualitative Ultrasound (QUS). The hypothesis was supported, in part, that 12 
weeks of interactive play would improve QUS parameters as compared to a control 
group. While all the individual components of stiffness index (SI) were not independently 
significant, there was a significant time*group interaction for the SI of the left foot, and a 
medium effect size. 
 
 
 
There is some discrepancy over what QUS actually measures, and it is known that certain 
parameters, mainly SOS, can be highly variable and not always dependent on bone 
structure (Njeh, Fuerst, Diessel, & Genant, 2001).  It has been suggested that BUA is the 
best predictor of overall bone health, instead of SI, but BUA has a non-linear relationship 
with BMD, so it can be difficult to definitely determine what any specific measure means 
in regards to bone health (Njeh et al., 2001; Bauer et al., 1997). In this study, BUA was 
stable for the right foot, but highly variable in the left, in comparison. SOS was stable for 
both feet across both visits (Table 44). While not statistically significant, BUA had a 
time*group interaction p-value of 0.081, which is trending toward significance (Table 
45). This could be indicative of a bone quality change occurring at the left heel, but the 
sample size was insufficient to detect the change. Because BUA mathematically 
contributes to SI, it is expected that SI should then also be influenced. The time*group 
interaction for the left SI has a p-value of 0.064, which is also trending toward 
significance. When the group means are plotted, the intervention group increases then 
remains stable, while the control group decreases and then increases, although not 
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statistically significant. The changes observed could be a function of bone remodeling or 
may be due to the variability of QUS outcomes. 
 
 
 
QUS has never been used in a long-term intervention before, so it is unclear what degree 
of change would be expected. However, the variability in one foot suggests that there is 
some remodeling occurring at that skeletal site. QUS typically correlates with changes in 
the femoral neck, as both experience similar load-bearing forces during activity, so it is 
also expected that there will be improvements in the left femoral neck as well (Njeh et al., 
2001). Those results will be discussed later on. While none of the parameters were 
considered to be statistically significant, which may be due to a small sample size, the 
differences in right foot consistency compared to left foot variability seem to indicate that 
greater skeletal activity is occurring in the intervention group. 
 
 
 
Dual-energy X-ray Absorptiometry (DXA). The results of this study support 
the hypothesis that 12-weeks of interactive play using the Wii Fit® will improve BMD as 
compared to a control group. The prominent changes occurred at the hip, with little to no 
change at the lumbar spine. 
 
 
 
When analyzing only the percent change of BMD at the total hip and spine, none of the 
changes were considered to be clinically significant (Table 46). While there is a change 
of 16.6% for the total hip, that value is outside the realm of what is considered 
physiologically possible for that time frame, and is being driven by one participant. This 
may be due to an alignment issue during the scan and the removal of this participant as an 
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outlier reduces the percent change at the total hip to less than one percent. There was a 
significant main effect for time for the z-score or the total hip, and both groups improved 
over time (Table 47, Figure 9). There were no significant time*group interactions for any 
of the t- or z-scores of the total hip or the lumbar spine. RM-ANOVAs were not run for 
BMD because BMD alone is a meaningless value, and determining osteoporosis risk is 
dependent on age, gender, and ethnicity. 
 
 
 
When looking at the individual change data for the total hip, both groups experienced 
gains and losses of BMD, with no clear trend (Figure 10). However, there was a more 
obvious trend for individual change data for the lumbar spine (Figure 11). The 
intervention group was much more metabolically active, experiencing greater losses and 
gains than the control group, which may be indicative of more bone remodeling activity. 
 
 
 
There is a more obvious trend that appears when the femoral neck is isolated from the 
total hip. For BMD, there was a clinically significant percent change at the left femoral 
neck (Table 48). Clinical significance is determined as a change of greater than one 
percent at an individual skeletal site (Hangartner, 2007). However, the same cannot be 
said about the right femoral neck BMD, where the change was minimal. There were no 
main effects for time for either the right or left t- and z-scores, but there were two 
significant time*group interactions for the left neck t- and z-scores (Table 49). For the 
left neck t-score, the intervention group increased while the control group decreased 
(Figure 12), and this pattern was similar for the left neck z-score (Figure 13). 
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For the individual change data at the right femoral neck, there is no clear trend (Figure 
14). Both groups experienced gains and losses of BMD at the right neck, but it appears 
that the control group was more active overall. However, for the left neck, an obvious 
trend appears. Overall, the intervention group gained BMD while, in general, the control 
group was losing bone mass (Figure 15). 
 
 
 
The mechanism behind one hip being remodeled while the other stayed static is related to 
the body’s protection of skeletal sites during remodeling. In general, the body will not 
remodel contralateral skeletal sites at the same time as a means to maintain skeletal 
integrity (Jordan et al., 2000). These women were considered extremely sedentary, so 
they likely were not experiencing much weight-bearing activity in their daily life. These 
women were also predominantly right-footed, meaning they favor the right foot when 
walking, standing, etc. In most normal adults, one hip will always be denser than the 
other, even if marginally, and the denser side is the one that is favored.  Because these 
women mostly favored the right side, the left hip was likely weaker, and would have been 
targeted first for remodeling. When looking at the means for each group for BMD, the 
left hip is consistently weaker, supporting the idea that it would be targeted first (Table 
48). 
 
 
 
The skeleton also responds to loading signals coming from weight-bearing physical 
activity. As mentioned previously, these women were very sedentary, and engaged in 
very little activity during the course of the week. For those who were introduced into the 
intervention, both hips were now experiencing loads that they were not accustomed to, 
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which is a primary signal to remodel a skeletal site (Frost, 1997). Combined with the 
concept that the left hip was already impaired in comparison to the right, it would be 
targeted first to be able to adapt to the new load being placed on the skeleton. 
 
 
 
The losses that were seen in the control group are also consistent with what has been 
reported as typical bone loss with age. Post-menopausal women, on average, lose 
upwards of 2.5% within a year, without pharmacological or exercise interventions 
(Martin & Seeman, 2008). What is important to note is that bone resorption does not 
necessarily need to be followed by bone formation, especially following menopause. As 
was noted before, most of these women could be considered calcium deficient. The body 
will signal for calcium release from the skeleton to maintain serum calcium levels, so 
these women may have been losing bone mass from calcium leeching and there was not 
enough in the diet to replace what was being released, leading to the bone loss observed. 
 
 
 
Interestingly, the QUS and the DXA tracked together, which has never previously been 
reported. The changes seen in the left femoral neck correspond to the changes in the left 
heel, which assists in validating the QUS’s ability to track bone health changes over time. 
The fact that both moved in a similar direction, as well as both right hip and right heel 
staying stable, may be important in future research to confirm or add more information to 
changes seen in the DXA alone. 
 
 
 
The lumbar spine did not behave in the same way as the femoral necks. Looking at raw 
BMD change in Table 50, none of the lumbar vertebrae experienced a BMD change 
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greater than 1%. There were also no main effects for time and any time*group 
interactions for the t- and z-scores of the lumbar vertebrae. Additionally, all effect sizes 
were very small (Table 51). For individual change at each of the lumbar vertebrae, each 
one responded differently. For L1, there was no clinically significant change for the 
intervention group, but the control group was much more metabolically active (Figure 
16). However, this could be a function of where they were in the remodeling cycle at the 
time of measurement, which could explain the gains observed. Any gains in the control 
group are being driven by the top two individuals, whereas the remainder of the change 
seen is within the range of error of the DXA. 
 
 
 
The opposite occurred for the L2 vertebrae (Figure 17). The control group was stable, 
whereas the intervention group experienced both significant gains and losses. Similar to 
the control group, this could be a function of where they were in the remodeling cycle at 
the time of measurements. L3 responded similarly, with the intervention group being 
much more metabolically active (Figure 18). L4 had large changes both positively and 
negatively for the intervention group while the control stayed stable (Figure 19). While 
such great losses appear to be concerning, they may actually be an artifact of the bone 
remodeling cycle. L4 experiences the most loading during activity, and is also typically 
the weakest when a person is sedentary, so it would be the vertebrae most likely to 
undergo remodeling (Martin & Seeman, 2008). 
 
 
 
All of the activities included in the intervention were standing, which would place a large 
load on the lumbar vertebrae in comparison to sitting or lying down. Like the hip, it is 
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expected that one vertebra would remodel during a turnover cycle. The body will only 
target one portion of one vertebral group at a time to help to maintain skeletal integrity 
along the spinal column (Jordan et al., 2000). Although there was such great variability in 
the L4 vertebra, no clinically significant change was detected during raw BMD change 
analysis. Looking at each individual change, it is because the entire group is not moving 
in a uniform direction. The majority of the individuals were experiencing greater than a 
1% change in their bone mass, but the opposite directions caused the average gross 
change to be less than 1%. 
 
 
 
Strengths. A major strength of this study is that skeletal health was assessed in a 
variety of ways. The combination of the DXA and the QUS serves to cross-validate the 
changes seen in both pieces of equipment, creating a more definite picture of the skeletal 
changes occurring over the course of the intervention. Another strength is that individual 
skeletal sites were analyzed, rather than the skeleton as a whole. Often in bone 
interventions, a total body t-score or BMD is used to assess skeletal health, which is not 
informative regarding specific sites of fracture. Having site-specific changes, especially 
at the femoral neck, is extremely important because hip fracture most often occurs at the 
neck (Christen et al., 2013). While total hip is more informative than total body, femoral 
neck is much more specific to fracture. For example, in this study, not change was 
detected when the total hip was analyzed, but assessment of the femoral neck alone 
detected a meaningful change that may have otherwise been missed. 
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Limitations. A limitation of this study is the short time-frame. Three months is 
the absolute minimum to detect change in bone health parameters using the DXA, so the 
pattern of BMD gain of loss may change over an extended timeframe. Because bone is 
influenced by a variety of factors, it is not possible to predict from the data available if 
bone would have continued to improve past the intervention period. While blood 
biomarkers provide some insight, which will be discussed later, it is unclear if the gains 
seen in the intervention group are the threshold, or if continued activity would produce 
greater bone deposition during a following turnover cycle. It is also not possible to 
predict if the right hip would ever remodel to the extent that the left did without directly 
tracking bone change with DXA. 
 
 
 
Future research. More research in this area is warranted, especially since such 
large gains in such a small timeframe have not been previously reported. A longer study 
period under the same conditions would help to answer questions about how bone will 
respond as the intervention continues. Especially in reference to the sites that appeared to 
be individually active, it is important to know if these large changes seen in individuals 
would lead to greater bone loss or gain over time. 
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SECONDARY HYPOTHESIS 3 
 
The results of this study support, in part, the hypothesis that 12-weeks of interactive play 
using the Wii Fit® will improve markers of bone turnover (increased osteocalcin) as 
compared to a control group. While the results were not statistically significant, likely 
due to a lack of power, there is a clear trend that emerges for both the group means and 
the individual responses. 
 
 
 
There is no clinical cutoff for osteocalcin to determine whether someone is healthy or at- 
risk for osteoporosis, but many studies have used osteocalcin as a means to track bone 
health in comparison to DXA. Generally, increases in osteocalcin tend to correlate well 
with improvements in BMD, as measured via DXA (Bharadwaj, Naidu, Betageri, 
Prasadarao, & Naidu, 2009). The results from this study did not wield statistically 
significant results for the change in osteocalcin (Table 54), but there is a clear trend to 
suggest that those in the intervention group had a greater improvement in bone formation 
over those in the control. 
 
 
 
Looking at the means across study visits (Table 53, Figure 20), the intervention group 
consistently increased while the control group remained somewhat static. In the 
individual change data, the trend is not as obvious when comparing week 6 to week 0 
(Figure 21) and week 12 to week 6 (Figure 22), but the overall change from week 0 to 
week 12 (Figure 23) showed a marked increase in the intervention over the control. This 
variability in the increase is to be expected based on the timing of the bone remodeling 
cycle. The remodeling cycle itself lasts 3-4 months, with bone resorption dominating 
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during the first 6-8 weeks (Frost, 1997). This explains why individual change is minimal 
when comparing week 6 to week 0, as at that point, the skeleton was likely undergoing 
bone resorption (Figure 21). The shift in cellular dominance is then more prominent as 
the intervention appears to be more metabolically active than the control from week 6 to 
week 12 (Figure 22). The fact that the intervention group is much more variable helps to 
justify the hypothesis from the DXA results that the intervention group was much more 
active overall in regards to bone turnover. 
 
 
 
These results also confirm what is seen in the femoral neck DXA results. While 
osteocalcin cannot be site-specific, as it indicates bone formation on a systemic level, it is 
expected that increases in osteocalcin should be seen in the group that is experiencing 
increases in bone mass. While the control group was also highly varied in the DXA 
results for some of the skeletal markers, many of the variations were within the range of 
error of the DXA equipment and were not clinically significant. Within that group, there 
were also a few women who did experience BMD gains and had some osteocalcin 
variability. 
 
 
 
Strengths. A major strength of this study is that the analysis of osteocalcin helps 
to support any changes seen in the DXA or QUS results. Without corresponding 
biomarker analysis, it would be difficult to definitively state that changes in bone mass 
were due to increased skeletal activity rather than issues with site alignment, technician 
error, or other sources or error associated with DXA analysis. Also, the use of three time 
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points  instead of the typical pre-post collection helps to determine how long an 
intervention would need to be to influence bone deposition following bone resorption. 
 
 
 
Limitations. A limitation of this study is the short time-frame. Osteocalcin 
appears to increase linearly, but without further time points, it is difficult to determine if 
the intervention group is at the end of bone formation, or if bone mass would continue to 
increase with time. Another limitation is the small sample size. Changes in osteocalcin 
levels were very small, so a larger sample size would have been necessary to detect any 
statistically significant changes, although there was a clear trend. Additionally, none of 
these women had osteocalcin levels that were abnormally low, which could indicate a 
metabolic disruption in bone formation, such as what happens in osteoporosis. It is 
difficult to say that such metabolic activity would be the same for women who may 
already be experiencing impaired bone metabolism as a result of age. There was also no 
analyzed marker of bone resorption to help determine skeletal metabolic activity, which 
could help to identify the location in the bone turnover cycle for each woman. 
 
 
 
Future research. Future research should focus on recruiting a more diverse study 
population over a longer period of time. The recruitment and inclusion of women with 
true osteoporosis would be more informative as to the utility of the Wii Fit® to prevent 
and treatment bone impairments during the aging process. A longer timeframe would also 
help to identify the extent to which bone mass can be improved or maintained following 
the initial improvements seen over a 12-week period. 
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CONCLUSION 
 
The Wii Fit® system does show some promise as a preventative tool for fall-risk, but 
more research needs to be done to determine any long-term benefits of using the system. 
Balance was improved in the most challenging foot position, which suggests that training 
on the gaming system may help to maintain or improve balance outcomes during the 
aging process. However, since none of the women enrolled in the study suffered from 
balance impairments, it is difficult to fully quantify the impact of the equipment on 
balance and center of pressure. More longitudinal research using the Wii Fit® is 
necessary to determine how it may function as a preventative therapy as individuals age, 
especially as usage and interest in engaging with the system may decrease with time. 
 
 
 
While muscular fitness was not improved, other research had indicated that similar 
interventions have been successful in improving peak torque of the knee flexors with less 
game time. With the raw data suggesting that the women participating in the study did 
not engage in the testing portion to their full potential, it is likely that the expected gains 
were lost. Like the balance portion, long-term studies are needed to determine if the Wii 
Fit can at least maintain muscular fitness with age, especially as participants begin to lose 
lean muscle mass and neuromuscular function. 
 
 
 
The most promise seems to be in the improvement of skeletal health. 12 weeks of game 
play resulted in unprecedented BMD gains that were supported by the results from all 
three measures (DXA, QUS, and osteocalcin). Because bone formation does not occur 
uniformly across contralateral skeletal sites (i.e., left and right femoral neck 
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simultaneously), future research is necessary to determine how skeletal remodeling 
occurs with continued engagement in the exercise program. Additionally, markers of 
bone resorption would help in further identifying the current stage of the bone 
remodeling cycle at each of the study visits. Such information could be informative 
regarding the bone turnover activity in the control group to see if the bone loss observed 
in that group could be a combination of muted bone formation in conjunction with 
increased bone resorption over time. 
 
 
 
While the Wii Fit® has been used extensively in older adults for the treatment of balance 
impairments, this study is the first of its kind to show that a 12 week intervention of an 
interactive gaming technology may be a valuable intervention for fall and fracture 
prevention as women age. This is especially relevant in regards to changes in bone health 
over time. The changes seen in this study exceed what is typically expected, and the 
values observed are similar across all the measures taken that assess bone health; this 
limits the possibility that what was observed occurred via change or problems with x-ray 
alignment. While changes in balance were minimal, the major health and financial risk 
from sustaining a fall is the fracture. If bone health was improved in such a short time 
frame, women may at least reduce their fracture risk even if the system was not able to 
improve actual fall risk. Overall this innovative technology holds great promise for 
improving bone health and decreasing fall risk in women as they age. 
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**Female Volunteers Needed for 
 
Wii Fit Study** 
 
Strength and Balance Study for Middle-aged Women 
 
 
 
The Exercise and Wellness Program is recruiting middle-aged women (45-60 y of 
age) who are willing to participate in a 12-week exercise study. 
 
Time Commitment: Three (3) study visits lasting approximately one hour each 
(in addition to weekly exercise time if assigned to the exercise group). The study 
visits involve the following measures at the Downtown Phoenix Campus: 
 
• Height/weight 
• Body fat % 
• Bone health 
• Balance 
• Strength 
• Short physical activity questionnaire 
• Blood draw 
 
 
 
Women between the ages of 45-60 who are not on any hormone replacement 
therapy or osteoporotic drugs, willing to volunteer their time, and willing to 
complete study procedures may be eligible to participate. 
 
For more information, please contact: 
 
Sarah Wherry  
swherry@asu.edu  
814-932-7481 
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IRB APPROVAL AND INFORMED CONSENT 
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EFFECT OF WII FIT INTERVENTION ON BALANCE IN MIDDLE-AGED 
WOMEN 
CONSENT FORM 
 
INTRODUCTION 
The purpose of this form is to provide you (as a prospective research study participant) 
information that may affect your decision as to whether or not to participate in this 
research and to record the consent of those who agree to be involved in the study. 
 
RESEARCHERS 
Dr. Pamela Swan, Associate Professor in the School of Nutrition and Health Promotion, 
and Sarah Wherry, Doctoral Student in the School of Nutrition and Health Promotion, 
have invited your participation in a research study. 
 
STUDY PURPOSE 
The purpose of the research is to evaluate changes in balance and muscular endurance in 
middle-aged  women  with  low  bone  mass  over  a  12-week  home-based  exercise 
intervention incorporating the Wii Fit balance games. 
 
DESCRIPTION OF RESEARCH STUDY 
If you decide to participate, then as a participant you will join a study involving research 
of the Wii Fit. Your total time commitment in the lab will include three (3) study visits 
(each lasting approximately one hour). Each study visit will involve completing 
questionnaires, testing your bone quality and quantity by taking an ultrasound of the heel 
of your foot and a DEXA scan of your hip and spine, measuring your balance, your lower 
limb muscular strength and a measure of your percent body fat. In addition, you will be 
asked to provide a small blood sample. Should you be assigned to the control group, your 
total time commitment will only involve the 3 study visits. Should you be assigned to the 
intervention group, you will be provided a WiiFit machine for your use and you will be 
expected to play the exercise games at home 30 minutes 3 days per week for a total of 90 
minutes/week. 
 
During the initial visit, you will complete a short physical activity questionnaire and have 
an ultrasound scan of the bone in your heel to determine bone health. If your heel scan 
shows that you have low bone mass (i.e., a t-score of less than 1), you will complete a 
DXA (dual energy xray absorptiometry) scan to confirm low bone density.  If the DXA 
also indicates that you have evidence of slightly low bone (i.e., a total hip and/or spine t- 
score of less than 0), then you will be randomly assigned to one of two groups. You will 
not have a choice of which group you will be assigned.  If you decide to continue in the 
study, then you will have your blood drawn to measure osteocalcin and C-telopeptide, 
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which are biochemical markers of bone turnover. Also, you will have your balance and 
muscular fitness assessed. Balance tests involve activities such as standing on one leg. 
Muscular fitness is assessed by getting up from a chair and with an automated machine 
that measures the strength of your legs as you extend or bend your knees. 
 
Should you be assigned to the intervention group, you will be provided a Wii Fit game 
console and balance board to be set up in your house. First we need to confirm that you 
have adequate space in your home and that you have a TV set that can be equipped to use 
the Wii system. One of the investigators will come to your house to help set the system 
up for you and make sure it works. Over the 12-week study, you will be asked to play 
exercise games on the Wii Fit system 3 times a week for 30 minutes each session. These 
games include strength, balance, and coordination movements. You will be given detailed 
instructions on which games to play and how to play them. In addition, you will be asked 
to keep a playing log recording the time at which you played and the duration. If you 
have any problems with using the Wii Fit system, an investigator will try to help you 
troubleshoot and/or come to your home and help you, should you need it. At the 
conclusion of the study, you will need to return the Wii Fit and balance board to the study 
personnel. 
 
Should you be assigned to the control group, DO NOT change your current physical 
activity habits. You will be asked to keep a physical activity journal recording any 
exercise you do. All participants will be contacted by study staff every 2 weeks via email 
or phone to complete the physical activity questionnaire and to track your progress. If at 
any time you encounter problems or issues, you will be provided a “HOT LINE” phone 
number where you can contact the study staff for assistance. 
 
RISKS 
Due to the DEXA scan, there is a small risk of radiation exposure. The DEXA scan will 
expose you to a small amount of radiation. We take all precautions to make this risk as 
minimal as possible. If you have not completed menopause, you will be asked to take a 
pregnancy test before your DXA scan as a precaution. 
 
The blood draw may cause some bruising or discomfort at the needle site as well as the 
risk of nausea or fainting. 
 
There are no risks associated with the ultrasound measurement. 
 
The risk of the exercise portion does not exceed those of daily living, such as muscle 
strain/pull or fatigue. However, there may be a chance of falling when using the Wii Fit 
system at home. In order to reduce this risk, follow all safety instructions provided by the 
research staff and in the Wii Fit manual that will be provided with the Wii Fit. If you fall 
and get injured, please contact your health care provider and contact the researchers after 
your visit with your physician. However, as with any research, there is some possibility 
that you may be subject to risks that have not yet been identified. 
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BENEFITS 
The  possible  benefit  of  your  participation  in  the  research  is  receiving  information 
regarding information about your balance and bone health. While the tools used cannot 
be used for diagnostic purposes, they may help you identify any weaknesses you have so 
that you can pursue further testing with your physician. 
 
NEW INFORMATION 
If the researchers find new information during the study that would reasonably change 
your decision about participating, then they will provide this information to you. 
 
CONFIDENTIALITY 
All information obtained in this study is strictly confidential unless disclosure is required 
by law. The results of this research study may be used in reports, presentations, and 
publications, but the researchers will not identify you.  In order to maintain 
confidentiality of your records, study personnel will provide you with a participant 
number that will be used on all documents. No research documents will ever include your 
name, and the key containing which name belongs to which number will be kept in a 
locked file that is only accessible to the study researchers. Additionally, all research 
documents containing your participant number (but not your name) will also be kept in a 
locked file accessible only to those conducting this study. 
 
WITHDRAWAL PRIVILEGE 
It is okay for you to say no. Even if you say yes now, you are free to say no later and 
withdraw from the study at any time. 
 
Your decision will not affect your relationship with Arizona State University or otherwise 
cause a loss of benefits to which you might otherwise be entitled. 
 
If you are a student or employee at Arizona State University, your participation is 
completely voluntary, and any decisions to withdraw will not impact your grade or 
employment status. 
 
COSTS AND PAYMENTS 
All parking costs will be covered, and you will receive $25 in cash should you complete 
the full 12-week study. In addition, if you complete the study, you will be entered into a 
drawing to win one of two (2) Wii Fit consoles and balance boards. One will be raffled to 
the intervention group, and the other to the control group. 
 
COMPENSATION FOR ILLNESS AND INJURY 
If you agree to participate in the study, then your consent does not waive any of your 
legal rights. However, no funds have been set aside to compensate you in the event of 
injury. 
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VOLUNTARY CONSENT 
Any questions you have concerning the research study or your participation in the study, 
before or after your consent, will be answered by Sarah Wherry at swherry@asu.edu or 
814-932-7481. 
If you have questions about your rights as a subject/participant in this research, or if you 
feel you have been placed at risk, you can contact the Chair of the Human Subjects 
Institutional Review Board, through the ASU Office of Research Integrity and 
Assurance, at 480-965-6788. 
 
This form explains the nature, demands, benefits and any risk of the project. By signing 
this form you agree knowingly to assume any risks involved. Remember, your 
participation is voluntary. You may choose not to participate or to withdraw your 
consent and discontinue participation at any time without penalty or loss of benefit. In 
signing this consent form, you are not waiving any legal claims, rights, or remedies. A 
copy of this consent form will be given (offered) to you. 
 
 
 
 
Your signature below indicates that you consent to participate in the above study. 
 
 
Subject's Signature                             Printed Name                                     Date 
 
 
 
 
INVESTIGATOR’S STATEMENT 
"I certify that  I have explained to the above individual the nature and purpose, the 
potential benefits and possible risks associated with participation in this research study, 
have answered any questions that have been raised, and have witnessed the above 
signature. These elements of Informed Consent conform to the Assurance given by 
Arizona State University to the Office for Human Research Protections to protect the 
rights of human subjects. I have provided (offered) the subject/participant a copy of this 
signed consent document." 
 
Signature of Investigator   Date  
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HEALTH HISTORY SCREENING QUESTIONNAIRES 
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Participant Number:   Date:   
Health History Questionnaire 
 
Wt. (lbs) Ht.(in) ___Birthdate mm/dd/year):   
 
Ethnic Background (circle): 
Caucasian African American Asian Hispanic Other 
 
Do you have any pre-existing conditions that would limit your ability to participant in an 
exercise program involving prolonged standing? (circle one) Yes No 
 
Have you begun menopause? (circle one) 
 
Yes 
 
No 
 
Have you lost height? (circle one) 
 
Yes 
 
No 
 
If so, by how many inches? (circle one)    
  
 
Are you a current smoker? (circle one) 
 
Yes 
 
No 
 
Are you on any hormone replacement therapy medications? 
 
Yes 
 
No 
 
If yes, which medications/therapies are you taking, and how long have you been taking 
them?    
 
Have you fractured your hip, back, shoulder, or wrist as an adult? Yes No 
If so, please describe how the fracture occurred (eg: fall, accident etc.) and at what age? 
 
Have either of your parents fractured a hip? (circle one) 
 
Yes 
 
No 
 
Do you have a family history of osteoporosis? (circle one) 
 
Yes 
 
No 
 
Have you had a bone density test before? (circle one) 
 
Yes 
 
No 
 
If yes, when did you have the bone density test?    
 
What was the result (circle one): Normal Osteopenia Osteoporosis 
Have you had any ankle/heel injuries, aside from mild sprains? (circle one)   Yes No 
If yes, what was the injury, and which foot was impacted?      
______________________________________________________________________ 
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APPENDIX D 
 
FOOD FREQUENCY QUESTIONNAIRE 
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APPENDIX E 
 
WOMEN’S HEALTH INITIATIVE PHYSICAL ACTIVITY QUESTIONNAIRE 
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The following questions are about your usual physical activity and exercise. This 
includes walking and sports. 
 
1. Think about the walking you do outside the home. How often do you walk outside the 
home for more than 10 minutes without stopping? (Mark only one.) 
 
• Rarely or never 
• 1-3 times each month 
• 1 time each week 
• 2-3 times each week 
• 4-6 times each week 
• 7 or more times each week 
 
1.1 When you walk outside the home for more than 10 minutes without stopping, for how 
many minutes do you usually walk? 
 
• Less than 20 min. 
• 20-39 min. 
• 40-59 min. 
• 1 hour or more 
 
1.2 What is your usual speed? 
 
• Casual strolling or walking (less than 2 miles an hour) 
• Average or normal (2-3 miles an hour) 
• Fairly fast (3-4 miles an hour) 
• Very fast (more than 4 miles an hour) 
• Don't know 
 
2.1 STRENUOUS OR VERY HARD EXERCISE (You work up a sweat and your heart 
beats fast.) For example, aerobics, aerobic dancing, jogging, tennis, swimming laps. 
 
• None 
• 2 days per week 
• 3 days per week 
• 4 days per week 
• 5 or more days per week 
 
2.2 How long do you usually exercise like this at one time? 
 
• Less than 20 min. 
• 20-39 min. 
• 40-59 min. 
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• 1 hour or more 
 
2.3 MODERATE EXERCISE (Not exhausting). For example, biking outdoors, using an 
exercise machine (like stationary bike or treadmill), calisthenics, easy swimming, popular 
or folk dancing. 
 
• None 
• 2 days per week 
• 3 days per week 
• 4 days per week 
• 5 or more days per week 
 
2.4 How long do you usually exercise like this at one time? 
 
• Less than 20 min. 
• 20-39 min. 
• 40-59 min. 
• 1 hour or more 
 
2.5 MILD EXERCISE. For example, slow dancing, bowling, golf 
 
• None 
• 2 days per week 
• 3 days per week 
• 4 days per week 
• 5 or more days per week 
 
2.6 How long do you usually exercise like this at one time? 
 
• Less than 20 min. 
• 20-39 min. 
• 40-59 min. 
• 1 hour or more 
 
3. I do activities to increase muscular strength, such as lifting weights or calisthenics, 
once a week or more. 
• No 
• Yes 
 
 
4. I do activities to increase flexibility, such as stretching or yoga, once a week or more. 
 
 
• No 
• Yes
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BLOOD BIOMARKER ELISA INSTRUCTIONS 
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Intact Human Osteocalcin EIA Kit 
 
About The Assay 
 
Osteocalcin (5800 daltons) is a specific product 
of the osteoblast. It is primarily deposited into 
the ECM of bone and only a small amount of 
newly synthesized osteocalcin is released 
directly into the circulation. Studies suggest that 
there are various forms of osteocalcin in the 
circulation and that different antibodies detect both intact and fragments of osteocalcin. 
The physiological significance of osteocalcin fragments is unclear but they may be 
derived from resorption, osteoblastic synthesis, systemic catabolism or all of these. Since 
serum proteases may also degrade the intact osteocalcin, it is recommended that blood 
samples be processed quickly in the presence of protease inhibitors. 
 
The BTI Intact Osteocalcin EIA measures only intact osteocalcin which is synthesized de 
novo by the osteoblast and it eliminates any interference by circulating fragments. The 
assay is a sandwich EIA which employs two monoclonal antibodies directed towards the 
amino-and the carboxy-terminal regions of the human osteocalcin. It recognizes only 
intact osteocalcin, requiring the full 49 residue protein for detection. This assay reacts 
with human, bovine, monkey and dog osteocalcin. 
 
The assay is highly sensitive (Range: 1-50ng/ml)  and requires only a 25ul sample. All 
the necessary reagents, a 96-well strip plate, and a complete 3½ hour protocol are 
included with the kit. 
 
 
 
 
Procedural Outline 
 
1. Add 25ul standard/sample. Add antibody and gently swirl.  Incubate 2½ hours at 
37oC. 
 
2. Aspirate and wash 3 times with wash buffer. 
 
3. Add Strep-Av-HRP, swirl, incubate ½ hour at room temperature. 
 
4. Repeat Step 2. Then add 100ul of substrate, swirl, develop 10 minutes in the dark. 
Add 100ul stop solution, swirl, measure absorbance at 450nm.
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BTI Intact Osteocalcin EIA Kit 
Catalog No:  BT-460 
(sufficient reagents and precoated 96-well strips) 
Quantity: 1 kit 
 
Specifications: 
Sample Size:  25ul 
Assay Time: 3.5 hours 
Sensitivity:  0.5 ng/ml 
Range: 1.0- 50 ng/ml 
Intraassay Variation: 7% 
Interassay Variation:  10.5% 
 
 
 
 
 
 
 
FOR RESEARCH USE ONLY. NOT FOR USE IN HUMANS OR AS AN IN-VITRO 
DIAGNOSTIC. 
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 APPENDIX G 
BALANCE SCALES (BERG AND FICSIT-4) 
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FICSIT-4 
(Frailty and Injuries: Cooperative Studies of Intervention Techniques) 
 
INSTRUCTIONS: Demonstrate each position to the subject, then ask them to perform and time. 
 
F-1. FEET CLOSELY TOGETHER, UNSUPPORTED, eyes open (ROMBERG POSITION) 
INSTRUCTIONS: Stand still with your feet together as demonstrated for 10 seconds. 
4 able to stand 10 seconds safely 
3 able to stand 10 seconds with supervision 
2 able to stand 3 seconds 
1 unable to stand 3 seconds but stays steady 
0 needs help to keep from falling 
If subject is able to do this, proceed to the next position, if not, stop. 
 
F-2. FEET CLOSELY TOGETHER, UNSUPPORTED, eyes closed (ROMBERG POSITION) 
INSTRUCTIONS: Please close your eyes and stand still with your feet together as demonstrated 
for 10 seconds. 
4 able to stand 10 seconds safely 
3 able to stand 10 seconds with supervision 
2 able to stand 3 seconds 
1 unable to keep eyes closed 3 seconds but stays steady 
0 needs help to keep from falling 
If subject is able to do this, proceed to the next position, if not, stop. 
 
 
 
F-3. SEMI-TANDEM: eyes open HEEL OF 1 FOOT PLACED TO THE SIDE OF THE 1ST 
TOE OF THE OPPOSITE FOOT (SUBJECT CHOOSES WHICH FOOT GOES FORWARD) 
INSTRUCTIONS: Please stand still with your feet together as demonstrated for 10 seconds. 
4 able to stand 10 seconds safely 
3 able to stand 10 seconds with supervision 
2 able to stand 3 seconds 
1 unable to stand 3 seconds but stays steady 
0 needs help to keep from falling 
If subject is able to do this, proceed to the next position, if not, stop. 
 
F-4. SEMI-TANDEM: eyes closed HEEL OF 1 FOOT PLACED TO THE SIDE OF THE 1ST 
TOE OF THE OPPOSITE FOOT (SUBJECT CHOOSES WHICH FOOT GOES FORWARD) 
INSTRUCTIONS: Please close your eyes and stand still with your feet together as demonstrated 
for 10 seconds. 
4 able to stand 10 seconds safely 
3 able to stand 10 seconds with supervision 
2 able to stand 3 seconds 
1 unable to keep eyes closed 3 seconds but stays steady 
0 needs help to keep from falling 
If subject is able to do this, proceed to the next position, if not, stop. 
187 
 
 
F-5. FULL TANDEM: eyes open HEEL OF 1 FOOT DIRECTLY IN FRONT OF THE OTHER 
FOOT (SUBJECT CHOOSES WHICH FOOT GOES FORWARD) 
INSTRUCTIONS: Please stand still with your feet together as demonstrated for 10 seconds. 
4 able to stand 10 seconds safely 
3 able to stand 10 seconds with supervision 
2 able to stand 3 seconds 
1 unable to stand 3 seconds but stays steady 
0 needs help to keep from falling 
If subject is able to do this, proceed to the next position, if not, stop. 
 
F-6. FULL TANDEM: eyes closed HEEL OF 1 FOOT DIRECTLY IN FRONT OF THE 
OTHER FOOT (SUBJECT CHOOSES WHICH FOOT GOES FORWARD) 
INSTRUCTIONS: Please stand still with your feet together as demonstrated for 10 seconds. 
4 able to stand 10 seconds safely 
3 able to stand 10 seconds with supervision 
2 able to stand 3 seconds 
1 unable to stand 3 seconds but stays steady 
0 needs help to keep from falling 
If subject is able to do this, proceed to the next position, if not, stop 
 
F-7. STANDING ON ONE LEG: eyes open 
INSTRUCTIONS: Stand on one leg as long as you can without holding. 
4 able to lift leg independently and hold >10 seconds 
3 able to lift leg independently and hold 5-10 seconds 
2 able to lift leg independently and hold = or >3 seconds 
1 tries to lift leg unable to hold 3 seconds but remains standing independently 
0 unable to try or needs assist to prevent fall 
 
Total FICSIT-4 Static Balance score = / 28 
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APPENDIX H 
WII FIT® EXERCISE LOG 
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 Wii Fit Study Exercise Log Participant: Date:   
 
 
 
Yoga 
Half-Moon □ Yes □ No 
Warrior □ Yes □ No 
Standing Knee □ Yes □ No 
 
Muscular Strength/Endurance 
Torso Twists □ Yes □ No 
Lunges □ Yes □ No 
 
Balance Games 
Tilt City □ Yes □ No 
Balance Bubble Plus □ Yes □ No 
Soccer Heading □ Yes □ No 
 
Additional Games 
Did you play any games not included above? □ Yes □ No 
Which ones? 
 
 
 
 
 
 
 
 
 
Comment
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APPENDIX I  
EXERCISE SCREENSHOTS
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 Balance Games: 
 
Tilt City/Table Tilt Balance Bubble 
 
 
Soccer Heading 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yoga Poses: 
 
Half-moon Standing Knee 
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Warrior 
 
 
 
 
 
 
 
 
Strength Training: 
 
Torso Twists Lunges 
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TABLE 13: BASELINE BALANCE PARAMETERS (FORCE PLATE) 
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Intervention  
(M ± SD) 
Control  
(M ± SD) 
p-value 
 
Open Base, Eyes Open             
 
Max Velocity X (mm/s) 3.96 ± 2.43 2.51 ± 0.70 0.102 
 
Max Velocity Y (mm/s) -3.34 ± 1.49 -3.43 ± 1.90 0.910 
 
Average Velocity (mm/s) 0.83 ± 0.21 0.88 ± 0.22 0.61 
 
Major Axis (mm
2
) 1.37 ± 0.56 1.25 ± 0.39 0.602 
 
Area Effective (mm
2
) 1.30 ± 0.94 0.99 ± 0.57 0.418 
 
Area 95 (mm
2
) 2.44 ± 1.43 1.77 ± 0.92 0.251 
Closed Base, Eyes Open             
 
Max Velocity X (mm/s) 4.42 ± 2.14 4.44 ± 3.02 0.987 
 
Max Velocity Y (mm/s) -4.17 ± 1.66 -3.84 ± 1.13 0.619 
 
Average Velocity (mm/s) 1.48 ± 0.40 1.55 ± 0.54 0.721 
 
Major Axis (mm
2
) 1.26 ± 0.54 1.11 ± 0.36 0.492 
 
Area Effective (mm
2
) 1.34 ± 0.99 0.98 ± 0.57 0.373 
 
Area 95 (mm
2
) 3.25 ± 1.66 2.61 ± 1.33 0.365 
Closed Base, Eyes Closed             
 
Max Velocity X (mm/s) 8.06 ± 4.79 6.12 ± 2.65 0.294 
 
Max Velocity Y (mm/s) -7.72 ± 5.83 -6.15 ± 2.16 0.457 
 
Average Velocity (mm/s) 2.66 ± 1.16 2.03 ± 0.33 0.135 
 
Major Axis (mm
2
) 1.66 ± 0.51 1.36 ± 0.41 0.210 
 
Area Effective (mm
2
) 2.35 ± 1.27 1.48 ± 0.91 0.118 
 
Area 95 (mm
2
) 5.02 ± 2.14 1.36 ± 0.41 0.376 
Semi-Tandem, Eyes Open             
 
Max Velocity X (mm/s) 5.42 ± 1.64 32.83 ± 81.8 0.259 
 
Max Velocity Y (mm/s) -5.32 ± 1.36 -17.37 ± 34.88 0.289 
 
Average Velocity (mm/s) 2.06 ± 0.37 3.72 ± 5.09 0.317 
 
Major Axis (mm
2
) 1.36 ± 0.29 2.52 ± 3.24 0.275 
 
Area Effective (mm
2
) 1.44 ± 0.51 9.14 ± 22.75 0.299 
  Area 95 (mm
2
) 3.87 ± 1.18 15.53 ± 35.38 0.311 
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Intervention  
(M ± SD) 
Control  
(M ± SD) 
p-value 
 
Semi-Tandem, Eyes Closed             
 
Max Velocity X (mm/s) 12.60 ± 4.46 38.50 ± 85.07 0.347 
 
Max Velocity Y (mm/s) -12.21 ± 5.05 -20.20 ± 36.45 0.500 
 
Average Velocity (mm/s) 3.83 ± 1.21 4.55 ± 5.21 0.673 
 
Major Axis (mm
2
) 2.29 ± 1.05 2.98 ± 3.33 0.546 
 
Area Effective (mm
2
) 4.35 ± 3.51 10.92 ± 23.84 0.399 
 
Area 95 (mm
2
) 10.79 ± 7.28 19.31 ± 36.76 0.482 
Tandem, Eyes Open             
  Max Velocity X (mm/s) 12.99 ± 6.25 18.87 ± 15.70 0.317 
  Max Velocity Y (mm/s) -12.17 ± 6.25 -19.17 ± 19.73 0.304 
  Average Velocity (mm/s) 4.12 ± 1.21 4.92 ± 2.48 0.377 
  Major Axis (mm
2
) 1.79 ± 0.66 3.60 ± 4.00 0.217 
  Area Effective (mm
2
) 2.56 ± 1.42 16.18 ± 32.19 0.240 
  Area 95 (mm
2
) 6.53 ± 3.44 30.46 ± 57.03 0.244 
Tandem, Eyes Closed             
  Max Velocity X (mm/s) 20.84 ± 7.04 9.60 ± 11.57 0.383 
  Max Velocity Y (mm/s) -19.67 ± 6.45 -8.15 ± 9.84 0.321 
  Average Velocity (mm/s) 6.31 ± 1.33 2.64 ± 2.64 0.281 
  Major Axis (mm
2
) 2.68 ± 0.824 1.73 ± 1.25 0.248 
  Area Effective (mm
2
) 5.49 ± 2.63 2.55 ± 3.02 0.230 
  Area 95 (mm
2
) 14.34 ± 6.77 6.31 ± 7.96 0.209 
Single Leg, Eyes Open             
  Max Velocity X (mm/s) 16.53 ± 8.96 18.14 ± 8.05 0.737 
  Max Velocity Y (mm/s) -18.44 ± 10.47 -14.21 ± 7.55 0.416 
  Average Velocity (mm/s) 6.00 ± 2.99 5.13 ± 2.31 0.567 
  Major Axis (mm
2
) 2.01 ± 1.22 1.74 ± 0.53 0.604 
  Area Effective (mm
2
) 3.84 ± 4.32 2.68 ± 1.56 0.521 
  Area 95 (mm
2
) 10.21 ± 10.81 7.64 ± 4.69 0.580 
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Intervention  
(M ± SD) 
Control  
(M ± SD) 
p-value 
 
Open Base, Eyes Closed             
  Max Velocity X (mm/s) 5.79 ± 9.01 2.02 ± 0.81 0.228 
  Max Velocity Y (mm/s) -4.43 ± 6.47 -1.94 ± 0.54 0.267 
  Average Velocity (mm/s) 2.82 ± 4.73 1.13 ± 0.23 0.298 
  Major Axis (mm
2
) 1.73 ± 1.62 1.02 ± 0.24 0.215 
  Area Effective (mm
2
) 3.95± 8.89 0.65 ± 0.26 0.280 
  Area 95 (mm
2
) 10.52 ± 25.61 1.14 ± 0.53 0.335 
Berg Tandem, Eyes Open             
  Max Velocity X (mm/s) 14.15 ± 3.06 20.64 ± 10.38 0.155 
  Max Velocity Y (mm/s) -13.17 ± 2.38 -21.95 ± 15.10 0.176 
  Average Velocity (mm/s) 3.74 ± 0.80 4.50 ± 1.65 0.241 
  Major Axis (mm
2
) 1.87 ± 0.29 2.41 ± 0.86 0.156 
  Area Effective (mm
2
) 2.79 ± 0.81 4.63 ± 3.07 0.170 
  Area 95 (mm
2
) 7.83 ± 2.29 11.79 ± 7.42 0.215 
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SCREENSHOTS OF ELECTRONIC RECORD
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Welcome Screen: 
 
 
 
 
 
 
Time Log: 
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